<SEC-DOCUMENT>0001493152-25-015997.txt : 20250929
<SEC-HEADER>0001493152-25-015997.hdr.sgml : 20250929
<ACCEPTANCE-DATETIME>20250929160537
ACCESSION NUMBER:		0001493152-25-015997
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250929
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250929
DATE AS OF CHANGE:		20250929

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SONIM TECHNOLOGIES INC
		CENTRAL INDEX KEY:			0001178697
		STANDARD INDUSTRIAL CLASSIFICATION:	TELEPHONE & TELEGRAPH APPARATUS [3661]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				943336783
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38907
		FILM NUMBER:		251356061

	BUSINESS ADDRESS:	
		STREET 1:		4445 EASTGATE MALL
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		650-378-8100

	MAIL ADDRESS:	
		STREET 1:		4445 EASTGATE MALL
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:SONM="http://sonimtech.com/20250929">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_SONM_sonimtech.com_20250929 -->
<!-- Field: Set; Name: xdx; ID: xdx_043_20250929_20250929 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0001178697 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000004" name="dei:EntityCentralIndexKey">0001178697</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="sonm-20250929.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-09-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-29</xbrli:startDate>
        <xbrli:endDate>2025-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_903_edei--DocumentType_c20250929__20250929_zaydcTYRAfI"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 OR 15(d)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
The Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported) <b><span id="xdx_90D_edei--DocumentPeriodEndDate_c20250929__20250929_z4oo5mf6mzol"><ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">September 29, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_906_edei--EntityRegistrantName_c20250929__20250929_zF6ZYX586qBd"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000011" name="dei:EntityRegistrantName">Sonim
Technologies, Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20250929__20250929_zfnWN2Gmsmb7"><ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityFileNumber_c20250929__20250929_zOO9N6jLCgCg"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000013" name="dei:EntityFileNumber">001-38907</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20250929__20250929_z4bJ3oBXwKM4"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000014" name="dei:EntityTaxIdentificationNumber">94-3336783</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20250929__20250929_zAccSPWoB0K2"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000015" name="dei:EntityAddressAddressLine1">4445
Eastgate Mall</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressAddressLine2_c20250929__20250929_zqRCTOBbbS8g"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 200</ix:nonNumeric></span>,</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressCityOrTown_c20250929__20250929_zmYUucXLme7b"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000017" name="dei:EntityAddressCityOrTown">San
Diego</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20250929__20250929_z6TLzIU3o0k"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000018" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> <span id="xdx_905_edei--EntityAddressPostalZipCode_c20250929__20250929_zR5FSeEuFJYa"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000019" name="dei:EntityAddressPostalZipCode">92121</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices, including Zip Code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--CityAreaCode_c20250929__20250929_zHkDSfgnyb4g"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000020" name="dei:CityAreaCode">(650)</ix:nonNumeric></span>
<span id="xdx_90D_edei--LocalPhoneNumber_c20250929__20250929_zlVhvg6lR9Ab"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000021" name="dei:LocalPhoneNumber">378-8100</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityInformationFormerLegalOrRegisteredName_c20250929__20250929_z976LJGhGxR7"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000022" name="dei:EntityInformationFormerLegalOrRegisteredName">Not
applicable.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report.)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--WrittenCommunications_c20250929__20250929_zDgL0SXNdCWi"><ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt:booleanfalse" id="Fact000023" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--SolicitingMaterial_c20250929__20250929_z0g4VTEgnpia"><ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt:booleanfalse" id="Fact000024" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementTenderOffer_c20250929__20250929_zVoTax9bEpgf"><ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20250929__20250929_zGNY7GAnaZq1"><ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each Class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 42%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--Security12bTitle_c20250929__20250929_zpKv5B19Sgsa"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000027" name="dei:Security12bTitle">Common
    Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--TradingSymbol_c20250929__20250929_zpvCI5tTpqE9"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000028" name="dei:TradingSymbol">SONM</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--SecurityExchangeName_c20250929__20250929_z6qy0vuTVds6"><ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">The
                                            Nasdaq Stock Market LLC</ix:nonNumeric></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Nasdaq
    Capital Market)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20250929__20250929_zSjDVIDr3qQ6"><ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01. Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 29, 2025, Sonim Technologies, Inc. (the &#8220;Company&#8221;) entered into a ChEF purchase agreement
(the &#8220;Purchase Agreement&#8221;) and registration rights agreement (the &#8220;Registration Rights Agreement&#8221;), each with
Chardan Capital Markets LLC (&#8220;Chardan&#8221;) related to a &#8220;ChEF,&#8221; Chardan&#8217;s committed equity facility (the &#8220;Facility&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Purchase Agreement, the Company has the right from time to time at its option to sell to Chardan up to the lesser of (i) $500,000,000
in aggregate gross purchase price of newly issued shares of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common
Stock&#8221;), and (ii) the Exchange Cap (as defined below), subject to certain conditions and limitations set forth in the Purchase
Agreement. The Company is under no obligation to sell any securities to Chardan under the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Facility</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
there are distinct differences, the Facility is structured similarly to a traditional &#8220;at-the-market&#8221; equity facility, insofar
as it allows the Company to raise primary equity capital on a periodic basis outside the context of a traditional underwritten follow-on
offering. From and after the Commencement (as defined below), sales of Common Stock to Chardan under the Purchase Agreement, and the
timing of any sales, will be determined by the Company from time to time in its sole discretion and will depend on a variety of factors
including, among other things, market conditions, the trading price of the Common Stock and determinations by the Company regarding the
use of proceeds of such Common Stock. The net proceeds from any sales under the Purchase Agreement will depend on the frequency with,
and prices at, which the shares of Common Stock are sold to Chardan. If and when the Company becomes eligible for use of a Registration
Statement on Form S-3 without limitations on the amount of securities that may be sold under such Registration Statement on Form S-3
pursuant General Instruction I.B.6., the Company and Chardan agreed to enter into an equity distribution or sales agreement providing
for &#8220;at-the-market&#8221; sales of Common Stock through Chardan (or its designee) as the Company&#8217;s sole placement agent on
customary terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mechanics
of Sales under the Facility</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the satisfaction of the conditions to Chardan&#8217;s purchase obligation set forth in the Purchase Agreement (the &#8220;Commencement&#8221;
and the date of initial satisfaction of all of such conditions, the &#8220;Commencement Date&#8221;), including that a registration statement
registering the resale by Chardan of shares of Common Stock issued to it by the Company under the Purchase Agreement (the &#8220;Initial
Resale Registration Statement&#8221;) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), which the Company
agreed to file with the Securities and Exchange Commission (the &#8220;SEC&#8221;) pursuant to the Registration Rights Agreement, is
declared effective by the SEC (the date of such effectiveness, the &#8220;Effective Date&#8221;) and a final prospectus relating thereto
is filed with the SEC, the Company will have the right, but not the obligation, from time to time at the Company&#8217;s sole discretion
over the term of the Purchase Agreement, to direct Chardan to purchase up to an amount of shares of Common Stock (the &#8220;VWAP Purchase
Share Amount&#8221;) not to exceed certain limitations set forth in the Purchase Agreement (each, a &#8220;VWAP Purchase&#8221;) by delivering
a written notice (a &#8220;VWAP Purchase Notice&#8221;) to Chardan after 6:00 a.m., New York City time, but prior to 9:00 a.m., New York
City time on any trading day (the &#8220;Purchase Date&#8221;), so long as all shares of Common Stock subject to all prior VWAP Purchases
and Intraday VWAP Purchases (as defined below) theretofore required to have been received by Chardan have been received by Chardan in
accordance with the Purchase Agreement and certain other conditions have been satisfied. The purchase price of the shares of Common Stock
that the Company elects to sell to Chardan pursuant to the Purchase Agreement will be determined by reference to the volume weighted
average price of the Common Stock (&#8220;VWAP&#8221;) during the applicable Purchase Date on which the Company has timely delivered
a VWAP Purchase Notice (and/or Intraday VWAP Purchase Notice (as defined below), as applicable), less a fixed 3.5% discount to such VWAP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the regular VWAP Purchases described above, after the Commencement, the Company will also have the right, but not the obligation,
subject to the continued satisfaction of the conditions set forth in the Purchase Agreement, from time to time at the Company&#8217;s
sole discretion over the 36-month period from and after the Effective Date, to offer to Chardan the right to or, in certain circumstances,
to direct Chardan, to purchase, on any trading day, including the same Purchase Date on which a regular VWAP Purchase is effected, up
to an amount of shares of Common Stock (the &#8220;Intraday VWAP Purchase Share Amount&#8221;) not to exceed certain limitations set
forth in the Purchase Agreement that are similar to those that apply to a regular VWAP Purchase (each, an &#8220;Intraday VWAP Purchase&#8221;),
by delivering a written notice (each, an &#8220;Intraday VWAP Purchase Notice&#8221;) to Chardan prior to 3:00 p.m., New York City time,
on such Purchase Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement provides that the number of shares of Common Stock issuable pursuant to any VWAP Purchase Notice (and, if applicable,
the number of shares of Common Stock issuable pursuant to any Intraday VWAP Purchase Notice delivered on the same Purchase Date that
such VWAP Purchase Notice is delivered) shall not, without Chardan&#8217;s express written agreement exceed the lesser of: (i) the number
of shares of Common Stock which, when aggregated with all other shares of Common Stock then beneficially owned by Chardan and its affiliates,
would exceed the Beneficial Ownership Limitation (as defined below), (ii) the number of shares of Common Stock which would cause the
total aggregate purchase price to be paid by Chardan in any VWAP Purchase together with, if applicable, all Intraday VWAP Purchases,
made on one Purchase Date, to exceed $1.0 million, (iii) the number of shares of Common Stock that equals 20% of the total number (or
volume) of shares of Common Stock traded on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) (or a successor Principal Market (as defined
in the Purchase Agreement)) during the applicable purchase period on such Purchase Date, and (iv) the VWAP Purchase Share Amount (for
a VWAP Purchase) or the Intraday VWAP Purchase Share Amount (for an Intraday VWAP Purchase).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the applicable rules and regulations of Nasdaq, in no event may the Company issue to Chardan under the Purchase Agreement more than 2,066,747
shares of Common Stock, which number of shares is equal to 19.99% of the shares of the Common Stock outstanding immediately prior to
the execution of the Purchase Agreement (the &#8220;Exchange Cap&#8221;), unless the Company&#8217;s stockholders have approved the issuance
of Common Stock pursuant to the Purchase Agreement in excess of the Exchange Cap in accordance with the applicable rules and regulations
of Nasdaq or such approval is not required in accordance with the applicable rules and regulations of Nasdaq or otherwise because the average price of all applicable sales of our Common Stock to Chardan pursuant to the Purchase Agreement
equals or exceeds $0.6277 per share, which represents the &#8220;Nasdaq Minimum Price&#8221; as of the date of the execution of the Purchase
Agreement. The
Exchange Cap is not applicable to issuances and sales of Common Stock pursuant to VWAP Purchases and Intraday VWAP Purchases that the
Company may effect pursuant to the Purchase Agreement to the extent such shares of Common Stock are sold in such VWAP Purchases or Intraday
VWAP Purchases (as applicable) at a price equal to or in excess of the applicable &#8220;minimum price&#8221; (as defined in Nasdaq Listing
Rule 5635(d)) of the Common Stock, calculated at the time such VWAP Purchases or Intraday VWAP Purchases (as applicable) are effected
by the Company under the Purchase Agreement, if any, as adjusted as necessary for compliance with the rules of Nasdaq to take into account
certain legal fees and expenses payable and/or reimbursable by the Company to Chardan. Moreover, the Company may not issue or sell any
shares of Common Stock to Chardan under the Purchase Agreement which, when aggregated with all other shares of Common Stock then beneficially
owned by Chardan and its affiliates (as calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended (the
&#8220;Exchange Act&#8221;), and Rule 13d-3 promulgated thereunder), would result in Chardan beneficially owning more than 4.99% of the
outstanding shares of Common Stock (the &#8220;Beneficial Ownership Limitation&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Terms and Conditions of the Purchase Agreement and Registration Rights Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no restrictions on future financings, and no rights of first refusal, participation rights, penalties, or liquidated damages in the
Purchase Agreement or Registration Rights Agreement, as applicable, other than a prohibition on entering (with certain limited exceptions)
into a Specified Transaction (as defined in the Purchase Agreement), as further described in the Purchase Agreement. At no time prior
to the date of the Purchase Agreement has Chardan engaged in or effected, in any manner whatsoever, directly or indirectly for its own
principal account, any (i) &#8220;short sale&#8221; (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of the
Common Stock or (ii) hedging transaction, which establishes a net short position with respect to the Common Stock that remains in effect
as of the date of the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Purchase Agreement and the Registration Rights Agreement contains customary representations, warranties, conditions and indemnification
obligations of the parties. The representations, warranties, and covenants contained in such agreements were made only for purposes of
such agreements and as of specific dates, were solely for the benefit of the parties to such agreements, and may be subject to limitations
agreed upon by the contracting parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement will automatically terminate on the earliest to occur of (i) the 36-month anniversary of the Effective Date of the
Initial Resale Registration Statement (such term being subject to extension by the parties to the Purchase Agreement), (ii) the date
on which Chardan shall have purchased $500,000,000 of shares of Common Stock pursuant to the Purchase Agreement, (iii) the date on which
the Common Stock shall have failed to be listed or quoted on Nasdaq or a successor Principal Market, and (iv) the commencement of certain
bankruptcy proceedings or similar transactions with respect to the Company or all or substantially all of its property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the right to terminate the Purchase Agreement at any time after Commencement, at no cost or penalty, upon ten (10) trading
days&#8217; prior written notice to Chardan. Chardan also has the right to terminate the Purchase Agreement upon ten (10) trading days&#8217;
prior written notice to the Company, but only upon the occurrence of certain customary events as listed in the Purchase Agreement. Neither
the Company nor Chardan may assign or transfer its rights and obligations under the Purchase Agreement or the Registration Rights Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will also reimburse Chardan up to $125,000 for fees and disbursements of Chardan&#8217;s legal counsel in connection with the
entry into the transaction documents and the review of the Initial Resale Registration Statement and additional fees and disbursements
of Chardan&#8217;s legal counsel not to exceed $25,000 for each fiscal quarter, in connection with Chardan&#8217;s ongoing due diligence
and review of any registration statements and deliverables pursuant to the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing descriptions of the Purchase Agreement and the Registration Rights Agreement do not purport to be complete and are qualified
in their entirety by reference to, and incorporate herein by reference, the full text of the Purchase Agreement and the Registration
Rights Agreement, which are filed herewith as Exhibit 10.1 and Exhibit 10.2, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there
be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state or other jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use
of Proceeds</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expects to use a minimum of thirty-three percent (33%) of proceeds from any sales under the Purchase Agreement for pre-payment
of the promissory note in the original principal amount of $2,755,000 issued by the Company to Streeterville Capital, LLC on July 11,
2025, pursuant to a note purchase agreement, until and unless such note is repaid. The Company intends to use any remaining proceeds
for operations, to support the overall business strategy, for working capital, and general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    9.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
Statements and Exhibits. </b></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">Exhibits.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br/>
    Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">ChEF Purchase Agreement, dated as of September 29, 2025, by and between Sonim Technologies, Inc. and Chardan Capital Markets LLC.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-2.htm">Registration Rights Agreement dated as of September 29, 2025, by and between Sonim Technologies, Inc. and Chardan Capital Markets LLC.</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SONIM
    TECHNOLOGIES, INC.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    September 29, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Clay Crolius</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clay
    Crolius</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LXMrqLg7HTrEKTJEvK0uk+LWjLT+PZJvad0QQyAk53wnQgxERktdI8NxXuSwx6atlUMosEJGc0bvSFfrBPws8KKtY2Vct/7AlDyDnhmH8uTvnfOuLZYJRNOhnAzlCOIoiSXMNiL46imZSpdonFY1KFPCjqlljU7xq0/YqycZal7dpwOy1WQSiMOol98gI5+3pbt6EF8t5HkqgkFXgciYbq13LZ4OzZeERY2Nf2d7+t/BB8T6SlA= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ChEF PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This <B>ChEF PURCHASE AGREEMENT</B>
is made and entered into as of September 29, 2025 (together with <U>Annex I</U>, this &ldquo;<B><I>Agreement</I></B>&rdquo;), by and between
Chardan Capital Markets LLC, a New York limited liability company (the &ldquo;<B><I>Investor</I></B>&rdquo;), and Sonim Technologies,
Inc., a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the parties desire
that, upon the terms and subject to the conditions and limitations of this Agreement, the Company may issue and sell to the Investor,
from time to time as provided herein, and the Investor shall purchase from the Company, up to the lesser of (i) $500,000,000 (the &ldquo;<B><I>Total
Commitment</I></B>&rdquo;) in aggregate gross purchase price of newly issued shares (the &ldquo;<B><I>Shares</I></B>&rdquo;) of the Company&rsquo;s
common stock, par value $0.001 per share (the &ldquo;<B><I>Common Stock</I></B>&rdquo;), and (ii) the Exchange Cap (to the extent applicable
under <U>Section 3.3</U>);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, such sales of
Common Stock by the Company to the Investor will be made in reliance upon the provisions of Section 4(a)(2) of the Securities Act (&ldquo;<B><I>Section
4(a)(2)</I></B>&rdquo;), Rule 506(b) of Regulation D promulgated by the Commission under the Securities Act (&ldquo;<B><I>Regulation D</I></B>&rdquo;),
and/or upon such other exemption from the registration requirements of the Securities Act as may be available with respect to any or all
of the issuances and sales of Common Stock by the Company to the Investor to be made hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS, </B>the parties hereto
are concurrently entering into a Registration Rights Agreement in the form attached as <U>Exhibit A</U> hereto (together with its exhibits,
the &ldquo;<B><I>Registration Rights Agreement</I></B>&rdquo;), pursuant to which the Company shall register the resale of the Registrable
Securities (as defined in the Registration Rights Agreement), upon the terms and subject to the conditions set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in consideration
of the representations, warranties, covenants and agreements contained herein and for other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, intending to be legally bound hereby, the Company and the Investor, hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
I&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>DEFINITIONS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Capitalized terms used in this
Agreement shall have the meanings ascribed to such terms in <U>Annex I</U> hereto, which is hereby made a part hereof, or as otherwise
set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
II&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>PURCHASE
AND SALE OF COMMON STOCK</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Section 2.1. <B><U>Purchase and
Sale of Stock</U></B>. Upon the terms and subject to the conditions and limitations of this Agreement, during the Investment Period, the
Company, in its sole discretion, shall have the right, but not the obligation, to issue and sell to the Investor, and, in such event,
the Investor shall purchase from the Company, up to the lesser of (i) the Total Commitment in aggregate gross purchase price of duly authorized,
validly issued, fully paid and non-assessable shares of Common Stock and (ii) the Exchange Cap, to the extent applicable under <U>Section
3.3</U> (such lesser number of shares of Common Stock, the &ldquo;<B><I>Aggregate Limit</I></B>&rdquo;), by the delivery to the Investor
of VWAP Purchase Notices or Intraday VWAP Purchase Notices as provided in <U>Article III</U>, <U>provided</U> that all of the conditions
precedent in <U>Article VII</U> shall have been fulfilled at the applicable times set forth in Article VII. For the avoidance of doubt,
the Investor shall have no obligation to purchase any Shares unless and until a VWAP Purchase Notice or Intraday VWAP Purchase Notices
is received and accepted by the Investor in accordance with the terms, and subject to the conditions and limitations, of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Section 2.2. <B><U>Closing Date;
Settlement Dates</U></B>. This Agreement shall become effective and binding (the &ldquo;<B><I>Closing</I></B>&rdquo;) upon the delivery
of counterpart signature pages of this Agreement and the Registration Rights Agreement executed by each of the parties hereto and thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Section 2.3. <B><U>Initial Public
Announcements and Required Filings</U></B>. The Company shall, not later than 8:30 a.m. (New York City time) on the first business day
after the date of this Agreement, file with the Commission a Current Report on Form 8-K disclosing the execution of this Agreement and
the Registration Rights Agreement by the Company and the Investor and describing the material terms thereof and attaching as exhibits
thereto copies of each of this Agreement and the Registration Rights Agreement and if applicable, any press release issued by the Company
disclosing the execution of this Agreement and the Registration Rights Agreement (including all exhibits thereto, the &ldquo;<B><I>Current
Report</I></B>&rdquo;). The Company shall provide the Investor and its legal counsel a reasonable opportunity to comment on a draft of
the Current Report prior to filing the Current Report with the Commission and shall give due consideration to all such comments. From
and after the filing of the Current Report with the Commission, the Company shall have publicly disclosed all material, nonpublic information
delivered to the Investor (or the Investor&rsquo;s representatives or agents) by the Company or any of its Subsidiaries, or any of their
respective officers, directors, employees, agents or representatives (if any) in connection with the transactions contemplated by the
Transaction Documents. During the term of this Agreement, the Company shall ensure that its public disclosures are updated within four
(4) Business Days of any material event. The Company shall use its best efforts to prepare and, within ten (10) business days following
the execution of this Agreement, file with the Commission the Initial Registration Statement covering only the resale by the Investor
of the Registrable Securities in accordance with the Securities Act and the Registration Rights Agreement. At or before 8:30 a.m. (New
York City time) on the second Trading Day immediately following the Effective Date of the Initial Registration Statement and any New Registration
Statement (or any post-effective amendment thereto), the Company shall use its best efforts to file with the Commission in accordance
with Rule 424(b) under the Securities Act the final Prospectus to be used in connection with sales pursuant to such Registration Statement
(or post-effective amendment thereto).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
III&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>PURCHASE
TERMS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Subject to the satisfaction of
the conditions set forth in <U>Article VII</U>, the parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 3.1. <U>VWAP Purchases</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) <B><U>Irrevocable Instructions</U></B>.
On the Effective Date of the Initial Registration Statement and prior to Commencement, the Company shall deliver or cause to be delivered
to its Transfer Agent (and thereafter, shall deliver or cause to be delivered to any subsequent transfer agent of the Company), irrevocable
instructions executed by the Company and acknowledged in writing by the Company&rsquo;s Transfer Agent (the &ldquo;<B><I>Commencement
Irrevocable Transfer Agent Instructions</I></B>&rdquo;) directing the Transfer Agent to issue in the Investor&rsquo;s name in a DRS account
or accounts at the Transfer Agent all Shares purchased by Investor, if and when, and in the manner in which, such Shares are purchased
in accordance with this Agreement, including <U>Section 3.1(b)</U> below. Upon issuance pursuant to this Agreement, the Shares purchased
by Investor in accordance with this Agreement shall constitute &ldquo;restricted securities&rdquo; as such term is defined in Rule 144(a)(3)
under the Securities Act and the certificate or book-entry statement representing such Shares shall bear the restrictive legend set forth
below in <U>Section 10.1(ii)</U>. At the time that the Company delivers the Commencement Irrevocable Transfer Agent Instructions to the
Transfer Agent, the Company shall use its commercially reasonable efforts to cause its legal counsel to deliver to the Transfer Agent
a legal opinion or other letter authorizing the Transfer Agent to remove the Securities Act restrictive legends required by <U>Section
10.1(ii)</U> on the Shares that have been resold by the Investor in a manner described under the caption &ldquo;Plan of Distribution&rdquo;
in the Registration Statement and otherwise in compliance with <U>Section 4.11</U> of this Agreement when the Transfer Agent receives
from the Investor the Transfer Agent Deliverables with respect to such resold Shares in accordance with this <U>Section 3.1</U>. The Company
shall be responsible for the fees of its Transfer Agent and its legal counsel associated with any such legend removals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) <B><U>Purchase Notices</U></B>.
Upon the initial satisfaction of all of the conditions set forth in <U>Section 7.2</U> (the &ldquo;<B><I>Commencement</I></B>&rdquo; and
the date of initial satisfaction of all of such conditions, the &ldquo;<B><I>Commencement Date</I></B>&rdquo;) and from time to time thereafter,
subject to the satisfaction of all of the conditions set forth in <U>Section 7.3</U>, the Company shall have the right, but not the obligation,
to direct the Investor, by its timely delivery to the Investor of a VWAP Purchase Notice (with a copy to the Transfer Agent), in substantially
the form attached hereto as <U>Exhibit D</U>, after 6:00 a.m., New York City time, but prior to 9:00 a.m., New York City time, on a VWAP
Purchase Date, to purchase the applicable VWAP Purchase Share Amount, at the applicable VWAP Purchase Price therefor on such VWAP Purchase
Date in accordance with this Agreement (each such purchase, a &ldquo;<B><I>VWAP Purchase</I></B>&rdquo;); provided, that, (i) for the
first VWAP Purchase Notice and (ii) in the event that no VWAP Purchase Notice has been delivered for a period of fourteen (14) consecutive
calendar days, such VWAP Purchase Notices shall be delivered by the Company no later than forty-eight 48 hours prior to the VWAP Purchase
Date for such VWAP Purchase Notice. If the Company timely delivers a VWAP Purchase Notice to the Investor in accordance with the foregoing
sentence and such VWAP Purchase Notice specifies a Target Number, then the Company shall have the right, but not the obligation, to direct
the Investor, by its timely delivery to the Investor of an Intraday VWAP Purchase Notice (with a copy to the Transfer Agent), in substantially
the form attached hereto as <U>Exhibit E</U>, to purchase during the Intraday VWAP Purchase Period the applicable Intraday VWAP Purchase
Share Amount, at the applicable VWAP Purchase Price, on such VWAP Purchase Date in accordance with this Agreement (each such purchase,
an &ldquo;<B><I>Intraday VWAP Purchase</I></B>&rdquo;). During a Trading Day, if the Company did not previously timely deliver a VWAP
Purchase Notice on such Trading Day in accordance with this <U>Section 3.1(b)</U>, then, subject to the satisfaction of all of the conditions
set forth in <U>Section 7.3</U>, the Company may submit an Intraday VWAP Purchase Notice to the Investor; if the Investor accepts such
Intraday VWAP Notice (which it may or may not do so in its sole discretion), the Investor shall purchase up to the Intraday VWAP Purchase
Share Amount as specified in such Intraday VWAP Purchase Notice, at the applicable VWAP Purchase Price, on such VWAP Purchase Date and
the Company&rsquo;s obligation to deliver the Shares that are the subject of such Intraday VWAP Purchase Notice shall be binding; <U>provided</U>
that if the Investor does not accept such Intraday VWAP Purchase Notice, then such Intraday VWAP Purchase Notice shall be null and void.
The Company may timely deliver a VWAP Purchase Notice to the Investor as often as every Trading Day (and may deliver a single Intraday
VWAP Purchase Notice in any given day, as specified in the previous sentences or as specified further below in this <U>Section 3.1(b)</U>),
so long as all Shares subject to all prior VWAP Purchases and Intraday VWAP Purchases theretofore required to have been received by the
Investor on a timely basis (as set forth in <U>Section 3.2</U> of this Agreement) have been received by the Investor in accordance with
this Agreement. Upon receipt of a VWAP Purchase Notice prepared and delivered by the Company prior to 9:00 a.m., New York City time, the
Investor must notify the Company of its receipt of such VWAP Purchase Notice (email being sufficient) (the &ldquo;<B><I>Acknowledgement
Receipt</I></B>&rdquo;) by 9:30 a.m., New York City time, on the applicable VWAP Purchase Date. In the event the Company does not receive
an Acknowledgement Receipt by 9:30 a.m., New York City time, on the applicable VWAP Purchase Date for such VWAP Purchase, the Company
must reforward the previously delivered VWAP Purchase Notice to the Investor (email being sufficient) by 10:00 a.m., New York City time.
The Investor must also deliver to the Company an Acknowledgement Receipt to indicate its acceptance of any VWAP Purchase Notice delivered
by the Company after 9:00 a.m., New York City time. If the VWAP Purchase Termination Time occurs prior to 3:00 p.m., New York City time,
on the applicable VWAP Purchase Date and the Company has delivered to the Investor an Intraday VWAP Purchase Notice prior to 3:00 p.m.,
New York City time, on such VWAP Purchase Date, the Investor shall be obligated to purchase, during the Intraday VWAP Purchase Period,
the Intraday VWAP Purchase Share Amount; <U>provided</U> that the Investor will not be obligated to purchase the Intraday VWAP Purchase
Share Amount to the extent that such Intraday VWAP Purchase Share Amount, when aggregated with the Shares purchased pursuant to the VWAP
Purchase Notice applicable to such VWAP Purchase Date would exceed the VWAP Purchase Commitment Amount. If the VWAP Purchase Share Amount
(together with the Intraday VWAP Purchase Share Amount) on any Trading Day exceeds the VWAP Purchase Commitment Amount applicable to that
Trading Day, the Investor may, in its sole discretion, purchase any amount of Shares that is not less than the VWAP Purchase Commitment
Amount and not more than the sum of the VWAP Purchase Share Amount and the Intraday VWAP Purchase Share Amount for such Trading Day. For
the avoidance of doubt, the Investor shall not be required to purchase any amount of Shares that is more than the VWAP Purchase Commitment
Amount for such Trading Day, and the Investor&rsquo;s commitment to purchase Shares is subject to the other conditions and limitations
provided in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) <B><U>Written Confirmation</U></B>.
At or prior to 5:30 p.m., New York City time, on the VWAP Purchase Date for each VWAP Purchase and each Intraday VWAP Purchase, if applicable,
the Investor shall provide to the Company and the Transfer Agent a written confirmation for such VWAP Purchase or Intraday VWAP Purchase
(i) confirming that the Investor&rsquo;s representations, warranties and covenants set forth in <U>Section 4.11</U> of this Agreement
are true and correct as of such VWAP Purchase Date, and (ii) setting forth the applicable VWAP Purchase Price, the total number of Shares
being purchased by the Investor in such VWAP Purchase or Intraday VWAP Purchase, the total aggregate VWAP Purchase Price to be paid by
the Investor for such VWAP Purchase or Intraday VWAP Purchase, the VWAP Purchase Period and (if applicable) the Intraday VWAP Purchase
Period, and, if the Investor is purchasing a number of Shares less than the VWAP Purchase Share Amount or Intraday VWAP Purchase Share
Amount, the Investor&rsquo;s calculation of the VWAP Purchase Commitment Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d) <B><U>Alternative Share Delivery</U></B>.
If the Investor has resold Shares in a manner described under the caption &ldquo;Plan of Distribution&rdquo; in the Registration Statement
and otherwise in compliance with <U>Section 4.11</U> of this Agreement prior to the delivery by the Investor to the Company of the written
confirmation described in <U>Section 3.1(c)</U> above, the Investor shall concurrently with the delivery by the Investor to the Company
of the written confirmation described in <U>Section 3.1(c)</U> above (i) send a confirmation to the Transfer Agent setting forth the number
of such Shares that have been so resold and the date of such resales (such confirmation, the &ldquo;<B><I>Transfer Agent Confirmation</I></B>&rdquo;)
and (ii) deliver to the Transfer Agent the items set forth in clause (b) of the definition of DWAC Shares with respect to such resold
Shares (collectively, the &ldquo;<B><I>Transfer Agent Deliverables</I></B>&rdquo;). With respect to Shares resold by the Investor as described
in the preceding sentence and as to which the Investor has timely delivered the Transfer Agent Deliverables with respect to such resold
Shares, in lieu of delivering such resold Shares to the Investor in accordance with <U>Section 3.2</U>, such Shares shall be delivered
and credited by the Transfer Agent using the Fast Automated Securities Transfer (FAST) Program maintained by DTC (or any similar program
hereafter adopted by DTC performing substantially the same function) to the account with DTC of the Investor&rsquo;s designated Broker-Dealer
as specified in the Transfer Agent Deliverables with respect to such resold Shares at the time such Shares would otherwise have been required
to be delivered to the Investor in accordance with <U>Section 3.2</U>, which Shares (x) shall only be used by the Investor&rsquo;s Broker-Dealer
to deliver such Shares to DTC for the purpose of settling the Investor&rsquo;s share delivery obligations with respect to the sale of
such Shares, which may include delivery to other accounts of such Broker-Dealer and inclusion in the number of Shares delivered by that
Broker-Dealer in &ldquo;net settling&rdquo; that Broker-Dealer&rsquo;s trading of shares of the Company&rsquo;s Common Stock, including
its positions with the Broker-Dealers of the respective persons who purchase such Shares from the Investor, and (y) shall remain &ldquo;restricted
securities&rdquo; as such term is defined in Rule 144(a)(3) under the Securities Act until so delivered. The Company and the Investor
acknowledge that, if and when the Investor has (i) resold Shares in a manner described under the caption &ldquo;Plan of Distribution&rdquo;
in the Registration Statement and otherwise in compliance with <U>Section 4.11</U> of this Agreement and (ii) timely delivered the Transfer
Agent Deliverables with respect to such resold Shares, the Transfer Agent shall cause such resold Shares (as applicable) to be subsequently
credited using the Fast Automated Securities Transfer (FAST) Program maintained by DTC (or any similar program hereafter adopted by DTC
performing substantially the same function) to the account with DTC of the Investor&rsquo;s designated Broker-Dealer as specified in the
Transfer Agent Deliverables with respect to such resold Shares, which Shares (x) shall only be used by the Investor&rsquo;s Broker-Dealer
to deliver such resold Shares (as applicable) to DTC for the purpose of settling the Investor&rsquo;s share delivery obligations with
respect to the sale of such Shares, which may include delivery to other accounts of such Broker-Dealer and inclusion in the number of
Shares delivered by that Broker-Dealer in &ldquo;net settling&rdquo; that Broker-Dealer&rsquo;s trading of shares of the Company&rsquo;s
Common Stock, including its positions with the Broker-Dealers of the respective persons who purchase such Shares from the Investor, and
(y) shall remain &ldquo;restricted securities&rdquo; as such term is defined in Rule 144(a)(3) under the Securities Act until so delivered.
The Company and the Investor acknowledge that such resold Shares credited to the account with DTC of the Investor&rsquo;s designated Broker-Dealer
shall be eligible for transfer to the third-party purchasers of such Shares or their respective Broker-Dealers as DWAC Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e) <B><U>Suspension of Purchase
Notices</U></B>. If the Investor has (i) resold Shares in a manner described under the caption &ldquo;Plan of Distribution&rdquo; in the
Registration Statement and otherwise in compliance with <U>Section 4.11</U> of this Agreement and (ii) timely delivered the Transfer Agent
Deliverables with respect to such resold Shares, and such Shares have not been delivered and credited by the Transfer Agent as required
by <U>Section 3.1(d)</U>, then the Investor may in its sole discretion return such Shares to the Company and the Company shall immediately
return any VWAP Purchase Amount that the Investor has paid for any Shares held by the Investor at the time of the disclosure of material,
non-public information and the Company&rsquo;s right to deliver a subsequent VWAP Purchase Notice or Intraday VWAP Purchase Notice to
the Investor pursuant to <U>Section 3.1(b)</U> shall be suspended until such time as (a) such Shares have been delivered and credited
by the Transfer Agent as required by <U>Section 3.1(d)</U> or (b) the Company has returned the VWAP Purchase Amount to the Investor for
such Shares, as applicable. In the event that the Company&rsquo;s right to deliver a VWAP Purchase Notice or Intraday VWAP Purchase Notice
to the Investor has been suspended pursuant to this <U>Section 3.1(e)</U>, the Investor shall provide to the Company written notice of
such suspension.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 3.2. <U>Payment and
Settlement</U></B>. The Shares purchased by the Investor in an applicable VWAP Purchase or Intraday VWAP Purchase shall be delivered to
the Investor not later than 1:00 p.m., New York City time, on the Trading Day immediately following the applicable VWAP Purchase Date
for such VWAP Purchase or Intraday VWAP Purchase (the &ldquo;<B><I>VWAP Purchase Share Delivery Date</I></B>&rdquo;). The Company acknowledges
and agrees that it may not deliver any additional VWAP Purchase Notices to the Investor until all such Shares subject to any previous
VWAP Purchases or Intraday VWAP Purchase &ndash; other than those to be delivered pursuant to a VWAP Purchase Notice delivered on the
same Trading Day or a VWAP Purchase Notice or an Intraday VWAP Purchase Notice delivered on the immediately preceding Trading Day &mdash;
have been received by the Investor or its designated Broker-Dealer in accordance with this Agreement. For each VWAP Purchase or Intraday
VWAP Purchase, the Investor shall pay to the Company an amount in cash equal to the product of (a) the total number of Shares purchased
by the Investor in such VWAP Purchase or Intraday VWAP Purchase and (b) the applicable VWAP Purchase Price for such Shares (the &ldquo;<B><I>VWAP
Purchase Amount</I></B>&rdquo;), as full payment for such Shares purchased by the Investor in such VWAP Purchase or Intraday VWAP Purchase,
via wire transfer of immediately available funds, not later than 5:00 p.m., New York City time, on the Trading Day immediately following
the applicable VWAP Purchase Share Delivery Date for such VWAP Purchase or Intraday VWAP Purchase, provided the Investor shall have timely
received all of such Shares purchased by the Investor in such VWAP Purchase or Intraday VWAP Purchase on such VWAP Purchase Share Delivery
Date in accordance with the first sentence of this <U>Section 3.2</U>, or, if any of such Shares are received by the Investor after 1:00
p.m., New York City time, then the Company&rsquo;s receipt of such funds in its designated account may occur on the Trading Day next following
the Trading Day on which the Investor shall have received all of such Shares, but not later than 5:00 p.m., New York City time, on such
next Trading Day. If the Company or the Transfer Agent shall fail for any reason to (i) deliver to the Investor any Shares purchased by
the Investor in a VWAP Purchase or Intraday VWAP Purchase prior to 10:30 a.m., New York City time, on the Trading Day immediately following
the applicable VWAP Purchase Share Delivery Date for such VWAP Purchase or Intraday VWAP Purchase, or (ii) deliver and credit Shares to
the account of the Investor&rsquo;s designated Broker-Dealer on the Trading Day on which such Shares were required to have been delivered
pursuant to <U>Section 3.1(d)</U>, and in the manner in which such Shares were required to have been delivered pursuant to <U>Section
3.1(d)</U>, and if on or after such Trading Day the Investor purchases (in an open market transaction or otherwise) shares of Common Stock
(the &ldquo;<B><I>Cover Shares</I></B>&rdquo;) to deliver in satisfaction of any sales by the Investor of such Shares that the Investor
anticipated receiving from the Company on such VWAP Purchase Share Delivery Date in respect of such VWAP Purchase or Intraday VWAP Purchase
or such Shares that were required to have been delivered pursuant to <U>Section 3.1(d)</U> (as applicable), then the Company shall, within
one (1) Trading Day after the Investor&rsquo;s request, either (i) pay cash to the Investor in an amount equal to the Investor&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased (the &ldquo;<B><I>Cover Price</I></B>&rdquo;),
at which point the Company&rsquo;s obligation to deliver such Shares shall terminate, or (ii) promptly honor its obligation to deliver
to the Investor such Shares and pay cash to the Investor in an amount equal to the excess (if any) of the Cover Price over the total purchase
price paid or, if not yet paid, required to be paid by the Investor pursuant to this Agreement for all of the Shares purchased by the
Investor in such VWAP Purchase or Intraday VWAP Purchase or such Shares that were resold by the Investor in the manner described in clause
(a) of the definition of DWAC Shares; provided that, to the extent the Investor borrows any shares of Common Stock through any securities
lending or similar arrangement (&ldquo;<B><I>Borrowed Shares</I></B>&rdquo;) instead of purchasing such shares as Cover Shares, the Company
shall promptly honor its obligation to deliver to the Investor such Shares and pay cash to the Investor in an amount equal to any securities
lending or related fees related to the borrowings of such Borrowed Shares. The Company shall not issue any fraction of a share of Common
Stock to the Investor in connection with any VWAP Purchase or Intraday VWAP Purchase effected pursuant to this Agreement. If the issuance
would result in the issuance of a fraction of a share of Common Stock, the Company shall round such fraction of a share of Common Stock
up or down to the nearest whole share. All payments to be made by the Investor pursuant to this Agreement shall be made by wire transfer
of immediately available funds to such account as the Company may from time to time designate by written notice to the Investor in accordance
with the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 3.3. <U>Compliance
with Rules of Principal Market</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) <B><U>Exchange Cap</U></B>.
The Company shall not issue or sell any shares of Common Stock pursuant to this Agreement, and the Investor shall not purchase or acquire
any shares of Common Stock pursuant to this Agreement, to the extent that after giving effect thereto, the aggregate number of Registrable
Shares that would be issued pursuant to this Agreement and the transactions contemplated by the Transaction Documents would exceed 2,066,747
shares of Common Stock (representing 19.99% of the voting power or number of shares of Common Stock issued and outstanding immediately
prior to the execution of this Agreement), which number of shares shall be reduced, on a share-for-share basis, by the number of shares
of Common Stock issued or issuable pursuant to any transaction or series of transactions that may be aggregated with the transactions
contemplated by the Transaction Documents under applicable rules of the Principal Market (such maximum number of shares, the &ldquo;<B><I>Exchange
Cap</I></B>&rdquo;), unless the Company&rsquo;s stockholders have approved the issuance of Common Stock pursuant to this Agreement in
excess of the Exchange Cap in accordance with the applicable rules of the Principal Market or such approval is not required in accordance
with the applicable rules of the Principal Market or otherwise. For the avoidance of doubt, the Company may, but shall be under no obligation
to, request its stockholders to approve the issuance of Common Stock pursuant to this Agreement; <U>provided</U>, that if such stockholder
approval is not obtained, the Exchange Cap shall be applicable for all purposes of this Agreement and the transactions contemplated by
the Transaction Documents at all times during the term of this Agreement (except as set forth in <U>Section 3.3(b)</U>). The Investor
shall not have the right or obligation to purchase or acquire any shares of Common Stock pursuant to this Agreement, to the extent that
after giving effect thereto, the aggregate number of shares of Common Stock held by the Investor immediately following such purchase will
cause the Investor to have beneficial ownership of more than the number of shares of Common Stock representing 19.99% of the voting power
or number of shares of Common Stock issued and outstanding immediately prior to such purchase, unless the Company&rsquo;s stockholders
have approved such purchase of Common Stock in accordance with the applicable rules of the Principal Market or such approval is not required
in accordance with the applicable rules of the Principal Market or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) <B><U>At Market Transaction</U></B>.
Notwithstanding <U>Section 3.3(a)</U> above, the Exchange Cap shall not be applicable for any purposes of this Agreement and the transactions
contemplated by the Transaction Documents, solely to the extent that (and only for so long as) the Average Price shall equal or exceed
the Base Price (it being hereby acknowledged and agreed that the Exchange Cap shall be applicable for all purposes of this Agreement and
the transactions contemplated by the Transaction Documents at all other times during the term of this Agreement, unless the stockholder
approval referred to in <U>Section 3.3(a)</U> is obtained or not required. The parties acknowledge and agree that the Minimum Price used
to determine the Base Price hereunder represents the lower of (i) the Nasdaq official closing price of the Common Stock on the Trading
Market (as reflected on Nasdaq.com) on the date of this Agreement and (ii) the average Nasdaq official closing price of the Common Stock
on the Trading Market (as reflected on Nasdaq.com) for the five (5) consecutive Trading Days ending on the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) <B><U>General</U></B>. The Company
shall not issue or sell any shares of Common Stock pursuant to this Agreement if such issuance or sale would or could reasonably be expected
to result in (A) a violation of the Securities Act or (B) a breach of the rules of the Principal Market. The provisions of this <U>Section
3.3</U> shall not be construed and implemented in a manner otherwise than in strict conformity with the terms of this <U>Section 3.3</U>
unless necessary to properly give effect to the limitations contained in this <U>Section 3.3</U>. Upon delivery of any VWAP Purchase Notice
or Intraday VWAP Purchase Notice to the Investor, the Company shall also deliver a copy of such notice to the Transfer Agent for informational
purposes only. For the avoidance of doubt, the Transfer Agent shall not issue any shares of Common Stock pursuant to a VWAP Purchase Notice
or Intraday VWAP Purchase Notice except pursuant to a written confirmation delivered by the Investor to the Company and the Transfer Agent
containing the information set forth in <U>Section 3.1(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 3.4. <U>Beneficial
Ownership Limitation</U></B>. Notwithstanding anything to the contrary contained in this Agreement, the Company shall not issue or sell,
and the Investor shall not be obligated to purchase or acquire, and shall not purchase or acquire, any shares of Common Stock under this
Agreement which, when aggregated with all other shares of Common Stock then beneficially owned by the Investor and its affiliates (as
calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder), would result in the beneficial ownership
by the Investor and its affiliates (on an aggregated basis) of more than 4.99% of the outstanding voting power or shares of Common Stock
(the &ldquo;<B><I>Beneficial Ownership Limitation</I></B>&rdquo;). Upon the written or oral request of the Investor, the Company shall
promptly (but not later than the next business day on which the Transfer Agent is open for business) confirm orally or in writing to the
Investor the number of shares of Common Stock then outstanding. The Investor and the Company shall each cooperate in good faith in the
determinations required under this <U>Section 3.4</U> and the application of this <U>Section 3.4</U>. The Investor&rsquo;s written certification
to the Company of the applicability of the Beneficial Ownership Limitation, and the resulting effect thereof hereunder at any time, shall
be conclusive with respect to the applicability thereof and such result absent manifest error. The provisions of this <U>Section 3.4</U>
shall not be construed and implemented in a manner otherwise than in strict conformity with the terms of this <U>Section 3.4</U> unless
necessary to properly give effect to the limitations contained in this <U>Section 3.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 3.5. <U>Post-Effective
Amendment Period</U>.</B> Notwithstanding anything to the contrary contained in this Agreement, the Company shall not deliver any VWAP
Purchase Notices or Intraday VWAP Purchase Notices to the Investor during the Post-Effective Amendment Period and shall comply with the
notification provisions regarding amendments to the Registration Statement under the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
IV</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>REPRESENTATIONS
AND WARRANTIES OF THE INVESTOR</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Investor hereby makes the
following representations, warranties and covenants to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 4.1. <U>Organization
and Standing of the Investor</U>.</B> The Investor is a limited liability company duly formed, validly existing and in good standing under
the laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 4.2. <U>Authorization
and Power</U>.</B> The Investor has the requisite limited liability company power and authority to enter into this Agreement and the Registration
Rights Agreement and to purchase or acquire the Shares in accordance with the terms hereof. The execution and delivery by the Investor
of this Agreement and the Registration Rights Agreement and the consummation by the Investor of the purchase or acquisition of Shares
contemplated hereby have been duly authorized by all necessary action on the part of the Investor, and no further consent or authorization
of the Investor or its sole member is required. Each of this Agreement and the Registration Rights Agreement has been duly executed and
delivered by the Investor and constitutes a valid and binding obligation of the Investor enforceable against it in accordance with its
terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservatorship,
receivership, or similar laws relating to, or affecting generally the enforcement of, creditor&rsquo;s rights and remedies or by other
equitable principles of general application (including any limitation of equitable remedies).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 4.3. <U>No Conflicts</U></B>.
The execution, delivery and performance by the Investor of this Agreement and the Registration Rights Agreement and the consummation by
the Investor of the purchase or acquisition of Shares contemplated hereby do not and shall not (i) result in a violation of such Investor&rsquo;s
certificate of formation, limited liability company agreement or other applicable organizational instruments, (ii) conflict with, constitute
a default (or an event which, with notice or lapse of time or both, would become a default) under, or give rise to any rights of termination,
amendment, acceleration or cancellation of, any material agreement, mortgage, deed of trust, indenture, note, bond, license, lease agreement,
instrument or obligation to which the Investor is a party or is bound, or (iii) result in a violation of any federal, state, local or
foreign statute, rule, or regulation, or any order, judgment or decree of any court or governmental agency applicable to the Investor
or by which any of its properties or assets are bound or affected, except, in the case of clauses (ii) and (iii), for such conflicts,
defaults, terminations, amendments, acceleration, cancellations and violations as would not, individually or in the aggregate, prohibit
or otherwise interfere with, in any material respect, the ability of the Investor to enter into this Agreement and the Registration Rights
Agreement and to purchase or acquire the Shares in accordance with the terms hereof. The Investor is not required under any applicable
federal, state or local law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with,
any court or governmental agency in order for it to execute, deliver or perform this Agreement and the Registration Rights Agreement or
to purchase or acquire the Shares in accordance with the terms hereof, other than as may be required by FINRA; <U>provided</U>, <U>however</U>,
that for purposes of the representation made in this sentence, the Investor is assuming and relying upon the accuracy of the representations
and warranties of the Company and the compliance by the Company with the conditions, covenants and agreements of the Company in the Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 4.4. <U>Accredited
Investor Status</U>.</B> The Investor is an &ldquo;accredited investor&rdquo; as that term is defined in Rule 501(a) of Regulation D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 4.5. <U>Reliance on
Exemptions</U></B>. The Investor understands that the Shares are being offered and sold to it in reliance on specific exemptions from
the registration requirements of U.S. federal and state securities laws and that the Company is relying in part upon the truth and accuracy
of, and the Investor&rsquo;s compliance with, the representations and warranties of the Investor set forth herein in order to determine
the availability of such exemptions and the eligibility of the Investor to acquire the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 4.6. <U>Information</U></B>.
All materials relating to the business, financial condition, management and operations of the Company and materials relating to the offer
and sale of the Shares which have been requested by the Investor have been furnished or otherwise made available to the Investor or its
advisors, including, without limitation, the Commission Documents. The Investor understands that its investment in the Shares involves
a high degree of risk. The Investor is able to bear the economic risk of an investment in the Shares and has such knowledge and experience
in financial and business matters that it is capable of evaluating the merits and risks of a proposed investment in the Shares. The Investor
and its advisors have been afforded the opportunity to ask questions of and receive answers from representatives of the Company concerning
the financial condition and business of the Company and other matters relating to an investment in the Shares. Neither such inquiries
nor any other due diligence investigations conducted by the Investor or its advisors, if any, or its representatives shall modify, amend
or affect the Investor&rsquo;s right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or in any
other Transaction Document or the Investor&rsquo;s right to rely on any other document or instrument executed and/or delivered in connection
with this Agreement or the consummation of the transaction contemplated hereby (including, without limitation, the opinions of the Company&rsquo;s
counsel delivered pursuant to this Agreement and the Registration Rights Agreement). The Investor has sought such accounting, legal and
tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Shares. The Investor
understands that it (and not the Company) shall be responsible for its own tax liabilities that may arise as a result of this investment
or the purchase or acquisition of Shares contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 4.7. <U>No Governmental
Review</U></B>. The Investor understands that no United States federal or state agency or any other government or governmental agency
has passed on or made any recommendation or endorsement of the Shares or the fairness or suitability of the investment in the Shares nor
have such authorities passed upon or endorsed the merits of the offering of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 4.8. <U>No General
Solicitation</U></B>. The Investor is not purchasing or acquiring the Shares as a result of any form of general solicitation or general
advertising (within the meaning of Regulation D) in connection with the offer or sale of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 4.9. <U>No Prior Short
Sales</U></B>. At no time prior to the date of this Agreement has the Investor, engaged in or effected, in any manner whatsoever, directly
or indirectly, for its own principal account, any (i) &ldquo;short sale&rdquo; (as such term is defined in Rule 200 of Regulation SHO
of the Exchange Act) of the Common Stock or (ii) hedging transaction, which establishes a net short position with respect to the Common
Stock that remains in effect as of the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 4.10. <U>Statutory
Underwriter Status</U></B>. The Investor acknowledges that it will be disclosed as an &ldquo;underwriter&rdquo; and a &ldquo;selling shareholder&rdquo;
in each Registration Statement and in any Prospectus contained therein to the extent required by applicable law and to the extent the
Prospectus is related to the resale of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 4.11. <U>Resales of
Shares</U></B>. The Investor represents, warrants and covenants that it will resell any Shares only pursuant to the Registration Statement
in which the resale of such Shares are registered under the Securities Act, in a manner described under the caption &ldquo;Plan of Distribution&rdquo;
in such Registration Statement, or in a manner in compliance with all applicable U.S. federal and state securities laws, rules and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
V&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>REPRESENTATIONS
AND WARRANTIES OF THE COMPANY</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company hereby makes the following
representations, warranties and covenants to the Investor:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.1. <U>Organization,
Good Standing and Power</U>.</B> The Company and each of its Subsidiaries are duly organized, validly existing and in good standing (to
the extent such concept is available) under the laws of their respective jurisdictions of organization. The Company and each of its Subsidiaries
are duly licensed or qualified as a foreign corporation for transaction of business and in good standing under the laws of each other
jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires such license
or qualification, and have all corporate power and authority necessary to own or hold their respective properties and to conduct their
respective businesses as described in the Commission Documents, except where the failure to be so qualified or in good standing or have
such power or authority would not, individually or in the aggregate, have a material adverse effect or would reasonably be expected to
have a material adverse effect on or affecting the assets, business, operations, earnings, properties, condition (financial or otherwise),
prospects, stockholders&rsquo; equity or results of operations of the Company and the Subsidiaries taken as a whole, or prevent or materially
interfere with consummation of the transactions contemplated by the Transaction Documents (a &ldquo;<B><I>Material Adverse Effect</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.2. <U>Subsidiaries</U></B>.
Each Subsidiary has been duly formed or organized, is validly existing under the applicable laws of its jurisdiction of incorporation
or organization and has the organizational power and authority to own, lease and operate its assets and properties and to conduct its
business as it is now being conducted. Each of the Company&rsquo;s Subsidiaries is duly licensed or qualified and in good standing (or
equivalent status as applicable) as a foreign corporation (or other entity, if applicable) in each jurisdiction in which the assets owned
or leased by it or the character of its activities require it to be licensed or qualified or in good standing (or equivalent status as
applicable), except where the failure to be so licensed or qualified, individually or in the aggregate, has not had and would not reasonably
be expected to have a Material Adverse Effect. Except as set forth in the Disclosure Documents, the Company owns, directly or indirectly,
all of the equity interests of the Subsidiaries free and clear of any lien, charge, security interest, encumbrance, right of first refusal
or other restriction, and all the equity interests of the Subsidiaries are validly issued and are fully paid, nonassessable and free of
preemptive and similar rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.3. <U>Authorization,
Enforcement</U></B>. The Company has the requisite corporate power and authority to enter into and perform its obligations under each
of the Transaction Documents and, assuming a sufficient number of authorized but unissued shares of Common Stock are available for issuance
when the Shares are issued, to issue the Shares in accordance with the terms hereof and thereof. The execution, delivery and performance
by the Company of each of the Transaction Documents and the consummation by it of the transactions contemplated hereby and thereby have
been duly and validly authorized by all necessary corporate action, and no further consent or authorization of the Company, its Board
of Directors or its stockholders is required, except for the approval of the Company&rsquo;s stockholders for issuances of Shares in excess
of the Exchange Cap. Each of the Transaction Documents has been duly executed and delivered by the Company and constitutes a valid and
binding obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability may be limited
by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservatorship, receivership or similar laws relating
to, or affecting generally the enforcement of, creditor&rsquo;s rights and remedies or by other equitable principles of general application
(including any limitation of equitable remedies).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.4. <U>Capitalization</U></B>.
The authorized capital stock of the Company and the shares thereof issued and outstanding were as set forth in the Disclosure Documents
as of the dates reflected therein. All of the outstanding shares of Common Stock have been duly authorized and validly issued and are
fully paid and non-assessable. Except as set forth in the Disclosure Documents, this Agreement and the Registration Rights Agreement,
there are no agreements or arrangements under which the Company is obligated to register the sale of any securities under the Securities
Act. Except as set forth in the Disclosure Documents, no shares of Common Stock are entitled to preemptive rights and there are no outstanding
debt securities and no contracts, commitments, understandings, or arrangements by which the Company is or may become bound to issue additional
shares of the capital stock of the Company or options, warrants, scrip, rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities or rights convertible into or exchangeable for, any shares of capital stock of the Company other
than those issued or granted in the ordinary course of business pursuant to the Company&rsquo;s equity incentive and/or compensatory plans
or arrangements. Except for customary transfer restrictions contained in agreements entered into by the Company to sell restricted securities
or as set forth in the Disclosure Documents, the Company is not a party to, and it has no knowledge of, any agreement restricting the
voting or transfer of any shares of the capital stock of the Company. Except as set forth in the Disclosure Documents, there are no securities
or instruments containing anti-dilution or similar provisions that will be triggered by this Agreement or any of the other Transaction
Documents or the consummation of the transactions described herein or therein. The Company has filed with the Commission true and correct
copies of the Company&rsquo;s Certification of Incorporation as in effect on the Closing Date (the &ldquo;<B><I>Charter</I></B>&rdquo;),
and the Company&rsquo;s Bylaws as in effect on the Closing Date (the &ldquo;<B><I>Bylaws</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.5. <U>Issuance of
Shares</U></B>. The Shares to be issued under this Agreement have been, duly and validly authorized by all necessary corporate action
on the part of the Company. The Shares, if and when issued and sold to the Investor against payment therefor in accordance with this Agreement,
shall be, validly issued and outstanding, fully paid and non-assessable and free from all liens, charges, taxes, security interests, encumbrances,
rights of first refusal, preemptive or similar rights and other encumbrances with respect to the issue thereof, and the Investor shall
be entitled to all rights accorded to a holder of Common Stock. At or prior to Commencement, the Company shall have duly authorized and
reserved a number of shares of Common Stock equal to the Exchange Cap for issuance and sale as Shares to the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.6. <U>No Conflicts</U></B>.
The execution, delivery and performance by the Company of each of the Transaction Documents and the consummation by the Company of the
transactions contemplated hereby and thereby do not and shall not (i) result in a violation of any provision of the Charter or Bylaws,
(ii) conflict with or constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or
give rise to any rights of termination, amendment, acceleration or cancellation of, any material agreement, mortgage, deed of trust, indenture,
note, bond, license, lease agreement, instrument or obligation to which the Company or any of its Subsidiaries is a party or is bound,
(iii) create or impose a lien, charge or encumbrance on any property or assets of the Company or any of its Subsidiaries under any agreement
or any commitment to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound
or to which any of their respective properties or assets is subject, (iv) result in a violation of any federal, state, local or foreign
statute, rule, regulation, order, judgment or decree applicable to the Company or any of its Subsidiaries, or by which any property or
asset of the Company or any of its Subsidiaries are bound or affected (including federal and state securities laws and regulations and
the rules and regulations of the Principal Market or applicable Principal Market), except, in the case of clauses (ii) and (iii), for
such conflicts, defaults, terminations, amendments, acceleration, cancellations, liens, charges, encumbrances and violations as would
not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect. Except as specifically contemplated
by this Agreement or the Registration Rights Agreement and as required under the Securities Act, any applicable state securities laws
and applicable rules of the Principal Market, the Company is not required under any federal, state or local rule or regulation to obtain
any consent, authorization or order of, or make any filing or registration with, any court or governmental agency (including, without
limitation, the Principal Market) in order for it to execute, deliver or perform any of its obligations under the Transaction Documents,
or to issue the Registrable Shares to the Investor in accordance with the terms hereof and thereof (other than such consents, authorizations,
orders, filings or registrations as have been obtained or made prior to the Closing Date); <U>provided</U>, <U>however</U>, that, for
purposes of the representation made in this sentence, the Company is assuming and relying upon the accuracy of the representations and
warranties of the Investor in this Agreement and the compliance by it with its covenants and agreements contained in this Agreement and
the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.7. <U>Disclosure
Documents, Financial Statements; Internal Controls Over Financial Reporting; Accountants</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) The Company has timely filed
(giving effect to permissible extensions in accordance with Rule 12b-25 under the Exchange Act) all filings required to be filed with
or furnished to the Commission by the Company under the Securities Act or the Exchange Act, including those required to be filed with
or furnished to the Commission under Section 13(a) or Section 15(d) of the Exchange Act. As of the date of this Agreement, no Subsidiary
of the Company is required to file or furnish any report, schedule, registration, form, statement, information or other document with
the Commission. As of its filing date, each Commission Document filed with or furnished to the Commission prior to the Closing Date complied
in all material respects with the requirements of the Securities Act or the Exchange Act, as applicable, and other federal, state and
local laws, rules and regulations applicable to it, and, as of its filing date (or, if amended or superseded by a filing prior to the
Closing Date, on the date of such amended or superseded filing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) Each Registration Statement,
on the date it is filed with the Commission, on the date it is declared effective by the Commission and on each VWAP Purchase Date shall
comply in all material respects with the requirements of the Securities Act (including, without limitation, Rule 415 under the Securities
Act) and shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
in order to make the statements therein not misleading, except that this representation and warranty shall not apply to statements in
or omissions from such Registration Statement made in reliance upon and in conformity with information relating to the Investor furnished
to the Company in writing by or on behalf of the Investor expressly for use therein. The Prospectus and each Prospectus Supplement, when
taken together, on its date and on each VWAP Purchase Date shall comply in all material respects with the requirements of the Securities
Act (including, without limitation, Rule 424(b) under the Securities Act) and shall not contain any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading, except that this representation and warranty shall not apply to statements in
or omissions from the Prospectus or any Prospectus Supplement made in reliance upon and in conformity with information relating to the
Investor furnished to the Company in writing by or on behalf of the Investor expressly for use therein. The statistical, demographic and
market-related data included in the Registration Statement and Prospectus are based on or derived from sources that are reliable and accurate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) Each Commission Document (other
than the Initial Registration Statement or any New Registration Statement, or the Prospectus included therein or any Prospectus Supplement
thereto) to be filed with or furnished to the Commission on or after the Closing Date and incorporated by reference in the Initial Registration
Statement or any New Registration Statement, or the Prospectus included therein or any Prospectus Supplement thereto required to be filed
pursuant to this Agreement or the Registration Rights Agreement (including, without limitation, the Current Report), when such document
is filed with or furnished to the Commission and, if applicable, when such document becomes effective, as the case may be, shall comply
in all material respects with the requirements of the Securities Act or the Exchange Act, as applicable, and other federal, state and
local laws, rules and regulations applicable to it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d) The Company has delivered or
made available to the Investor via EDGAR or otherwise true and complete copies of all comment letters and substantive correspondence received
by the Company from the Commission relating to the Commission Documents filed with or furnished to the Commission as of the Closing Date,
together with all written responses of the Company thereto in the form such responses were filed via EDGAR. There are no outstanding or
unresolved comments or undertakings in such comment letters received by the Company from the Commission. The Commission has not issued
any stop order or other order suspending the effectiveness of any registration statement filed by the Company under the Securities Act
or the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e) The consolidated financial statements
of the Company included or incorporated by reference in the Commission Documents, together with the related notes and schedules, present
fairly, in all material respects, the consolidated financial position of the Company and its then consolidated subsidiaries as of the
dates indicated, and the consolidated results of operations, cash flows and changes in stockholders&rsquo; equity of the Company and its
then consolidated subsidiaries for the periods specified and have been prepared in compliance with the published requirements of the Securities
Act and the Exchange Act, as applicable, and in conformity with generally accepted accounting principles in the United States (&ldquo;<B><I>GAAP</I></B>&rdquo;)
applied on a consistent basis. The summary consolidated financial data included or incorporated by reference in the Commission Documents
present fairly the information shown therein and have been compiled on a basis consistent with that of the financial statements included
or incorporated by reference in the Commission Documents, as of and at the dates indicated. Any pro forma condensed combined financial
statements and the pro forma combined financial statements and any other pro forma financial statements or data with respect to any entity
to be acquired by the Company (each, an &ldquo;<B><I>Acquired Entity</I></B>&rdquo;) included or incorporated by reference in the Commission
Documents comply with the requirements of Regulation S-X of the Securities Act, including, without limitation, Article 11 thereof, and
the assumptions used in the preparation of such pro forma financial statements and data are reasonable, the pro forma adjustments used
therein are appropriate to give effect to the circumstances referred to therein and the pro forma adjustments have been properly applied
to the historical amounts in the compilation of those statements and data. <FONT STYLE="background-color: white">To the knowledge of the
Company, the historical financial statements of any Acquired Entity, together with the related notes thereto, included in the Registration
Statement and the Prospectus after the date hereof, will fairly present the financial position of such Acquired Entity at the respective
dates indicated and the results of operations of such Acquired Entity for the respective periods indicated, in each case in accordance
with GAAP consistently applied throughout such periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f) The other financial and statistical
data with respect to the Company and the Subsidiaries contained or incorporated by reference in the Commission Documents, if any, are
accurately and fairly presented and prepared on a basis consistent with the financial statements and books and records of the Company.
There are no financial statements (historical or pro forma) that are required to be included or incorporated by reference in the Disclosure
Documents that are not included or incorporated by reference as required. The Company and the Subsidiaries do not have any material liabilities
or obligations, direct or contingent (including any off-balance sheet obligations or any &ldquo;variable interest entities&rdquo; as that
term is used in Accounting Standards Codification Paragraph 810-10-25-20), not described in Commission Documents which are required to
be described in the Commission Documents. All disclosures contained or incorporated by reference in the Disclosure Documents, if any,
regarding &ldquo;non-GAAP financial measures&rdquo; (as such term is defined by the rules and regulations of the Commission) comply in
all material respects with Regulation G of the Exchange Act and Item 10 of Regulation S-K under the Securities Act, to the extent applicable.
The interactive data in eXtensible Business Reporting Language included in the Commission Documents fairly presents the information called
for in all material respects and has been prepared in accordance with the Commission&rsquo;s rules and guidelines applicable thereto.
No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) contained in
the Commission Documents has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(g) Baker Tilly US, LLP (&ldquo;<B><I>Baker</I></B>&rdquo;),
as a legal successor of Moss Adams LLP, independent public accountants for the Company, whose report on the consolidated financial statements
of the Company as of and for the years ended December 31, 2024 and 2023 is included in the Company&rsquo;s Annual Report on Form 10-K
for the year ended December 31, 2024, are and, during the periods covered by their report, were an independent public accounting firm
within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To the Company&rsquo;s knowledge,
Baker is not in violation of the auditor independence requirements of the Sarbanes-Oxley Act of 2002 (the &ldquo;<B><I>Sarbanes-Oxley
Act</I></B>&rdquo;) with respect to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(h) There is and has been no failure
on the part of the Company or any of the Company&rsquo;s directors or officers, in their capacities as such, to comply in all material
respects with any applicable provisions of the Sarbanes-Oxley Act and the rules and regulations promulgated thereunder. Each of the principal
executive officer and the principal financial officer of the Company (or each former principal executive officer of the Company and each
former principal financial officer of the Company as applicable) has made all certifications required by Sections 302 and 906 of the Sarbanes-Oxley
Act with respect to all reports, schedules, forms, statements and other documents required to be filed by it or furnished by it to the
Commission. For purposes of the preceding sentence, &ldquo;principal executive officer&rdquo; and &ldquo;principal financial officer&rdquo;
shall have the meanings given to such terms in the Sarbanes-Oxley Act. The Company and the Subsidiaries maintain and keep accurate books
and records reflecting their assets and maintain internal accounting controls in a manner designed to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles and including those policies and procedures that (i) pertain to the maintenance of records that in reasonable
detail accurately and fairly reflect the transactions and dispositions of the assets of the Company, (ii) provide reasonable assurance
that transactions are recorded as necessary to permit the preparation of the Company&rsquo;s consolidated financial statements in accordance
with generally accepted accounting principles, (iii) that receipts and expenditures of the Company are being made only in accordance with
management&rsquo;s and the Company&rsquo;s directors&rsquo; authorization, and (iv) provide reasonable assurance regarding prevention
or timely detection of unauthorized acquisition, use or disposition of the Company&rsquo;s assets that could have a material effect on
its financial statements. The Company and the Subsidiaries maintain such controls and other procedures, including, without limitation,
those required by Sections 302 and 906 of the Sarbanes-Oxley Act, and the applicable regulations thereunder that are designed to ensure
that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed,
summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms, including, without limitation, controls
and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under
the Exchange Act is accumulated and communicated to the Company&rsquo;s management, including its principal executive officer and principal
financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure and
to ensure that material information relating to the Company or the Subsidiaries is made known to them by others within those entities,
particularly during the period in which such periodic reports are being prepared.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.8. <U>No Material
Adverse Effect; Absence of Certain Changes</U></B>. Since the date of the latest audited financial statements included in the Registration
Statement or the Prospectus, there has not been (i) any Material Adverse Effect or the occurrence of any development that could reasonably
be expected to result in a Material Adverse Effect, (ii) any transaction which is material to the Company and the Subsidiaries taken as
a whole, (iii) any obligation or liability, direct or contingent (including any off-balance sheet obligations), incurred by the Company
or any Subsidiary, which is material to the Company and the Subsidiaries taken as a whole, (iv) any material change in the capital stock
(other than (A) the grant of additional awards under the Company&rsquo;s existing equity incentive plans, (B) changes in the number of
outstanding Common Stock of the Company due to the issuance of shares upon the exercise or conversion of securities exercisable for, or
convertible into, Common Stock outstanding on the date hereof, (C) as described in a proxy statement filed on Schedule 14A or a Registration
Statement on Form S-4, or (D) otherwise publicly announced on a Form 8-K or Company press release) or outstanding long-term indebtedness
of the Company or any of its Subsidiaries or (v) any dividend or distribution of any kind declared, paid or made on the capital stock
of the Company or any Subsidiary, other than in each case above (A) in the ordinary course of business or (B) as otherwise disclosed in
the Disclosure Documents (including any document deemed incorporated by reference therein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.9. <U>No Material
Defaults</U>. </B>Neither the Company nor any of its Subsidiaries has defaulted on any installment on indebtedness for borrowed money
or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would reasonably be expected to have
a Material Adverse Effect. The Company has not filed a report pursuant to Section 13(a) or 15(d) of the Exchange Act indicating that it
(i) has failed to pay any dividend or sinking fund installment on preferred stock or (ii) has defaulted on any installment on indebtedness
for borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would reasonably
be expected to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is (i) in violation of its Charter or Bylaws
or other organizational documents; or (ii) in default, and no event has occurred that, with notice or lapse of time or both, would constitute
such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of
trust, loan agreement or other agreement or instrument to which the Company or any of its Subsidiaries is a party or by which the Company
or any of its Subsidiaries is bound or to which any of the property or assets of the Company or any of its Subsidiaries are subject, except,
in the case of clause (ii) above, for any such violation or default that would not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.10. <U>No Preferential
Rights</U>.</B> Except as set forth in the Disclosure Documents or provided hereunder, (i) no Person, has the right, contractual or otherwise,
to cause the Company to issue or sell to such Person any Common Stock or shares of any other capital stock or other securities of the
Company, (ii) no Person has any preemptive rights, resale rights, rights of first refusal, rights of co-sale, or any other rights (whether
pursuant to a &ldquo;poison pill&rdquo; provision or otherwise) to purchase any Common Stock or shares of any other capital stock or other
securities of the Company, (iii) no Person has the right to act as an underwriter, agent or financial advisor to the Company in connection
with the offer and sale of the Common Stock or to receive a fee with respect thereto, and (iv) no Person has the right, contractual or
otherwise, to require the Company to register under the Securities Act any Common Stock or shares of any other capital stock or other
securities of the Company, or to include any such shares or other securities in the Registration Statement or the offering contemplated
thereby, whether as a result of the filing or effectiveness of the Registration Statement or the sale of the Registrable Shares as contemplated
thereby or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.11. <U>Material Contracts</U></B>.
Neither the Company nor any of its Subsidiaries is in material breach of or default in any respect under the terms of any Material Contract
and, to the knowledge of the Company, as of the date hereof, no other party to any Material Contract is in material breach of or default
under the terms of any Material Contract. Each agreement between the Company and a third party is in full force and effect and is a valid
and binding obligation of the Company or the Subsidiary of the Company that is party thereto and, to the knowledge of the Company, is
a valid and binding obligation of each other party thereto. The Company has not received any written notice of the intention of any other
party to a Material Contract to terminate for default, convenience or otherwise, or not renew, any Material Contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.12. <U>Solvency</U></B>.
The Company has not taken any steps, and does not currently expect to take any steps, to seek protection pursuant to Title 11 of the United
States Code or any similar federal or state bankruptcy law or law for the relief of debtors, nor does the Company have any knowledge that
its creditors intend to initiate involuntary bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings for
relief under Title 11 of the United States Code or any other federal or state bankruptcy law or any law for the relief of debtors. The
Company is financially solvent and is generally able to pay its debts as they become due. All of the Company&rsquo;s outstanding secured
and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments through such date
were as set forth in the Disclosure Documents as of the dates reflected therein. For the purposes of this Agreement, &ldquo;Indebtedness&rdquo;
shall mean (a) any liabilities for borrowed money or amounts owed in excess of $100,000 (other than trade accounts payable incurred in
the ordinary course of business), (b) all guaranties, endorsements, indemnities and other contingent obligations in respect of Indebtedness
of others in excess of $100,000, whether or not the same are or should be reflected in the Company&rsquo;s balance sheet (or the notes
thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary
course of business; and (c) the present value of any lease payments in excess of $100,000 due under leases required to be capitalized
in accordance with GAAP. There is no existing or continuing default or event of default in respect of any Indebtedness of the Company
or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.13. <U>Real Property;
Intellectual Property</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) Except as set forth in the Disclosure
Documents, the Company and its Subsidiaries have good and marketable title in fee simple to all items of real property owned by them,
good and valid title to all personal property described in the Commission Documents as being owned by them, in each case free and clear
of all liens, encumbrances and claims, except those matters that (i) do not materially interfere with the use made and proposed to be
made of such property by the Company and any of its Subsidiaries or (ii) would not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect. Any real or personal property described in the Commission Documents as being leased by the Company
and any of its Subsidiaries is held by them under valid, existing and enforceable leases, except those matters that (A) do not materially
interfere with the use made or proposed to be made of such property by the Company or any of its Subsidiaries or (B) would not be reasonably
expected, individually or in the aggregate, to have a Material Adverse Effect. Each of the properties of the Company and its Subsidiaries
complies with all applicable codes, laws and regulations (including, without limitation, building and zoning codes, laws and regulations
and laws relating to access to such properties), except if and to the extent disclosed in the Disclosure Documents or except for such
failures to comply that would not, individually or in the aggregate, reasonably be expected to interfere in any material respect with
the use made and proposed to be made of such property by the Company and its Subsidiaries or otherwise have a Material Adverse Effect.
None of the Company or its Subsidiaries has received from any Governmental Authorities any notice of any condemnation of, or zoning change
affecting, the properties of the Company and its Subsidiaries, and the Company knows of no such condemnation or zoning change which is
threatened, except for such that would not, individually or in the aggregate, reasonably be expected to interfere in any material respect
with the use made and proposed to be made of such property by the Company and its Subsidiaries or otherwise have a Material Adverse Effect,
individually or in the aggregate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) The Company and its Subsidiaries
own, possess, license or have other rights to use all foreign and domestic patents, patent applications, trade and service marks, trade
and service mark registrations, trade names, copyrights, licenses, inventions, trade secrets, technology, Internet domain names, know-how
and other intellectual property (collectively, the &ldquo;<B><I>Intellectual Property</I></B>&rdquo;), necessary for the conduct of their
respective businesses as now conducted except to the extent that the failure to own, possess, license or otherwise hold adequate rights
to use such Intellectual Property would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
None of the Company&rsquo;s material trademarks, trade names, service marks, service mark registrations, service names, patents, patent
rights, copyrights, inventions, licenses, approvals, government authorizations, trade secrets or other intellectual property rights have
expired or terminated, or, by the terms and conditions thereof, could expire or terminate within two years from the date of this Agreement.
Except as disclosed in the Disclosure Documents (i) there are no rights of third parties to any such Intellectual Property owned by the
Company and its Subsidiaries; (ii) to the Company&rsquo;s knowledge, there is no infringement by third parties of any such Intellectual
Property; (iii) there is no pending or, to the Company&rsquo;s knowledge, threatened action, suit, proceeding or claim by others challenging
the Company&rsquo;s and its Subsidiaries&rsquo; rights in or to any such Intellectual Property, and the Company is unaware of any facts
which could form a reasonable basis for any such action, suit, proceeding or claim; (iv) there is no pending or, to the Company&rsquo;s
knowledge, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property;
(v) there is no pending or, to the Company&rsquo;s knowledge, threatened action, suit, proceeding or claim by others that the Company
and its Subsidiaries infringe or otherwise violate any patent, trademark, copyright, trade secret or other proprietary rights of others;
(vi) to the Company&rsquo;s knowledge, there is no third-party U.S. patent or published U.S. patent application which contains claims
for which an Interference Proceeding (as defined in 35 U.S.C. &sect; 135) has been commenced against any patent or patent application
described in the Commission Documents as being owned by or licensed to the Company; and (vii) the Company and its Subsidiaries have complied
with the terms of each agreement pursuant to which Intellectual Property has been licensed to the Company or such Subsidiary, and all
such agreements are in full force and effect, except, in the case of any of clauses (i)-(vii) above, for any such rights infringement
by third parties or any such pending or threatened suit, action, proceeding or claim as would not, individually or in the aggregate, reasonably
be expected to result in a Material Adverse Effect. The Company and its Subsidiaries have taken commercially reasonable efforts to maintain
the confidentiality of all material trade secrets and other material confidential information of the Company and its Subsidiaries and
any confidential information owned by any Person to whom the Company or any of its Subsidiaries has a written confidentiality obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.14. <U>Actions Pending</U></B>.
There are no actions, suits or proceedings by or before any Governmental Authority or legal proceedings pending, nor, to the Company&rsquo;s
knowledge, any audits or investigations by or before any Governmental Authority to which the Company or a Subsidiary is a party or to
which any property of the Company or any of its Subsidiaries is the subject that, individually or in the aggregate, would reasonably be
expected to have a Material Adverse Effect and, to the Company&rsquo;s knowledge, no such legal proceedings, actions, suits, proceedings,
audits or investigations are threatened or contemplated by any Governmental Authority or threatened by others; and (i) there are no current
or pending audits or investigations, actions, suits or proceedings by or before any Governmental Authority that are required under the
Securities Act to be described in the Disclosure Documents that are not so described; and (ii) there are no contracts or other documents
that are required under the Securities Act to be filed as exhibits to the Disclosure Documents that are not so filed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.15. <U>Compliance
with Laws</U></B>. The Company and each of its Subsidiaries are in compliance with all applicable laws, regulations and statutes (including
all Environmental Laws and regulations) in the jurisdictions in which it carries on business (&ldquo;<B><I>Applicable Laws</I></B>&rdquo;),
except where failure to be so in compliance, individually or in the aggregate, would not reasonably be expected to result in a Material
Adverse Effect; neither the Company or any of its Subsidiaries has received a notice of non-compliance, nor knows of, nor has reasonable
grounds to know of, any facts that could give rise to a notice of non-compliance with any such laws, regulations and statutes, and is
not aware of any pending change or contemplated change to any applicable law or regulation or governmental position; in each case that
would reasonably be expected to materially adversely affect the business of the Company or the business or legal environment under which
the Company or any of its Subsidiaries operates. Each of the Company and its Subsidiaries: (A) has not received any notice of non-compliance,
adverse finding, warning letter, untitled letter or other correspondence or notice from any Governmental Authority alleging or asserting
noncompliance with any Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits and supplements or
amendments thereto required by any such Applicable Laws (&ldquo;<B><I>Authorizations</I></B>&rdquo;); (B) does not know of, nor has any
reasonable grounds to suspect, any facts that could give rise to a notice of non-compliance with any such Applicable Laws; (C) possesses
all material Authorizations and such Authorizations are valid and in full force and effect and are not in material violation of any term
of any such Authorizations; (D) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration
or other action from any Governmental Authority or third party alleging that any product operation or activity is in violation of any
Applicable Laws or Authorizations and has no knowledge that any such Governmental Authority or third party is considering any such claim,
litigation, arbitration, action, suit, investigation or proceeding; (E) has not received notice that any Governmental Authority has taken,
is taking or intends to take action to limit, suspend, modify or revoke any Authorizations and has no knowledge that any such Governmental
Authority is considering such action; (F) has filed, obtained, maintained or submitted all material reports, documents, forms, notices,
applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations and that
all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete and
correct on the date filed (or were corrected or supplemented by a subsequent submission); and (G) has not, either voluntarily or involuntarily,
initiated, conducted, or issued or caused to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety alert,
post-sale warning, or other notice or action relating to the alleged lack of safety or efficacy of any product or any alleged product
defect or violation and, to the Company&rsquo;s knowledge, no third party has initiated, conducted or intends to initiate any such notice
or action, except in the case of each of (A) through (G) above, as would not reasonably be expected, individually or in the aggregate,
to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.16. <U>Certain Fees</U></B>.
Neither the Company nor any of its Subsidiaries has incurred any liability for any finder&rsquo;s fees, brokerage commissions or similar
payments in connection with the transactions herein contemplated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.17. <U>Disclosure</U></B>.
The Company confirms, as of date of each VWAP Purchase Notice (or if such date precedes the applicable VWAP Purchase Date, such VWAP Purchase
Date), that neither it nor any other Person acting on its behalf has provided the Investor or any of its agents, advisors or counsel with
any information that constitutes or would reasonably be expected to constitute material, nonpublic information concerning the Company
or any of its Subsidiaries, other than the existence of the transactions contemplated by the Transaction Documents. The Company understands
and confirms that the Investor will rely on the foregoing representations in effecting resales of Registrable Shares under the Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.18. <U>Broker/Dealer
Relationships</U></B>. Neither the Company nor any of the Subsidiaries (i) is required to register as a &ldquo;broker&rdquo; or &ldquo;dealer&rdquo;
in accordance with the provisions of the Exchange Act or (ii) directly or indirectly through one or more intermediaries, controls or is
a &ldquo;person associated with a member&rdquo; or &ldquo;associated person of a member&rdquo; (within the meaning set forth in the FINRA
Manual).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.19. <U>Accounting
Controls and Disclosure Controls</U></B>. The Company makes and keeps accurate books and records. The Company and each of its Subsidiaries
maintain systems of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with generally accepted accounting principles and to maintain asset accountability; (iii) access to assets is
permitted only in accordance with management&rsquo;s general or specific authorization; and (iv) the recorded accountability for assets
is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company&rsquo;s
internal control over financial reporting is effective and the Company is not aware of any material weaknesses in its internal control
over financial reporting (other than as set forth in the Disclosure Documents). The Company is not aware of any fraud, whether or not
material, that involves management or other employees of the Company. Since the date of the latest audited financial statements of the
Company included in the Disclosure Documents, there has been no change in the Company&rsquo;s internal control over financial reporting
that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal control over financial reporting
(other than as set forth in the Disclosure Documents). The Company has established disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15 and 15d-15) for the Company and designed such disclosure controls and procedures to ensure that material information
relating to the Company and each of its Subsidiaries is made known to the certifying officers by others within those entities, particularly
during the period in which the Company&rsquo;s Annual Report on Form 10-K or Quarterly Report on Form 10-Q, as the case may be, is being
prepared. The Company&rsquo;s certifying officers have evaluated the effectiveness of the Company&rsquo;s disclosure controls and procedures
as of a date within 90 days prior to the filing date of the Form 10-K for the fiscal year most recently ended (such date, the &ldquo;<B><I>Evaluation
Date</I></B>&rdquo;). The Company presented in its Form 10-K for the fiscal year most recently ended the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date and the
disclosure controls and procedures are effective. Since the Evaluation Date, there have been no significant changes in the Company&rsquo;s
internal controls (as such term is defined in Item 307(b) of Regulation S-K under the Securities Act) or, to the Company&rsquo;s knowledge,
in other factors that could significantly affect the Company&rsquo;s internal controls. The Company&rsquo;s auditors and the Audit Committee
of the board of directors have been advised of: (i) any significant deficiencies in the design or operation of internal controls which
could adversely affect the Company&rsquo;s ability to record, process, summarize and report financial data and (ii) any fraud, whether
or not material, that involves management or other employees who have a role in the Company&rsquo;s internal controls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.20. <U>Permits</U>.</B>
The Company and its Subsidiaries have made all filings, applications and submissions required by, and possess and are operating in compliance
with, all approvals, licenses, certificates, certifications, clearances, consents, grants, exemptions, marks, notifications, orders, permits
and other authorizations issued by, the appropriate federal, state or foreign Governmental Authority necessary for the ownership or lease
of their respective properties or to conduct its businesses as described in the Commission Documents (collectively, &ldquo;<B><I>Permits</I></B>&rdquo;),
except for such Permits the failure of which to possess, obtain or make the same would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect; the Company and its Subsidiaries are in compliance with the terms and conditions of all
such Permits, except where the failure to be in compliance would not have a Material Adverse Effect; all of the Permits are valid and
in full force and effect, except where any invalidity, individually or in the aggregate, would not be reasonably expected to have a Material
Adverse Effect; and neither the Company nor any of its Subsidiaries has received any written notice relating to the limitation, revocation,
cancellation, suspension, modification or non-renewal of any such Permit which, individually or in the aggregate, if the subject of an
unfavorable decision, ruling or finding, would reasonably be expected to have a Material Adverse Effect, or has any reason to believe
that any such license, certificate, permit or authorization will not be renewed in the ordinary course.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.21. <U>Environmental
Compliance</U></B>. Except as set forth in the Disclosure Documents, the Company and its Subsidiaries (i) are in compliance with any and
all applicable federal, state, local and foreign laws, rules, regulations, decisions and orders relating to the protection of human health
and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (collectively, &ldquo;<B><I>Environmental
Laws</I></B>&rdquo;); (ii) have received and are in compliance with all permits, licenses or other approvals required of them under applicable
Environmental Laws to conduct their respective businesses; and (iii) have not received any notice or communication from any Governmental
Authority or any other Person regarding any actual, alleged or potential liability for the investigation or remediation of any disposal
or release of hazardous or toxic substances or wastes, pollutants or contaminants, except, in the case of any of clauses (i), (ii) or
(iii) above, for any such failure to comply, failure to receive required permits, licenses, other approvals or liability as would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.22. <U>No Improper
Practices</U></B>. (i) Neither the Company nor the Subsidiaries, nor any director, officer, or employee of the Company or any Subsidiary
nor, to the Company&rsquo;s knowledge, any agent, affiliate or other person acting on behalf of the Company or any Subsidiary has, in
the past five years, made any unlawful contributions to any candidate for any political office (or failed fully to disclose any contribution
in violation of applicable law) or made any contribution or other payment to any official of, or candidate for, any federal, state, municipal,
or foreign office or other person charged with similar public or quasi-public duty in violation of any applicable law or of the character
required to be disclosed in the Disclosure Documents; (ii) no relationship, direct or indirect, exists between or among the Company or
any Subsidiary or any affiliate of any of them, on the one hand, and the directors, officers and stockholders of the Company or any Subsidiary,
on the other hand, that is required by the Securities Act to be described in the Disclosure Documents that is not so described; (iii)
no relationship, direct or indirect, exists between or among the Company or the Subsidiaries or any affiliate of them, on the one hand,
and the directors, officers, or stockholders of the Company or any Subsidiary, on the other hand, that is required by the rules of FINRA
to be described in the Disclosure Documents that is not so described; (iv) except as described in the Disclosure Documents, there are
no material outstanding loans or advances or material guarantees of indebtedness by the Company or any Subsidiary to or for the benefit
of any of their respective officers or directors or any of the members of the families of any of them; and (v) the Company has not offered,
or caused any placement agent to offer, Common Stock to any person with the intent to influence unlawfully (A) a customer or supplier
of the Company or the Subsidiaries to alter the customer&rsquo;s or supplier&rsquo;s level or type of business with the Company or any
Subsidiary or (B) a trade journalist or publication to write or publish favorable information about the Company or the Subsidiaries or
any of their respective products or services, and, (vi) neither the Company nor the Subsidiaries nor any director, officer or employee
of the Company or any Subsidiary nor, to the Company&rsquo;s knowledge, any agent, affiliate or other person acting on behalf of the Company
or any Subsidiary has (A) violated or is in violation of any applicable provision of the U.S. Foreign Corrupt Practices Act of 1977, as
amended, or any other applicable anti-bribery or anti-corruption law (collectively, &ldquo;<B><I>Anti-Corruption Laws</I></B>&rdquo;),
(B) promised, offered, provided, attempted to provide or authorized the provision of anything of value, directly or indirectly, to any
person for the purpose of obtaining or retaining business, influencing any act or decision of the recipient, or securing any improper
advantage; or (C) made any payment of funds of the Company or any Subsidiary or received or retained any funds in violation of any Anti-Corruption
Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.23. <U>AML Compliance</U></B>.
The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record
keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes
of all jurisdictions to which the Company or its Subsidiaries are subject, the rules and regulations thereunder and any related or similar
rules, regulations or guidelines, issued, administered or enforced by any Governmental Authority (collectively, the &ldquo;<B><I>Money
Laundering Laws</I></B>&rdquo;); and no action, suit or proceeding by or before any Governmental Authority involving the Company or any
of its Subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.24. <U>OFAC</U>.
</B>Neither the Company nor any of its Subsidiaries (collectively, the &ldquo;<B><I>Entity</I></B>&rdquo;), nor any director, officer,
any employee, agent, affiliate or representative of the Company or any director or officer of any Subsidiary, is a Person that is, or
is owned or controlled by a Person that is (i) the subject of any sanctions administered or enforced by the (&ldquo;<B><I>OFAC</I></B>&rdquo;),
the United Nations Security Council, the European Union, His Majesty&rsquo;s Treasury, or other relevant sanctions authorities, including,
without limitation, designation on OFAC&rsquo;s Specially Designated Nationals and Blocked Persons List or OFAC&rsquo;s Foreign Sanctions
Evaders List or other relevant sanctions authority (collectively, &ldquo;<B><I>Sanctions</I></B>&rdquo;), nor (ii) located, organized
or resident in a country or territory that is the subject of Sanctions that broadly prohibit dealings with that country or territory (including,
without limitation, the so-called Donetsk People&rsquo;s Republic, or so-called Luhansk People&rsquo;s Republic and the Crimea region
of the Ukraine, Russia, Cuba, Iran, North Korea, Sudan and Syria (the &ldquo;<B><I>Sanctioned Countries</I></B>&rdquo;)). The Entity will
not, directly or indirectly, use the proceeds from the sale of Shares, or lend, contribute or otherwise make available such proceeds to
any subsidiary, joint venture partner or other Person (a) to fund or facilitate any activities or business of or with any Person or in
any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions or is a Sanctioned Country, or
(b) in any other manner that will result in a violation of Sanctions by any Person (including any Person participating in the transactions
contemplated by the Transaction Documents, whether as underwriter, advisor, investor or otherwise). The Entity has not engaged in, and
is now not engaged in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or
transaction is or was the subject of Sanctions or was a Sanctioned Country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.25. <U>Off-Balance
Sheet Arrangements</U></B>. There are no transactions, arrangements and other relationships between and/or among the Company, and/or any
of its affiliates and any unconsolidated entity, including, but not limited to, any structural finance, special purpose or limited purpose
entity (each, an &ldquo;<B><I>Off-Balance Sheet Transaction</I></B>&rdquo;) that could reasonably be expected to affect materially the
Company&rsquo;s liquidity or the availability of or requirements for its capital resources, including those Off-Balance Sheet Transactions
described in the Commission&rsquo;s Statement about Management&rsquo;s Discussion and Analysis of Financial Conditions and Results of
Operations (Release Nos. 33-8056; 34-45321; FR-61), required to be described in the Disclosure Documents which have not been described
as required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.26. <U>Transactions
with Affiliates</U></B>. No relationship, direct or indirect, exists between or among the Company or any of its Subsidiaries on the one
hand, and the directors, officers, trustees, managers, stockholders, partners, customers or suppliers of the Company or any of the Subsidiaries
on the other hand, which would be required by the Securities Act or the Exchange Act to be disclosed in the Disclosure Documents, which
is not so disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.27. <U>Labor Disputes</U></B>.
None of the Company nor any of its Subsidiaries is bound by or subject to any collective bargaining or similar agreement with any labor
union, and, to the knowledge of the Company, none of the employees, representatives or agents of the Company or any of its Subsidiaries
is represented by any labor union. The Company and its Subsidiaries have complied with all employment laws applicable to employees of
the Company and its Subsidiaries, except where non-compliance with any such employment laws would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect. No labor disturbance by or dispute with employees of the Company or any of its
Subsidiaries exists or, to the knowledge of the Company, is threatened which, individually or in the aggregate, would reasonably be expected
to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.28. <U>Use of Proceeds</U></B>.
The proceeds from the sale of the Shares by the Company to Investor shall be used by the Company in the manner as will be set forth in
the Prospectus included in any Registration Statement (and any post-effective amendment thereto) and any Prospectus Supplement thereto
filed pursuant to the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.29. <U>Investment
Company Act Status</U></B>. The Company is not, and as a result of the consummation of the transactions contemplated by the Transaction
Documents and the application of the proceeds from the sale of the Shares as will be set forth in the Prospectus included in any Registration
Statement (and any post-effective amendment thereto) and any Prospectus Supplement thereto filed pursuant to the Registration Rights Agreement
the Company will not be an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.30. <U>Margin Rules</U></B>.
Neither the issuance, sale and delivery of the Shares nor the application of the proceeds thereof by the Company as described in the Disclosure
Documents will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board
of Governors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.31. <U>Taxes</U></B>.
The Company and each of its Subsidiaries have filed all federal, state, local and foreign tax returns which have been required to be filed
and paid all taxes shown thereon through the date hereof, to the extent that such taxes have become due and are not being contested in
good faith, except where the failure to so file or pay would not, individually or in the aggregate, have a Material Adverse Effect. No
tax deficiency has been determined adversely to the Company or any of its Subsidiaries which has had, or would reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect. The Company has no knowledge of any federal, state or other governmental
tax deficiency, penalty or assessment which has been or might be asserted or threatened against it which would, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.32. <U>ERISA</U></B>.
To the knowledge of the Company, each material employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income
Security Act of 1974, as amended (&ldquo;<B><I>ERISA</I></B>&rdquo;), that is maintained, administered or contributed to by the Company
or any of its affiliates for employees or former employees of the Company and any of its Subsidiaries has been maintained in material
compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to
ERISA and the Internal Revenue Code of 1986, as amended (the &ldquo;<B><I>Code</I></B>&rdquo;); no prohibited transaction, within the
meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred which would result in a material liability to the Company with
respect to any such plan excluding transactions effected pursuant to a statutory or administrative exemption; and for each such plan that
is subject to the funding rules of Section 412 of the Code or Section 302 of ERISA, except as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect, the minimum funding standards in Section 412 of the Code have been satisfied
and the fair market value of the assets of each such plan (excluding for these purposes accrued but unpaid contributions) exceeds the
present value of all benefits accrued under such plan determined using reasonable actuarial assumptions; no litigation or governmental
administrative proceeding, audit or other proceeding (other than those relating to routine claims for benefits) is pending or, to the
knowledge of the Company, threatened with respect to any material employee benefit plan or any fiduciary or service provider thereof and,
to the knowledge of the Company, there is no reasonable basis for any such litigation or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.33. <U>Stock Transfer
Taxes</U></B>. All stock transfer or other taxes (other than income taxes) which are required to be paid in connection with the sale and
transfer of the Registrable Shares to be sold hereunder will be, or will have been, fully paid or provided for by the Company and all
laws imposing such taxes will be or will have been fully complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.34. <U>Insurance</U></B>.
The Company and each of its Subsidiaries carry, or are covered by, insurance in such amounts and covering such risks as the Company and
each of its Subsidiaries reasonably believe are adequate for the conduct of their business and as is customary for companies engaged in
similar businesses in similar industries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.35. <U>Exemption
from Registration</U></B>. Subject to, and in reliance on, the representations, warranties and covenants made herein by the Investor,
the offer and sale of the Registrable Shares in accordance with the terms and conditions of this Agreement is exempt from the registration
requirements of the Securities Act pursuant to Section 4(a)(2) and/or Rule 506(b) of Regulation D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.36. <U>No General
Solicitation or Advertising</U></B>. Neither the Company, nor any of its Subsidiaries or Affiliates, nor any Person acting on its or their
behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with
the offer or sale of the Registrable Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.37. <U>No Integrated
Offering</U></B>. None of the Company, its Subsidiaries or any of their Affiliates, nor any Person acting on their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would require
registration of the issuance of any of the Registrable Shares under the Securities Act, whether through integration with prior offerings
or otherwise, or cause this offering of the Shares to require approval of stockholders of the Company under any applicable stockholder
approval provisions, including, without limitation, under the rules and regulations of the Principal Market. None of the Company, its
Subsidiaries, their Affiliates nor any Person acting on their behalf will take any action or steps referred to in the preceding sentence
that would require registration of the issuance of any of the Registrable Shares under the Securities Act or cause the offering of any
of the Shares to be integrated with other offerings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.38. <U>Dilutive Effect</U></B>.
The Company is aware and acknowledges that issuance of the Registrable Shares could cause dilution to existing stockholders and could
significantly increase the outstanding number of shares of Common Stock. The Company further acknowledges that its obligation to issue
the Shares to be purchased by the Investor pursuant to a VWAP Purchase or Intraday VWAP Purchase is, upon the Company&rsquo;s delivery
to the Investor of a VWAP Purchase Notice for a VWAP Purchase or an Intraday VWAP Purchase Notice for an Intraday VWAP Purchase in accordance
with this Agreement, absolute and unconditional following the delivery of such VWAP Purchase Notice or Intraday VWAP Purchase Notice to
the Investor, regardless of the dilutive effect that such issuance may have on the ownership interests of other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.39. <U>Manipulation
of Price</U></B>. Neither the Company nor any of its officers, directors or its Affiliates has, and, to the knowledge of the Company,
no Person acting on their behalf has, (i) taken, directly or indirectly, any action designed or intended to cause or to result in the
stabilization or manipulation of the price of any security of the Company, or which caused or resulted in, or which would in the future
reasonably be expected to cause or result in, the stabilization or manipulation of the price of any security of the Company, in each case
to facilitate the sale or resale of any of the Registrable Shares, (ii) sold, bid for, purchased, or paid any compensation for soliciting
purchases of, any of the Registrable Shares, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase
any other securities of the Company. Neither the Company nor any of its officers, directors or its Affiliates will during the term of
this Agreement, and, to the knowledge of the Company, no Person acting on their behalf will during the term of this Agreement, take any
of the actions referred to in the immediately preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.40. <U>Listing and
Maintenance Requirements; DTC Eligibility</U></B>. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act, and the
Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the
Common Stock under the Exchange Act, nor has the Company received any notification that the Commission is contemplating terminating such
registration. The Company has not received any notice from the Principal Market to the effect that the Company is not in compliance with
the listing or maintenance requirements of the Principal Market or any notice from the Principal Market to the effect that the Company
is not in compliance with the listing or maintenance requirements of the Principal Market that the Company has not appealed or responded
to within the requisite time period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.41. <U>Application
of Takeover Protections</U></B>. The Company and its Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s Charter or the laws of its state of incorporation that is or could become applicable
to the Investor as a result of the Investor and the Company fulfilling their respective obligations or exercising their respective rights
under the Transaction Documents (as applicable), including, without limitation, as a result of the Company&rsquo;s issuance of the Registrable
Shares and the Investor&rsquo;s ownership of the Registrable Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.42. <U>Information
Technology; Compliance with Data Privacy Laws</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) The Company and its Subsidiaries&rsquo;
information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively,
&ldquo;<B><I>IT Systems</I></B>&rdquo;) are adequate for, and operate and perform as required in connection with the operation of the
business of the Company as currently conducted, and, to the Company&rsquo;s knowledge, are free and clear of all bugs, errors, viruses,
Trojan horses, trap doors, time bombs, and any other malware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) Except as would not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect, the Company and its Subsidiaries have implemented and maintain
commercially reasonable physical, technical and administrative controls, policies, procedures, and safeguards designed to maintain and
protect their confidential information and the integrity, continuous operation, redundancy and security of their IT Systems and data,
including all Personal Data (as defined below) and all sensitive, confidential or regulated data (&ldquo;<B><I>Confidential Data</I></B>&rdquo;)
used in connection with their businesses. &ldquo;<B><I>Personal Data</I></B>&rdquo; means (A) a natural person&rsquo;s name, street address,
telephone number, e-mail address, photograph, social security number or tax identification number, driver&rsquo;s license number, passport
number, credit card number, bank information, or customer or account number; (B) any information which would qualify as &ldquo;personally
identifying information&rdquo; under the Federal Trade Commission Act, as amended; (C) &ldquo;personal data&rdquo; as defined by the European
Union General Data Protection Regulation (EU 2016/679); (D) any &ldquo;personal information&rdquo; as defined by the California Consumer
Privacy Act; and (E) any other piece of information that allows the identification of such natural person, or his or her family. Except
as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect: (x) to the knowledge of the
Company, there have been no breaches, violations, outages or unauthorized uses of or accesses to their IT Systems or Personal Data maintained
or processed by the Company, except for those that have been remedied without material cost or liability or the duty to notify any other
person, nor any incidents under internal review or investigations relating to the same and (y) the Company and its Subsidiaries are presently
in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental
or regulatory authority, external policies and contractual obligations relating to the privacy and security of their IT Systems, Confidential
Data, and Personal Data (collectively, &ldquo;<B><I>Privacy Laws</I></B>&rdquo;) and to the protection of such IT Systems, Confidential
Data, and Personal Data from unauthorized use, access, misappropriation or modification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) Except as would not reasonably
be expected, individually or in the aggregate, to have a Material Adverse Effect: (i) to the extent required by applicable Privacy Laws,
the Company has in place commercially reasonable policies and procedures relating to data privacy and security and the collection, storage,
use, processing, disclosure, handling, and analysis of Personal Data and Confidential Data (the &ldquo;<B><I>Policies</I></B>&rdquo;);
(ii) the Company has made disclosures to users or customers to the extent required by applicable Privacy Laws, and none of such disclosures
made or contained in any Policy have been inaccurate or in violation of any applicable Privacy Laws; (iii) neither the Company nor any
Subsidiary has received written notice of any actual or potential liability under or relating to, or actual or potential violation of,
any applicable Privacy Laws, and there is no action, suit or proceeding by or before any court or governmental agency, authority or body
pending or, to the Company&rsquo;s knowledge, threatened alleging non-compliance with any applicable Privacy Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.43. <U>Acknowledgement
Regarding Investor&rsquo;s Acquisition of Shares; Affiliate Relationships</U>.</B> The Company acknowledges and agrees, to the fullest
extent permitted by law, that the Investor is acting solely in the capacity of an arm&rsquo;s-length purchaser with respect to this Agreement
and the transactions contemplated by the Transaction Documents. The Company further acknowledges that the Investor will be deemed to be
a statutory &ldquo;underwriter&rdquo; with respect to the transactions contemplated by the Transaction Documents in accordance with interpretive
positions of the Commission and the Investor is a &ldquo;trader&rdquo; that is registered with the Commission as a broker-dealer under
Section 15(a) of the Securities Exchange Act of 1934. The Company further acknowledges that the Investor and its representatives are not
acting as a financial advisor or fiduciary of the Company (or in any similar capacity, except as noted above) with respect to this Agreement
and the transactions contemplated by the Transaction Documents, and any advice given by the Investor or any of its representatives or
agents in connection therewith is merely incidental to the Investor&rsquo;s acquisition of the Shares. The Company further represents
to the Investor that the Company&rsquo;s decision to enter into the Transaction Documents to which it is a party has been based solely
on the independent evaluation of the transactions contemplated thereby by the Company and its representatives. The Company acknowledges
and agrees that the Investor has not made and does not make any representations or warranties with respect to the transactions contemplated
by the Transaction Documents other than those specifically set forth in <U>Article IV</U>. Affiliates of the Investor engage in a wide
range of activities for their own accounts and the accounts of customers, including corporate finance, mergers and acquisitions, merchant
banking, equity and fixed income sales, trading and research, derivatives, foreign exchange, futures, asset management, custody, clearance
and securities lending. In the course of its business, affiliates of Investor may, directly or indirectly, hold long or short positions,
trade and otherwise conduct such activities in or with respect to debt or equity securities and/or bank debt of, and/or derivative products
relating to, the Company. Any such position will be created, and maintained, independently of the position Investor takes in the Company,
and Investor. In addition, at any given time Affiliates of Investor may have been and/or be engaged by one or more entities that may be
competitors with, or otherwise adverse to, the Company in matters unrelated to the transactions contemplated by the Transaction Documents,
and Affiliates of Investor may have or may in the future provide investment banking or other services to the Company in matters unrelated
to the transactions contemplated by the Transaction Documents. Activities of any of Investor&rsquo;s Affiliates performed on behalf of
the Company may give rise to actual or apparent conflicts of interest given Investor&rsquo;s potentially competing interests with those
of the Company. The Company expressly acknowledges the benefits it receives from Investor&rsquo;s participation in the transactions contemplated
by the Transaction Documents, on the one hand, and Investor&rsquo;s affiliates&rsquo; activities, if any, on behalf of the Company unrelated
to the transactions contemplated by the Transaction Documents, on the other hand, and understands the conflict or potential conflict of
interest that may arise in this regard, and has consulted with such independent advisors as it deems appropriate in order to understand
and assess the risks associated with these potential conflicts of interest. Consistent with applicable legal and regulatory requirements,
applicable Affiliates of the Investor have adopted policies and procedures to establish and maintain the independence of their research
departments and personnel from their investment banking groups and Investor. As a result, research analysts employed by Affiliates of
the Investor may hold views, make statements or investment recommendations and/or publish research reports with respect to the Company
or the transactions contemplated by the Transaction Documents that differ from the views of Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.44. <U>Regulatory
Filings</U></B>. Except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect and except
as disclosed in the Disclosure Documents, neither the Company nor any of its Subsidiaries has failed to file with the applicable Governmental
Authorities, any required filing, declaration, listing, registration, report or submission, except for such failures that, as would not
reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect; except as disclosed in the Disclosure Documents,
all such filings, declarations, listings, registrations, reports or submissions were in compliance with applicable laws when filed and
no deficiencies have been asserted by any applicable regulatory authority with respect to any such filings, declarations, listings, registrations,
reports or submissions that have not yet been remedied, except for any deficiencies that, as would not reasonably be expected, individually
or in the aggregate, to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.45. <U>Government
Contracts.</U></B> Neither the Company nor any of its Subsidiaries is party to: (i) any Contract, including an individual task order,
delivery order, purchase order, basic ordering agreement, letter Contract or blanket purchase agreement with any Governmental Authority
or (ii) any subcontract or other Contract by which the Company or one of its Subsidiaries has agreed to provide goods or services through
a prime contractor directly to a Governmental Authority that is expressly identified in such subcontract or other Contract as the ultimate
consumer of such goods or services (such Contracts, &ldquo;<B><I>Government Contracts</I></B>&rdquo;). Neither the Company nor any of
its Subsidiaries has provided any offer, bid, quotation or proposal to sell products made or services provided by the Company or any of
its Subsidiaries that, if accepted or awarded, would lead to any Contract or subcontract of the type described by the foregoing sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 5.47. <U>Certificates</U></B>.
Any certificate signed by any officer, including the Chief Executive Officer, Chief Financial Officer, General Counsel or representative
of the Company or any of its subsidiaries and delivered to the Investor or counsel for the Investor in connection with the transactions
contemplated by the Transaction Documents shall be deemed a representation and warranty by the Company to the Investor as to the matters
covered thereby on the date of such certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
VI&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>ADDITIONAL
COVENANTS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company covenants with the
Investor, and the Investor covenants with the Company, as follows, which covenants of one party are for the benefit of the other party,
during the Restricted Period (and with respect to the Company, for the period following the termination of this Agreement specified in
<U>Section 8.3</U> pursuant to and in accordance with <U>Section 8.3</U>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.1. <U>Securities
Compliance</U></B>. The Company shall notify the Commission and the Principal Market, if and as applicable, in accordance with their respective
rules and regulations, of the transactions contemplated by the Transaction Documents, and shall take all necessary action, undertake all
proceedings and obtain all registrations, permits, consents and approvals for the legal and valid issuance of the Shares to the Investor
in accordance with the terms of the Transaction Documents, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.2. <U>Reservation
of Common Stock</U></B>. The Company has available and the Company shall reserve and keep available at all times, free of preemptive and
other similar rights of stockholders, the requisite aggregate number of authorized but unissued shares of Common Stock to enable the Company
to timely effect the issuance, sale and delivery of all Shares to be issued, sold and delivered in respect of each VWAP Purchase or Intraday
VWAP Purchase effected under this Agreement. Without limiting the generality of the foregoing, as of the Commencement Date, the Company
shall have reserved, out of its authorized and unissued Common Stock, a number of shares of Common Stock equal to the Exchange Cap solely
for the purpose of effecting VWAP Purchases and Intraday VWAP Purchases under this Agreement. The number of shares of Common Stock so
reserved for the purpose of effecting VWAP Purchases and Intraday VWAP Purchases under this Agreement may be increased from time to time
by the Company from and after the Commencement Date, and such number of reserved shares may be reduced from and after the Commencement
Date only by the number of Shares actually issued, sold and delivered to the Investor pursuant to any VWAP Purchase or Intraday VWAP Purchase
effected from and after the Commencement Date pursuant to this Agreement. The Company shall use its commercially reasonable efforts to
obtain shareholder approval as required by the applicable rules of the Principal Market, for issuances of Shares in excess of the Exchange
Cap no later than the Company&rsquo;s next proxy statement filing, which may be in connection with a special meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.3. <U>Registration
and Listing</U></B>. The Company shall use its commercially reasonable efforts to cause the Common Stock to continue to be registered
as a class of securities under Sections 12(b) of the Exchange Act, and to comply with its reporting and filing obligations under the Exchange
Act, and shall not take any action or file any document (whether or not permitted by the Securities Act or the Exchange Act) to terminate
or suspend such registration or to terminate or suspend its reporting and filing obligations under the Exchange Act or Securities Act,
except as permitted herein. The Company shall use its commercially reasonable efforts to continue the listing and trading of its Common
Stock and the listing of the Shares to be issued, sold and delivered in respect of each VWAP Purchase or Intraday VWAP Purchase effected
under this Agreement hereunder on the Principal Market and to comply with the Company&rsquo;s reporting, filing and other obligations
under the rules and regulations of the Principal Market. The Company shall not take any action which could be reasonably expected to result
in the delisting or suspension of the Common Stock on the Principal Market. If the Company receives any final and non-appealable notice
that the listing or quotation of the Common Stock on the Principal Market shall be terminated on a date certain or any notice that the
listing or quotation of the Common Stock on the Principal Market shall be terminated on a date certain that the Company has not appealed
or responded to within the requisite time period, the Company shall promptly (and in any case within 24 hours) notify the Investor of
such fact in writing and shall use its commercially reasonable efforts to cause the Common Stock to be listed or quoted on another Principal
Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.4. <U>Compliance
with Laws</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) The Company shall comply with
applicable provisions of the Securities Act and the Exchange Act, including Regulation M thereunder, applicable state securities or &ldquo;Blue
Sky&rdquo; laws, and applicable listing rules of the Principal Market, in connection with the transactions contemplated by the Transaction
Documents, except as would not, individually or in the aggregate, prohibit or otherwise interfere with the ability of the Company to enter
into and perform its obligations under this Agreement in any material respect or the ability of the Investor to sell or resell shares
of Common Stock under the Registration Statement in any material respect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) The Investor shall comply with
all laws, rules, regulations and orders applicable to the performance by it of its obligations under this Agreement and its investment
in the Shares, except as would not, individually or in the aggregate, prohibit or otherwise interfere with the ability of the Investor
to enter into this Agreement and to purchase or acquire the Shares in accordance with the terms hereof in any material respect. Without
limiting the foregoing, the Investor shall comply with all applicable provisions of the Securities Act and the Exchange Act, including
Regulation M thereunder, and all applicable state securities or &ldquo;Blue Sky&rdquo; laws, in connection with the transactions contemplated
by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.5. <U>Keeping of
Records and Books of Account; Due Diligence</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) The Investor and the Company
shall each maintain records showing the remaining Total Commitment, the remaining Aggregate Limit and the dates and VWAP Purchase Share
Amount or Intraday VWAP Purchase Share Amount for each VWAP Purchase and Intraday VWAP Purchase, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) Subject to the requirements
of <U>Section 6.12</U>, from time to time from and after the Closing Date, the Company shall make available for inspection and review
by the Investor during normal business hours and after reasonable notice, customary documentation reasonably requested by the Investor
and/or its appointed counsel or advisors to conduct due diligence; <U>provided</U>, <U>however</U>, that after the Closing Date, the Investor&rsquo;s
continued due diligence shall not be a condition precedent to the Company&rsquo;s right to deliver to the Investor any VWAP Purchase Notice
or Intraday VWAP Purchase Notice or the settlement thereof except to the extent expressly contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.6. <U>No Frustration;
No Specified Transactions; No Equity Lines of Credit</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) <B><U>No Frustration</U></B>.
The Company shall not enter into, announce or recommend to its stockholders any agreement, plan, arrangement or transaction in or of which
the terms thereof would restrict, materially delay, conflict with or impair the ability or right of the Company to perform its obligations
under the Transaction Documents, including, without limitation, the obligations of the Company to deliver the Shares to the Investor in
respect of a VWAP Purchase or Intraday VWAP Purchase not later than the VWAP Purchase Share Delivery Date. For the avoidance of doubt,
nothing in this <U>Section 6.6(a)</U> shall in any way limit the Company&rsquo;s right to terminate this Agreement in accordance with
<U>Section 8.2</U> (subject in all cases to <U>Section 8.3</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) <B><U>No Specified Transactions</U></B>.
The Company shall not effect or enter into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock
or Common Stock Equivalents (or a combination of units thereof) involving a Specified Transaction other than in connection with an Exempt
Issuance. The Investor shall be entitled to seek injunctive relief against the Company and its Subsidiaries to preclude any such issuance,
which remedy shall be in addition to any right to collect damages, without the necessity of showing economic loss and without any bond
or other security being required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.7. <U>Corporate Existence</U></B>.
The Company shall take all steps necessary to preserve and continue the corporate existence of the Company; <U>provided</U>, <U>however</U>,
that, except as provided in <U>Section 6.8</U>, nothing in this Agreement shall be deemed to prohibit the Company from engaging in any
Fundamental Transaction with another Person. For the avoidance of doubt, nothing in this <U>Section 6.7</U> shall in any way limit the
Company&rsquo;s right to terminate this Agreement in accordance with <U>Section 8.2</U> (subject in all cases to <U>Section 8.3</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.8. <U>Fundamental
Transaction</U></B>. If a VWAP Purchase Notice or Intraday VWAP Purchase Notice has been delivered to the Investor, the Company shall
not effect any Fundamental Transaction until the expiration of five (5) Trading Days following the later of (i) the date on which the
Company has issued all Shares issuable pursuant to the VWAP Purchase or Intraday VWAP Purchase to which such VWAP Purchase Notice or Intraday
VWAP Purchase Notice relates and (ii) the date on which the Investor has paid to the Company the VWAP Purchase Amount for all Shares issuable
pursuant to the VWAP Purchase or Intraday VWAP Purchase to which such VWAP Purchase Notice or Intraday VWAP Purchase Notice relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.9. <U>Selling Restrictions</U></B>.
Except as expressly set forth below, the Investor covenants that none of the Investor or any entity managed or controlled by the Investor
(collectively, the <B>&ldquo;</B>Restricted Persons<B>&rdquo;</B> and each of the foregoing is referred to herein as a &ldquo;<B><I>Restricted
Person</I></B>&rdquo;) shall, directly or indirectly, (i) engage in any Short Sales of the Common Stock or (ii) hedging transaction, which,
with respect to each of clauses (i) and (ii) hereof, establishes a net short position with respect to the Common Stock (i.e., taking into
account the holdings of all Restricted Persons), either for its own principal account or for the principal account of any other Restricted
Person. Notwithstanding the foregoing, it is expressly understood and agreed that nothing contained herein shall (without implication
that the contrary would otherwise be true) prohibit any Restricted Person during the Restricted Period from: (1) selling <B>&ldquo;</B>long<B>&rdquo;</B>
(as defined under Rule 200 promulgated under Regulation SHO) the Shares or any other shares of Common Stock or the Company<B>&rsquo;</B>s
other securities; or (2) selling a number of shares of Common Stock equal to the number of Shares that such Restricted Person may purchase
under a pending VWAP Purchase Notice or Intraday VWAP Purchase Notice but has not yet received from the Company or the Transfer Agent
pursuant to this Agreement, so long as (x) such Restricted Person (including the Investor or any Broker-Dealer it designates, as applicable)
delivers the Shares purchased pursuant to such VWAP Purchase Notice or Intraday VWAP Purchase Notice to the purchaser thereof or the applicable
Broker-Dealer promptly upon such Restricted Person<B>&rsquo;</B>s receipt of such Shares from the Company in accordance with <U>Section
3.2</U> of this Agreement or (y) the Company or the Transfer Agent fails for any reason to deliver such Shares to the Investor or any
Broker-Dealer it designates so that such Shares are received by the Investor on the applicable VWAP Purchase Share Delivery Date in accordance
with <U>Section 3.2</U> of this Agreement, including, without limitation, within the time period specified for receipt of such Shares
by the Investor or its Broker-Dealer from the Company or the Transfer Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.10. <U>Effective
Registration Statement</U></B>. The Company shall use its best efforts to maintain the continuous effectiveness of the Initial Registration
Statement and each New Registration Statement filed with the Commission under the Securities Act for the applicable Registration Period
pursuant to and in accordance with the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.11. <U>Blue Sky</U></B>.
The Company shall take such action, if any, as is necessary by the Company in order to obtain an exemption for or to qualify the Shares
for sale by the Company to the Investor pursuant to the Transaction Documents, and at the request of the Investor, the subsequent resale
of Registrable Securities by the Investor, in each case, under applicable state securities or &ldquo;Blue Sky&rdquo; laws and shall provide
evidence of any such action so taken to the Investor from time to time following the Closing Date; <U>provided</U>, <U>however</U>, that
the Company shall not be required in connection therewith or as a condition thereto to (x) qualify to do business in any jurisdiction
where it would not otherwise be required to qualify but for this <U>Section 6.11</U>, (y) subject itself to general taxation in any such
jurisdiction, or (z) file a general consent to service of process in any such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.12. <U>Non-Public
Information</U></B>. Neither the Company or any of its Subsidiaries, nor any of their respective directors, officers, employees or agents
shall disclose any material non-public information about the Company to the Investor, unless a simultaneous public announcement thereof
is made by the Company in the manner contemplated by Regulation FD. In the event of a breach of the foregoing covenant by the Company
or any of its Subsidiaries, or any of their respective directors, officers, employees and agents (as determined in the reasonable good
faith judgment of the Investor), (i) the Investor shall promptly provide written notice of such breach to the Company and (ii) after such
notice has been provided to the Company and, provided that the Company shall have failed to demonstrate to the Investor in writing within
24 hours that such information does not constitute material, non-public information or the Company shall have failed to publicly disclose
such material, non-public information within 24 hours following demand therefor by the Investor, in addition to any other remedy provided
herein or in the other Transaction Documents, the Investor may in its sole discretion return such Shares to the Company and the Company
shall immediately return any VWAP Purchase Amount that the Investor has paid for any Shares held by the Investor at the time of the disclosure
of material, non-public information. The Investor may also, in its sole discretion, return Shares it is holding at the time of any receipt
of notice from the Company of the happening of any event of the kind described in Section 3(p)(x), 3(p)(y) or the first sentence of 3(f)
of the Registration Rights Agreement, in which case the Company shall immediately return any VWAP Purchase Amount that the Investor paid
for such Shares; provided that any Shares, as of the date of any such proposed return, are not the subject of a VWAP Purchase Notice dated
30 days or more prior to the date of any such proposed return.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.13. <U>Broker/Dealer</U></B>.
The Investor shall use one or more broker-dealers (which may be the Investor) to effectuate all sales, if any, of the Shares that it may
purchase or otherwise acquire from the Company pursuant to the Transaction Documents, as applicable, which (or whom) shall be a DTC participant
(collectively, the &ldquo;<B><I>Broker-Dealer</I></B>&rdquo;). The Investor shall, from time to time, provide the Company and the Transfer
Agent with all information regarding the Broker-Dealer reasonably requested by the Company. The Investor shall be solely responsible for
all fees and commissions of the Broker-Dealer (if any), which shall not exceed customary brokerage fees and commissions and shall be responsible
for designating only a DTC participant eligible to receive the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.14. <U>FINRA Filing
and Fee</U></B>. In connection with the filing to be made with the FINRA Corporate Financing Department (the &ldquo;<B><I>Department</I></B>&rdquo;)
pursuant to Rule 5110 of the FINRA Manual with respect to the transactions contemplated by this Agreement (the &ldquo;<B><I>FINRA Filing</I></B>&rdquo;),
on or prior to the date of the initial FINRA Filing, the Company shall pay the applicable FINRA filing fee by wire transfer of immediately
available funds. The Company shall provide Investor with any information and documents reasonably requested by the Investor in order to
complete the FINRA Filing and obtain as promptly as practicable a letter from the Department to the effect that the Department has determined
not to raise any objection with respect to the fairness and reasonableness of the terms of the transactions contemplated by the Transaction
Documents (a &ldquo;<B><I>No Objections Letter</I></B>&rdquo;). The Commencement Date shall not occur until such No Objections Letter
has been received.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.15. <U>Qualified
Independent Underwriter</U></B>. <FONT STYLE="background-color: white">If required, p</FONT>rior to the Effective Date of the Initial
Registration Statement, the Company agrees to cooperate with the Investor and execute such documentation as may reasonably by required
to engage a Qualified Independent Underwriter (&ldquo;<B><I>QIU</I></B>&rdquo;) and (ii) the Company shall cause any opinion or opinions,
10b-5 letter, comfort letters and Bring-Down Comfort Letters to be delivered under this Agreement to be addressed to the QIU in addition
to the Investor, unless FINRA has advised the Company prior to the Effective Date of the Initial Registration Statement that a QIU is
not required to participate in the transactions contemplated by the Transaction Documents pursuant to Rule 5121 of the FINRA Manual.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.16. <U>Delivery of
Bring-Down Opinions and Officer&rsquo;s and Secretary&rsquo;s Certificates Upon Occurrence of Certain Events</U></B>. The Company agrees
that on or prior to the earlier of the date of the first VWAP Purchase Notice or first Intraday VWAP Purchase Notice and, during the term
of this Agreement, within three (3) Trading Days after each of the following: (i) the date of filing of an annual report on Form 10-K
under the Exchange Act (including any Form 10-K/A containing amended financial information or a material amendment to the previously filed
Form 10-K); (ii) the date of filing of a quarterly report on Form 10-Q under the Exchange Act; (iii) the date of filing of a current report
on Form 8-K containing amended financial information (other than information &ldquo;furnished&rdquo; pursuant to Items 2.02 or 7.01 of
Form 8-K or to provide disclosure pursuant to Item 8.01 of Form 8-K relating to the reclassification of certain properties as discontinued
operations in accordance with Statement of Financial Accounting Standards No. 144) under the Exchange Act; (iv) the date of effectiveness
of the Initial Registration Statement, any New Registration Statement, or any supplement or post-effective amendment thereto, or (v) the
date of each reasonable request by the Investor, not more than once per calendar quarter (the date within such three (3) Trading Days
after the foregoing dates in items (i) through (v) on which the documents set forth in items (1) through (3) below are delivered, each,
a &ldquo;<B><I>Representation Date</I></B>&rdquo;) the Company shall (1) deliver to the Investor an Officer&rsquo;s Certificate in the
form attached hereto as <U>Exhibit B</U> (the &ldquo;<B><I>Officer&rsquo;s Certificate</I></B>&rdquo;), dated as of such Representation
Date, and a Secretary&rsquo;s Certificate in the form attached hereto as <U>Exhibit C</U> (the &ldquo;<B><I>Secretary&rsquo;s Certificate</I></B>&rdquo;),
dated as of such Representation Date, (2) cause to be furnished to the Investor an opinion and a 10b-5 letter, dated as of such Representation
Date, each from outside counsel to the Company and in the form mutually agreed to by the Company and the Investor prior to the date of
this Agreement and (3) cause to be furnished to the Investor a comfort letter, dated as of such Representation Date (each such letter,
a &ldquo;<B><I>Bring-Down Comfort Letter</I></B>&rdquo;) from Baker or such other accounting firm as applicable, who has audited any financial
statements of the Company, its predecessors or any other entity included or incorporated by reference in the Registration Statement <FONT STYLE="background-color: white">and
the Prospectus</FONT>, (in the case of a post-effective amendment, only if such amendment contains amended or new financial information),
<FONT STYLE="background-color: white">or any other </FONT>independent registered public accounting firm <FONT STYLE="background-color: white">that
has certified financial statements of any Acquired Entity, in each case, that are included or incorporated by reference in the Registration
Statement and the Prospectus,</FONT> modified, as necessary, to relate to such Registration Statement or post-effective amendment, or
the Prospectus contained therein as then amended or supplemented by such Prospectus Supplement, as applicable, each in the form mutually
agreed to by the Company and the Investor prior to the date of this Agreement. <FONT STYLE="background-color: white">The Investor shall
have been furnished with such further certificates and documents as it may reasonably request. For the avoidance of doubt, following a
Representation Date, the right of the Company to deliver VWAP Purchase Notices or Intraday VWAP Purchase Notices under this Agreement,
and the obligation of the Investor to accept VWAP Purchase Notices or Intraday VWAP Purchase Notices under this Agreement, are subject
to the Company having delivered to the Investor the Officer&rsquo;s Certificate, the Secretary&rsquo;s Certificate, opinions, 10b-5 letter
and Bring-Down Comfort Letters referred to in clauses (1) through (3) above, each for the most recent Representation Date</FONT>, and
the Company having informed the Investor on a Trading Day that is at least ten (10) calendar days on or prior to the earlier of the date
of the first VWAP Purchase Notice or first Intraday VWAP Purchase Notice or any upcoming Representation Date of such upcoming VWAP Purchase
Notice or such Intraday VWAP Purchase Notice or upcoming Representation Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.17. <U>Trading in
the Common Stock</U></B>. The Company consents to the Investor&rsquo;s trading in Company&rsquo;s Common Stock for the Investor&rsquo;s
own account and for the account of its clients at the same time as sales of Shares occur pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 6.18. <U>At-The-Market
Transactions</U></B>. The Company and Investor acknowledge that, as of the date of this Agreement, offers and sales of Shares by the Company
pursuant to a Form S-3 Registration Statement are limited under General Instruction I.B.6 for Form S-3 (the &ldquo;<B><I>Baby Shelf Rule</I></B>&rdquo;).
Prior to or promptly upon the Company becoming eligible for use of a Registration Statement on Form S-3 without limitations on the amount
of securities that may be sold under such Registration Statement on Form S-3 pursuant General Instruction I.B.6., the Company and the
Investor shall enter into an equity distribution or sales agreement &nbsp;(the &ldquo;<B><I>ATM Agreement</I></B>&rdquo;) providing for
&ldquo;at-the-market&rdquo; sales of Common Stock through Investor (or its designee) as the Company&rsquo;s sole placement agent, which
agreement shall include representations and warranties of the Company and Investor, and economics to the Company and the Investors&nbsp;substantively
equivalent to those set forth in this Agreement. The Company and the Investor agree to cooperate in good faith and use their respective
reasonable best efforts to enter into the ATM Agreement and to file and cause to become effective a Form S-3 Registration Statement with
respect to such &ldquo;at-the-market&rdquo; offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
VII&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>CONDITIONS
TO CLOSING AND CONDITIONS TO THE SALE AND PURCHASE OF THE SHARES</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 7.1. <U>Conditions
Precedent to Closing</U></B>. The Closing is subject to the satisfaction of each of the conditions set forth in this <U>Section 7.1</U>
on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(i) <B><U>Accuracy of
the Investor&rsquo;s Representations and Warranties</U></B>. The representations and warranties of the Investor contained in this Agreement
(a) that are not qualified by &ldquo;materiality&rdquo; shall be true and correct in all material respects as of the Closing Date, except
to the extent such representations and warranties are as of another date, in which case, such representations and warranties shall be
true and correct in all material respects as of such other date and (b) that are qualified by &ldquo;materiality&rdquo; shall be true
and correct as of the Closing Date, except to the extent such representations and warranties are as of another date, in which case, such
representations and warranties shall be true and correct as of such other date.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(ii) <B><U>Accuracy of
the Company&rsquo;s Representations and Warranties</U></B>. The representations and warranties of the Company contained in this Agreement
(a) that are not qualified by &ldquo;materiality&rdquo; or &ldquo;Material Adverse Effect&rdquo; shall be true and correct in all material
respects as of the Closing Date, except to the extent such representations and warranties are as of another date, in which case, such
representations and warranties shall be true and correct in all material respects as of such other date and (b) that are qualified by
&ldquo;materiality&rdquo; or &ldquo;Material Adverse Effect&rdquo; shall be true and correct as of the Closing Date, except to the extent
such representations and warranties are as of another date, in which case, such representations and warranties shall be true and correct
as of such other date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(iii) <B><U>Closing Deliverables</U></B>.
At the Closing, counterpart signature pages of this Agreement and the Registration Rights Agreement executed by each of the parties hereto
shall be delivered as provided in <U>Section 2.2</U>. Simultaneously with the execution and delivery of this Agreement and the Registration
Rights Agreement, the Investor&rsquo;s counsel shall have (a) agreed to the forms of opinions to be delivered to the Investor on the Commencement
Date, and (b) agreed to the forms of the Officer&rsquo;s Certificate and the Secretary&rsquo;s Certificate to be delivered to the Investor
on the Commencement Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 7.2. <U>Conditions
Precedent to Commencement</U></B>. The right of the Company to commence delivering VWAP Purchase Notices or Intraday VWAP Purchase Notices
under this Agreement, and the obligation (or option, as applicable) of the Investor to accept VWAP Purchase Notices or Intraday VWAP Purchase
Notices delivered to the Investor by the Company under this Agreement, are subject to the initial satisfaction, at Commencement, of each
of the conditions set forth in this <U>Section 7.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(i) <B><U>Accuracy of
the Company&rsquo;s Representations and Warranties</U></B>. The representations and warranties of the Company contained in this Agreement
(a) that are not qualified by &ldquo;materiality&rdquo; or &ldquo;Material Adverse Effect&rdquo; shall have been true and correct in all
material respects when made and shall be true and correct in all material respects as of the Commencement Date with the same force and
effect as if made on such date, except to the extent such representations and warranties are as of another date, in which case, such representations
and warranties shall be true and correct in all material respects as of such other date and (b) that are qualified by &ldquo;materiality&rdquo;
or &ldquo;Material Adverse Effect&rdquo; shall have been true and correct when made and shall be true and correct as of the Commencement
Date with the same force and effect as if made on such date, except to the extent such representations and warranties are as of another
date, in which case, such representations and warranties shall be true and correct as of such other date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(ii) <B><U>Performance
of the Company</U></B>. The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by this Agreement and the Registration Rights Agreement to be performed, satisfied or complied with by the Company
at or prior to the Commencement. The Company shall deliver to the Investor on the Commencement Date an Officer&rsquo;s Certificate and
a Secretary&rsquo;s Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(iii) <B><U>Initial Registration
Statement Effective</U></B>. The Initial Registration Statement covering the resale by the Investor of the Registrable Securities included
therein required to be filed by the Company with the Commission pursuant to Section 2(a) of the Registration Rights Agreement shall have
been declared effective under the Securities Act by the Commission, and the Investor shall be permitted to utilize the Prospectus therein
to resell all of the Shares included in such Prospectus and FINRA shall have issued a &ldquo;No Objections&rdquo; letter allowing for
the distribution of securities to the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(iv) <B><U>No Material
Notices</U></B>. None of the following events shall have occurred and be continuing: (a) receipt of any request by the Commission or any
other federal or state governmental authority for any additional information relating to the Initial Registration Statement, the Prospectus
contained therein or any Prospectus Supplement thereto, or for any amendment of or supplement to the Initial Registration Statement, the
Prospectus contained therein or any Prospectus Supplement thereto; (b) the issuance by the Commission or any other federal or state governmental
authority of any stop order suspending the effectiveness of the Initial Registration Statement or prohibiting or suspending the use of
the Prospectus contained therein or any Prospectus Supplement thereto, or of the suspension of qualification or exemption from qualification
of the Shares for offering or sale in any jurisdiction, or the initiation or contemplated initiation of any proceeding for such purpose
or the receipt of a notice of objection of the Commission to the use of the Initial Registration Statement pursuant to Rule 401(g)(2)
of the 1933 Act Regulations; (c) the objection of FINRA to the terms of the transactions contemplated by the Transaction Documents or
to the compensation in connection with this Agreement or (d) the occurrence of any event or the existence of any condition or state of
facts, which makes any statement of a material fact made in the Initial Registration Statement, the Prospectus contained therein or any
Prospectus Supplement thereto untrue or which requires the making of any additions to or changes to the statements then made in the Initial
Registration Statement, the Prospectus contained therein or any Prospectus Supplement thereto in order to state a material fact required
by the Securities Act to be stated therein or necessary in order to make the statements then made therein (in the case of the Prospectus
or any Prospectus Supplement, in the light of the circumstances under which they were made) not misleading, or which requires an amendment
to the Initial Registration Statement or a supplement to the Prospectus contained therein or any Prospectus Supplement thereto to comply
with the Securities Act or any other law. The Company shall have no knowledge of any event that would reasonably be expected to have the
effect of causing the suspension of the effectiveness of the Initial Registration Statement or the prohibition or suspension of the use
of the Prospectus contained therein or any Prospectus Supplement thereto in connection with the resale of the Registrable Securities by
the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(v) <B><U>Other Commission
Filings</U></B>. The Current Report shall have been filed with the Commission as required pursuant to <U>Section 2.3</U>. The final Prospectus
included in the Initial Registration Statement shall have been filed with the Commission prior to Commencement in accordance with <U>Section
2.3</U> and the Registration Rights Agreement. All reports, schedules, registrations, forms, statements, information and other documents
required to have been filed by the Company with the Commission pursuant to the reporting requirements of the Exchange Act, including all
material required to have been filed pursuant to Section 13(a) or 15(d) of the Exchange Act prior to Commencement, shall have been timely
filed with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(vi) <B><U>No Suspension
of Trading in or Notice of Delisting of Common Stock</U></B>. Trading in the Common Stock shall not have been suspended by the Commission,
the Principal Market or FINRA (except for any suspension of trading of limited duration agreed to by the Company, which suspension shall
be terminated prior to the Commencement Date), the Company shall not have received any final and non-appealable notice that the listing
or quotation of the Common Stock on the Principal Market shall be terminated on a date certain or any notice that the listing or quotation
of the Common Stock on the Principal Market shall be terminated on a date certain that the Company has not appealed or responded to within
the requisite time period (unless, prior to such date certain, the Common Stock is listed or quoted on any other Principal Market), nor
shall there have been imposed any suspension of, or restriction on, accepting additional deposits of the Common Stock, electronic trading
or book-entry services by DTC with respect to the Common Stock that is continuing, the Company shall not have received any notice from
DTC to the effect that a suspension of, or restriction on, accepting additional deposits of the Common Stock, electronic trading or book-entry
services by DTC with respect to the Common Stock is being imposed or is contemplated (unless, prior to such suspension or restriction,
DTC shall have notified the Company in writing that DTC has determined not to impose any such suspension or restriction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(vii) <B><U>Compliance
with Laws</U></B>. The Company shall have complied with all applicable federal, state and local governmental laws, rules, regulations
and ordinances in connection with the execution, delivery and performance of this Agreement and the other Transaction Documents to which
it is a party and the consummation of the transactions contemplated hereby and thereby, including, without limitation, the Company shall
have obtained all permits and qualifications required by any applicable state securities or &ldquo;Blue Sky&rdquo; laws for the offer
and sale of the Shares by the Company to the Investor and the subsequent resale of the Registrable Securities by the Investor (or shall
have the availability of exemptions therefrom).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(viii) <B><U>No Injunction</U></B>.
No statute, regulation, order, decree, writ, ruling or injunction shall have been enacted, entered, promulgated, threatened or endorsed
by any court or governmental authority of competent jurisdiction which prohibits the consummation of or which would materially modify
or delay any of the transactions contemplated by the Transaction Documents.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(ix) <B><U>No Proceedings
or Litigation</U></B>. No action, suit or proceeding before any arbitrator or any court or governmental authority shall have been commenced,
and no inquiry or investigation by any governmental authority shall have been commenced, against the Company or any Subsidiary, or any
of the officers, directors or Affiliates of the Company or any Subsidiary, seeking to restrain, prevent or change the transactions contemplated
by the Transaction Documents, including by way of restraining trading in the shares of the Common Stock on the Principal Market, or seeking
material damages in connection with such transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(x) <B><U>Listing of Shares</U></B>.
All of the Shares that have been and may be issued pursuant to this Agreement shall have been approved for listing or quotation on the
Principal Market as of the Commencement Date, subject only to notice of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(xi) <B><U>No Material
Adverse Effect</U></B>. No condition, occurrence, state of facts or event constituting a Material Adverse Effect shall have occurred and
be continuing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(xii) <B><U>No Bankruptcy
Proceedings</U></B>. No Person shall have commenced a proceeding against the Company pursuant to or within the meaning of any Bankruptcy
Law. The Company shall not have, pursuant to or within the meaning of any Bankruptcy Law, (a) commenced a voluntary case, (b) consented
to the entry of an order for relief against it in an involuntary case, (c) consented to the appointment of a Custodian of the Company
or for all or substantially all of its property, or (d) made a general assignment for the benefit of its creditors. A court of competent
jurisdiction shall not have entered an order or decree under any Bankruptcy Law that (I) is for relief against the Company in an involuntary
case, (II) appoints a Custodian of the Company or for all or substantially all of its property, or (III) orders the liquidation of the
Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(xiii) <B><U>Delivery
of Commencement Irrevocable Transfer Agent Instructions and Notice of Effectiveness</U></B>. The Commencement Irrevocable Transfer Agent
Instructions shall have been executed by the Company and delivered to acknowledged in writing by the Company&rsquo;s Transfer Agent, and
the Notice of Effectiveness relating to the Initial Registration Statement shall have been executed by the Company&rsquo;s outside counsel
and delivered to the Transfer Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(xiv) <B><U>Certificates</U></B>.
The Company shall have delivered the Officer&rsquo;s Certificate and the Secretary&rsquo;s Certificate, dated the Commencement Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(xv) <B><U>Reservation
of Shares</U></B>. As of the Commencement Date, the Company shall have reserved out of its authorized and unissued Common Stock a number
of shares of Common Stock equal to the Exchange Cap solely for the purpose of effecting VWAP Purchases and Intraday VWAP Purchases under
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(xvi) <B><U>Opinions of
Company Counsel</U></B>. On the Commencement Date, the Investor shall have received an opinion and a 10b-5 letter, dated as of the Commencement
Date, each from outside counsel to the Company, each in the form mutually agreed to by the Company and the Investor prior to the date
of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(xvii) <B><U>Comfort Letter
of Accountants</U></B>. On the Commencement Date, the Investor shall have received from Baker <FONT STYLE="background-color: white">or
any other </FONT>independent registered public accounting firm, who has audited any financial statements of the Company, its predecessors,
any Acquired Entity or any other entity, <FONT STYLE="background-color: white">in each case, that are included or incorporated by reference
in the Registration Statement and the Prospectus</FONT>, a comfort letter dated as of the Commencement Date addressed to the Investor,
in form and substance reasonably satisfactory to the Investor with respect to the audited and unaudited financial statements and certain
financial information contained in the Registration Statement and the Prospectus, and any Prospectus Supplement, except that the specific
date referred to therein for the carrying out of procedures shall be no more than three business days prior to the Commencement Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(xviii) <B><U>Due Diligence
Review</U></B>. In connection with the Commencement Date, the Company will timely cooperate with any reasonable due diligence review conducted
by the Investor or counsel for the Investor in connection with the sale of Shares contemplated herein, including upon reasonable notice,
providing such information and making available such documents and appropriate corporate officers, as the Investor may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(xix) <B><U>Additional
Documents</U></B>. <FONT STYLE="background-color: white">The Investor shall have been furnished with such further certificates and documents
as it may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(xx) <B><U>Research and
Marketing Efforts</U></B>. Neither the Investor nor any Affiliate of the Investor shall have, during the thirty (30) calendar day period
immediately prior to, but not including, the Commencement Date (or of such shorter period as specified in the last sentence of this Section
7.2(xix)): (i) published or distributed any research report (as such term is defined in Rule 500 of Regulation AC) concerning the Company
or (ii) assisted the Company with, or participated in, any activities in connection with the marketing of the Company&rsquo;s shares of
Common Stock, including without limitation, any non-deal road shows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 7.3. <U>Conditions
Precedent to VWAP Purchases after Commencement Date</U></B>. The right of the Company to deliver VWAP Purchase Notices or Intraday VWAP
Purchase Notices under this Agreement after the Commencement Date, and the obligation of the Investor to accept VWAP Purchase Notices
or Intraday VWAP Purchase Notices under this Agreement after the Commencement Date, are subject to the satisfaction of each of the conditions
set forth in this <U>Section 7.3</U> at the applicable VWAP Purchase Commencement Time for the VWAP Purchase or the applicable Intraday
VWAP Purchase Commencement Time for the Intraday VWAP Purchase to be effected pursuant to the applicable VWAP Purchase Notice or Intraday
VWAP Purchase Notice timely delivered by the Company to the Investor in accordance with this Agreement, including the conditions set forth
in <U>Section 3.1</U> of this Agreement (each such time, a &ldquo;<B><I>VWAP Purchase Condition Satisfaction Time</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(i) <B><U>Satisfaction
of Certain Prior Conditions</U></B>. Each of the conditions set forth in subsections <U>(i)</U>, <U>(ii)</U>, <U>(v) </U>through <U>(xii)</U>
and <U>(xvii)</U> through <U>(xxi)</U> set forth in <U>Section 7.2</U> shall be satisfied at the applicable VWAP Purchase Condition Satisfaction
Time after the Commencement Date (with the terms &ldquo;<B><I>Commencement</I></B>&rdquo; and &ldquo;<B><I>Commencement Date</I></B>&rdquo;
in the conditions set forth in subsections (i), (ii) and (xix) of <U>Section 7.2</U> replaced with &ldquo;<B><I>applicable VWAP Purchase
Condition Satisfaction Time</I></B>&rdquo;); <U>provided</U>, <U>however</U>, that the Company shall not be required to deliver the Officer&rsquo;s
Certificate and Secretary&rsquo;s Certificate after the Commencement Date, except as provided in <U>Section 6.16</U> and <U>Section 7.3(x)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(ii) <B><U>Initial Registration
Statement Effective</U></B>. The Initial Registration Statement covering the resale by the Investor of the Registrable Securities included
therein required to be filed by the Company with the Commission pursuant to Section 2(a) of the Registration Rights Agreement, and any
post-effective amendment thereto required to be filed by the Company with the Commission after the Commencement Date and prior to the
applicable VWAP Purchase Date pursuant to the Registration Rights Agreement, in each case shall have been declared effective under the
Securities Act by the Commission and shall remain effective for the applicable Registration Period (as defined in the Registration Rights
Agreement), and the Investor shall be permitted to (and to continue to) utilize the Prospectus therein, and any Prospectus Supplement
thereto, to resell all of the Shares included in the Initial Registration Statement, and any post-effective amendment thereto, that have
been issued and sold to the Investor hereunder pursuant to all VWAP Purchase Notices and Intraday VWAP Purchase Notices delivered by the
Company to the Investor prior to such applicable VWAP Purchase Date, and all of the Shares included in the Initial Registration Statement,
and any post-effective amendment thereto, that are issuable pursuant to the applicable VWAP Purchase Notice or Intraday VWAP Purchase
Notice delivered by the Company to the Investor with respect to a VWAP Purchase or Intraday VWAP Purchase to be effected hereunder on
such applicable VWAP Purchase Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(iii) <B><U>Any Required
New Registration Statement Effective</U></B>. Any New Registration Statement covering the resale by the Investor of the Registrable Securities
included therein, and any post-effective amendment thereto, required to be filed by the Company with the Commission pursuant to the Registration
Rights Agreement after the Commencement Date and prior to the applicable VWAP Purchase Date, in each case shall have been declared effective
under the Securities Act by the Commission and shall remain effective for the applicable Registration Period, and the Investor shall be
permitted to utilize the Prospectus therein, and any Prospectus Supplement thereto, to resell, (s) all of the Shares included in such
New Registration Statement, and any post-effective amendment thereto, that have been issued and sold to the Investor hereunder pursuant
to all VWAP Purchase Notices and Intraday VWAP Purchase Notices delivered by the Company to the Investor prior to such applicable VWAP
Purchase Date and (b) all of the Shares included in such new Registration Statement, and any post-effective amendment thereto, that are
issuable pursuant to the applicable VWAP Purchase Notice or Intraday VWAP Purchase Notice delivered by the Company to the Investor with
respect to a VWAP Purchase or Intraday VWAP Purchase to be effected hereunder on such applicable VWAP Purchase Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(iv) <B><U>Delivery of
Notice of Effectiveness</U></B>. With respect to any post-effective amendment to the Initial Registration Statement, any New Registration
Statement or any post-effective amendment to any New Registration Statement, in each case declared effective by the Commission after the
Commencement Date, the Company shall have delivered or caused to be delivered to the Transfer Agent the Notice of Effectiveness, in each
case modified as necessary to refer to such Registration Statement or post-effective amendment and the Registrable Securities included
therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(v) <B><U>No Material
Notices</U></B>. None of the following events shall have occurred and be continuing: (a) receipt of any request by the Commission or any
other federal or state governmental authority for any additional information relating to the Initial Registration Statement or any post-effective
amendment thereto, any New Registration Statement or any post-effective amendment thereto, or the Prospectus contained in any of the foregoing
or any Prospectus Supplement thereto, or for any amendment of or supplement to the Initial Registration Statement or any post-effective
amendment thereto, any New Registration Statement or any post-effective amendment thereto, or the Prospectus contained in any of the foregoing
or any Prospectus Supplement thereto; (b) the issuance by the Commission or any other federal or state governmental authority of any stop
order suspending the effectiveness of the Initial Registration Statement or any post-effective amendment thereto, any New Registration
Statement or any post-effective amendment thereto, or prohibiting or suspending the use of the Prospectus contained in any of the foregoing
or any Prospectus Supplement thereto, or of the suspension of qualification or exemption from qualification of the Shares for offering
or sale in any jurisdiction, or the initiation or contemplated initiation of any proceeding for such purpose or the receipt of a notice
of objection of the Commission to the use of the Initial Registration Statement pursuant to Rule 401(g)(2) of the 1933 Act Regulations;
(c) the objection of FINRA to the terms of the transactions contemplated by the Transaction Documents or to the underwriting compensation
or (d) the occurrence of any event or the existence of any condition or state of facts, which makes any statement of a material fact made
in the Initial Registration Statement or any post-effective amendment thereto, any New Registration Statement or any post-effective amendment
thereto, or the Prospectus contained in any of the foregoing or any Prospectus Supplement thereto untrue or which requires the making
of any additions to or changes to the statements then made in the Initial Registration Statement or any post-effective amendment thereto,
any New Registration Statement or any post-effective amendment thereto, or the Prospectus contained in any of the foregoing or any Prospectus
Supplement thereto in order to state a material fact required by the Securities Act to be stated therein or necessary in order to make
the statements then made therein (in the case of the Prospectus or any Prospectus Supplement, in the light of the circumstances under
which they were made) not misleading, or which requires an amendment to the Initial Registration Statement or any post-effective amendment
thereto, any New Registration Statement or any post-effective amendment thereto, or the Prospectus contained in any of the foregoing or
any Prospectus Supplement thereto to comply with the Securities Act or any other law (other than the transactions contemplated by the
applicable VWAP Purchase Notice or Intraday VWAP Purchase Notice delivered by the Company to the Investor with respect to a VWAP Purchase
or Intraday VWAP Purchase to be effected hereunder on such applicable VWAP Purchase Date and the settlement thereof). The Company shall
have no knowledge of any event that would reasonably be expected to have the effect of causing the suspension of the effectiveness of
the Initial Registration Statement or any post-effective amendment thereto, any New Registration Statement or any post-effective amendment
thereto, or the prohibition or suspension of the use of the Prospectus contained in any of the foregoing or any Prospectus Supplement
thereto in connection with the resale of the Registrable Securities by the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(vi) <B><U>Other Commission
Filings</U></B>. The final Prospectus included in any post-effective amendment to the Initial Registration Statement, and any Prospectus
Supplement thereto, required to be filed by the Company with the Commission pursuant to <U>Section 2.3</U> and the Registration Rights
Agreement after the Commencement Date and prior to the applicable VWAP Purchase Date, shall have been filed with the Commission in accordance
with <U>Section 2.3</U> and the Registration Rights Agreement. The final Prospectus included in any New Registration Statement and in
any post-effective amendment thereto, and any Prospectus Supplement thereto, required to be filed by the Company with the Commission pursuant
to <U>Section 2.3</U> and the Registration Rights Agreement after the Commencement Date and prior to the applicable VWAP Purchase Date,
shall have been filed with the Commission in accordance with <U>Section 2.3</U> and the Registration Rights Agreement. All reports, schedules,
registrations, forms, statements, information and other documents required to have been filed by the Company with the Commission pursuant
to the reporting requirements of the Exchange Act, including all material required to have been filed pursuant to Section 13(a) or 15(d)
of the Exchange Act, after the Commencement Date and prior to the applicable VWAP Purchase Date, shall have been filed with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(vii) <B><U>No Suspension
of Trading in or Notice of Delisting of Common Stock</U></B>. Trading in the Common Stock shall not have been suspended by the Commission,
the Principal Market or the FINRA (except for any suspension of trading of limited duration agreed to by the Company, which suspension
shall be terminated prior to the applicable VWAP Purchase Date), the Company shall not have received any final and non-appealable notice
that the listing or quotation of the Common Stock on the Principal Market shall be terminated on a date certain or any notice that the
listing or quotation of the Common Stock on the Principal Market shall be terminated on a date certain that the Company has not appealed
or responded to within the requisite time period (unless, prior to such date certain, the Common Stock is listed or quoted on any other
Principal Market), nor shall there have been imposed any suspension of, or restriction on, accepting additional deposits of the Common
Stock, electronic trading or book-entry services by DTC with respect to the Common Stock that is continuing, the Company shall not have
received any notice from DTC to the effect that a suspension of, or restriction on, accepting additional deposits of the Common Stock,
electronic trading or book-entry services by DTC with respect to the Common Stock is being imposed or is contemplated (unless, prior to
such suspension or restriction, DTC shall have notified the Company in writing that DTC has determined not to impose any such suspension
or restriction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(viii) <B><U>Certain Limitations</U></B>.
The issuance and sale of the Shares issuable pursuant to the applicable VWAP Purchase Notice (and, if applicable, the Shares issuable
pursuant to an Intraday VWAP Purchase Notice delivered for the same VWAP Purchase Date) shall not (a) without the Investor&rsquo;s express
written agreement, exceed the applicable VWAP Purchase Commitment Amount; provided that for the avoidance of doubt, the Investor shall
not be obligated to purchase any amount of Shares that is in excess of the VWAP Purchase Commitment Amount, (b) without the Investor&rsquo;s
express written agreement, cause the Aggregate Limit or the Beneficial Ownership Limitation to be exceeded, or (c) cause the Exchange
Cap (to the extent applicable under <U>Section 3.3</U>) to be exceeded, unless (in the case of this clause (c)), the Company&rsquo;s stockholders
have theretofore approved the issuance of Common Stock under this Agreement in excess of the Exchange Cap in accordance with the applicable
rules of the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(ix) <B><U>Shares Authorized
and Delivered</U></B>. All of the Shares issuable pursuant to the applicable VWAP Purchase Notice or Intraday VWAP Purchase Notice shall
have been duly authorized by all necessary corporate action of the Company. All Shares relating to all prior VWAP Purchase Notices and
Intraday VWAP Purchase Notices required to have been received by the Investor under this Agreement prior to the applicable VWAP Purchase
Condition Satisfaction Time for the applicable VWAP Purchase or Intraday VWAP Purchase shall have been delivered to the Investor in accordance
with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(x) <B><U>Bring-Down Opinions
of Company Counsel, Bring-Down Comfort Letters and Officer&rsquo;s Certificates and Secretary&rsquo;s Certificates</U></B>. The Investor
shall have received (a) an opinion and a 10b-5 letter, dated as of the most recent Representation Date, each from outside counsel to the
Company, for which the Company was obligated to instruct its outside counsel to deliver to the Investor prior to the applicable VWAP Purchase
Condition Satisfaction Time for the applicable VWAP Purchase or Intraday VWAP Purchase, (b) all Bring-Down Comfort Letters, dated as of
the most recent Representation Date, provided by the Company&rsquo;s auditors and delivered to the Investor prior to the applicable VWAP
Purchase Condition Satisfaction Time for the applicable VWAP Purchase or Intraday VWAP Purchase and (c) all Officer&rsquo;s Certificates
and Secretary&rsquo;s Certificates, dated as of the most recent Representation Date, from the Company that the Company was obligated to
deliver to the Investor prior to the applicable VWAP Purchase Condition Satisfaction Time for the applicable VWAP Purchase or Intraday
VWAP Purchase, in each case in accordance with <U>Section 6.16</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(xi) <B><U>Trading in
the Common Stock</U></B>. The Company consents to the Investor&rsquo;s trading in the Company&rsquo;s Common Stock for the Investor&rsquo;s
own account and for the account of its clients at the same time as sales of Shares occur pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(xii) <B><U>Due Diligence
Review</U></B>. In connection with each Representation Date, the Company will timely cooperate with any reasonable due diligence review
conducted by the Investor or counsel for the Investor in connection with the sale of Shares contemplated herein, including upon reasonable
notice, providing such information and making available such documents and appropriate corporate officers, as the Investor may reasonably
request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(xiii) <B><U>Material
Non-Public Information</U></B>. Neither the Company nor, in the Investor&rsquo;s sole discretion, the Investor, shall be in possession
of any material non-public information concerning the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(xiv) <B><U>Payment of
Expenses</U></B>. The Company shall be in compliance with its obligations pursuant to <U>Section 10.1(i)</U> of this Agreement and invoices
for reimbursement of the fees and disbursements of legal counsel to the Investor shall not be more than 18 days in arrears.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
VIII&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>TERMINATION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 8.1. <U>Automatic Termination</U></B>.
Unless earlier terminated as provided hereunder, this Agreement shall terminate automatically on the earliest to occur of (i) the 36-month
anniversary of the Effective Date of the Initial Registration Statement (it being hereby acknowledged and agreed that such term may be
extended by the parties hereto), (ii) the date on which the Investor shall have purchased the Total Commitment worth of Shares pursuant
to this Agreement, (iii) the date on which the Common Stock shall have failed to be listed or quoted on the Principal Market or any successor
Principal Market, and (iv) the date on which, pursuant to or within the meaning of any Bankruptcy Law, the Company commences a voluntary
case or any Person commences a proceeding against the Company, a Custodian is appointed for the Company or for all or substantially all
of its property, or the Company makes a general assignment for the benefit of its creditors (each date of such termination, an &ldquo;<B><I>Automatic
Termination Event</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 8.2. <U>Other Termination</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) Subject to <U>Section 8.3</U>,
the Company may terminate this Agreement after the Commencement effective upon ten (10) Trading Days&rsquo; prior written notice to the
Investor in accordance with <U>Section 10.4</U> (the date of such termination, a &ldquo;<B><I>Company Termination Event</I></B>&rdquo;);
<U>provided</U>, <U>however</U>, that (i) the Company shall have reimbursed the fees and disbursements of legal counsel required to be
paid to the Investor or its counsel pursuant to <U>Section 10.1</U> of this Agreement, and (ii) prior to issuing any press release, or
making any public statement or announcement, with respect to such termination, the Company shall consult with the Investor and its counsel
on the form and substance of such press release or other disclosure. Subject to <U>Section 8.3</U>, this Agreement may be terminated at
any time by the mutual written consent of the parties, effective as of the date of such mutual written consent unless otherwise provided
in such written consent. Subject to <U>Section 8.3</U>, the Investor shall have the right to terminate this Agreement effective upon ten
(10) Trading Days&rsquo; prior written notice to the Company, which notice shall be made in accordance with <U>Section 10.4</U>, if: (a)
any condition, occurrence, state of facts or event constituting a Material Adverse Effect has occurred and is continuing; (b) a Fundamental
Transaction shall have occurred; or (c) the Company is in breach or default in any material respect of any of its covenants and agreements
in the Registration Rights Agreement, and, if such breach or default is capable of being cured, such breach or default is not cured within
fifteen (15) Trading Days after notice of such breach or default is delivered to the Company pursuant to <U>Section 10.4</U>; (d) while
a Registration Statement, or any post-effective amendment thereto, is required to be maintained effective pursuant to the terms of the
Registration Rights Agreement and the Investor holds any Registrable Securities, the effectiveness of such Registration Statement, or
any post-effective amendment thereto, lapses for any reason (including, without limitation, the issuance of a stop order by the Commission)
or such Registration Statement or any post-effective amendment thereto, the Prospectus contained therein or any Prospectus Supplement
thereto otherwise becomes unavailable to the Investor for the resale of all of the Registrable Securities included therein in accordance
with the terms of the Registration Rights Agreement, and such lapse or unavailability continues for a period of forty-five (45) consecutive
Trading Days or for more than an aggregate of ninety (90) Trading Days in any three hundred and sixty-five (365)-day period, other than
due to acts of the Investor; (e) trading in the Common Stock on the Principal Market (or successor Principal Market) shall have been suspended
and such suspension continues for a period of five (5) consecutive Trading Days; (f) the Company is in material breach or default of any
of its covenants and agreements contained in this Agreement, and, if such breach or default is capable of being cured, such breach or
default is not cured within fifteen (15) Trading Days after notice of such breach or default is delivered to the Company pursuant to <U>Section
10.4</U> of this Agreement; or (g) the Company has been required to pay the Cover Price or similar charges under <U>Section 3.2</U> of
this Agreement more than twice. Unless notification thereof is required elsewhere in this Agreement (in which case such notification shall
be provided in accordance with such other provision), the Company shall promptly (but in no event later than twenty-four (24) hours) notify
the Investor (and, if required under applicable law, including, without limitation, Regulation FD promulgated by the Commission, or under
the applicable rules and regulations of the Principal Market (or successor Principal Market), the Company shall publicly disclose such
information in accordance with Regulation FD and the applicable rules and regulations of the Principal Market (or successor Principal
Market, as applicable)) upon becoming aware of any of the events set forth in the immediately preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) In addition, after notice and
a reasonable opportunity to cure, the Company will have a right to terminate the Investor&rsquo;s engagement hereunder for cause in the
event of the Investor&rsquo;s material failure to provide the services contemplated hereunder (other than a failure caused by or as a
result of circumstances outside of the Investor&rsquo;s control (including, without limitation, market, economic or political conditions))
(a &ldquo;<B><I>Termination for Cause</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 8.3. <U>Effect of Termination</U></B>.
In the event of termination by the Company or the Investor (other than by mutual termination) pursuant to <U>Section 8.2</U>, written
notice thereof shall forthwith be given to the other party as provided in <U>Section 10.4</U> and the transactions contemplated by this
Agreement following the effectiveness of termination shall be terminated without further action by either party as of the effectiveness
of termination. If this Agreement is terminated as provided in <U>Section 8.1</U> or <U>Section 8.2</U>, this Agreement shall become void
and of no further force and effect, except that (i) the provisions of <U>Article V</U> (Representations, Warranties and Covenants of the
Company), <U>Article IX</U> (Indemnification), <U>Article X</U> (Miscellaneous) and this <U>Article VIII </U>(Termination) shall remain
in full force and effect indefinitely notwithstanding such termination, and, (ii) so long as the Investor owns any Registrable Shares,
the covenants and agreements of the Company contained in <U>Article VI</U> (Additional Covenants) shall remain in full force and notwithstanding
such termination for a period of six (6) months following such termination. Notwithstanding anything in this Agreement to the contrary,
no termination of this Agreement by any party shall (i) become effective prior to the second (2nd) Trading Day immediately following the
date on which the purchase of Shares by the Investor pursuant to any pending VWAP Purchase or Intraday VWAP Purchase has been fully settled,
including, without limitation, the delivery by the Company to the Investor of all Shares purchased by the Investor pursuant to such pending
VWAP Purchase or Intraday VWAP Purchase on the applicable VWAP Purchase Share Delivery Date therefor, and the delivery by the Investor
to the Company of the aggregate VWAP Purchase Price payable by the Investor for such Shares, in each case in accordance with the settlement
procedures set forth in <U>Section 3.2</U> of this Agreement (it being hereby acknowledged and agreed that no termination of this Agreement
shall limit, alter, modify, change or otherwise affect any of the Company&rsquo;s or the Investor&rsquo;s rights or obligations under
the Transaction Documents with respect to any pending VWAP Purchase or Intraday VWAP Purchase that has not fully settled, and that the
parties shall fully perform their respective obligations with respect to any such pending VWAP Purchase or Intraday VWAP Purchase under
the Transaction Documents), (ii) limit, alter, modify, change or otherwise affect the Company&rsquo;s or the Investor&rsquo;s rights or
obligations under the Registration Rights Agreement, all of which shall survive any such termination, or (iii) affect the reimbursement
of fees and disbursements of legal counsel to the Investor, which shall be non-refundable when paid pursuant to <U>Section 10.1(i)</U>.
Nothing in this <U>Section 8.3</U> shall be deemed to release the Company or the Investor from any liability for any breach or default
under this Agreement, the Registration Rights Agreement or any of the other Transaction Documents, or to impair the rights of the Company
and the Investor to compel specific performance by the other party of its obligations under this Agreement, the Registration Rights Agreement
or any of the other Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
IX&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>INDEMNIFICATION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 9.1. <U>Indemnification
of Investor</U></B>. In consideration of the Investor&rsquo;s execution and delivery of this Agreement and acquiring the Shares hereunder
and in addition to all of the Company&rsquo;s other obligations under the Transaction Documents, subject to the provisions of this <U>Section
9.1</U>, the Company shall indemnify and hold harmless the Investor, its affiliates, each of their respective directors, officers, stockholders,
members, partners, employees, agents and representatives (and any other Persons with a functionally equivalent role of a Person holding
such titles notwithstanding the lack of such title or any other title) and each Person, if any, who controls the Investor within the meaning
of the Securities Act or the Exchange Act and each of the directors, officers, stockholders, members, partners, employees, agents, and
representatives (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding the lack of
such title or any other title) of such controlling Person (each, an &ldquo;<B><I>Investor Party</I></B>&rdquo; and collectively, the &ldquo;<B><I>Investor
Parties</I></B><I>&rdquo;</I>), from and against all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses
(including all judgments, amounts paid in settlement, court costs, all reasonable out-of-pocket legal or other expenses reasonably incurred
in investigating, preparing or defending any litigation, commenced or threatened, or any claim whatsoever), amounts paid in settlement
or expenses, joint or several, (collectively, &ldquo;<B><I>Claims</I></B>&rdquo;) reasonably incurred in investigating, preparing or defending
any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or governmental,
administrative or other regulatory agency, body or the Commission, whether commenced, pending or threatened, whether or not an Investor
Party is or may be a party thereto (&ldquo;<B><I>Indemnified Damages</I></B>&rdquo;), to which any Investor Party may become subject insofar
as such Claims (or actions or proceedings, whether commenced or threatened, in respect thereof) are (a) as a result of, relate to or arise
out of, or are based upon any untrue statement or alleged untrue statement of a material fact contained in any Commission Document (or
any amendment thereto), or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to
make the statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a material fact included
in any Commission Document, or the omission or alleged omission therefrom of a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U>, <U>however</U>, that this indemnity
in (a) shall not apply to any Claim to the extent arising out of an untrue statement or omission, or alleged untrue statement or omission
in a Commission Document, made in reliance upon and in conformity with information furnished in writing to the Company by the Investor
for the Investor expressly for use in connection with the preparation of the Registration Statement, Prospectus or Prospectus Supplement
or any such amendment thereof or supplement thereto (it being hereby acknowledged and agreed that the written information set forth on
<U>Exhibit B</U> to the Registration Rights Agreement is the only written information furnished to the Company by or on behalf of the
Investor expressly for use in any Registration Statement, Prospectus or Prospectus Supplement), (b) incurred or suffered to the extent
of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any Governmental Authority, commenced
or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission,
(c) incurred or suffered in investigating, preparing or defending against any litigation, or any investigation or proceeding by any Governmental
Authority, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue
statement or omission (whether or not a party), to the extent that any such expense is not paid under (a) or (b) above, (d) as a result
of, relating to or arising out of any breach by the Company of its representations, warranties, covenants or agreements under this Agreement,
or (e) as a result of, relating to or arising out of any other action, suit, claim or proceeding against an Investor Party arising out
of or otherwise in connection with the Transaction Documents. The Company agrees to promptly notify the Investor of the commencement of
any litigation or proceedings against the Company or any of its officers, directors or controlling persons in connection with the issue
and sale of the Shares or in connection with the Registration Statement or the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company shall reimburse any
Investor Party promptly upon demand (with accompanying presentation of documentary evidence) for all legal and other costs and expenses
reasonably incurred by such Investor Party in connection with (i) any action, suit, claim or proceeding, whether at law or in equity,
to enforce compliance by the Company with any provision of the Transaction Documents or (ii) any other any action, suit, claim or proceeding,
whether at law or in equity, with respect to which it is entitled to indemnification under this <U>Section 9.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 9.2. <U>Indemnification
Procedures</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) Promptly after an Investor Party
receives notice of a claim or the commencement of an action for which the Investor Party intends to seek indemnification under <U>Section
9.1</U>, the Investor Party will notify the Company in writing of the claim or commencement of the action, suit or proceeding; <U>provided</U>,
<U>however</U>, that failure to notify the Company will not relieve the Company from liability under <U>Section 9.1</U>, except to the
extent it has been materially prejudiced by the failure to give such notice as evidenced by the forfeiture of by the Company of substantive
rights or defenses. The Company will be entitled to participate in the defense of any claim, action, suit or proceeding as to which indemnification
is being sought, and if the Company acknowledges in writing the obligation to indemnify the Investor Party against whom the claim or action
is brought, the Company may (but will not be required to) assume the defense against the claim, action, suit or proceeding with counsel
reasonably satisfactory to Investor Party. After the Company notifies the Investor Party that the Company wishes to assume the defense
of a claim, action, suit or proceeding, the Company will not be liable for any further legal or other expenses incurred by the Investor
Party in connection with the defense against the claim, action, suit or proceeding unless (1) the employment of counsel by the Investor
Party has been authorized in writing by the Company, (2) the Investor Party has reasonably concluded (based on advice of counsel) that
there may be legal defenses available to it or another Investor Party that are different from or in addition to those available to the
Company, (3) a conflict or potential conflict exists (based on advice of counsel to the Investor Party) between an Investor Party and
the Company (in which case the Company will not have the right to direct the defense of such action on behalf of the Investor Party) or
(4) the Company has not in fact employed counsel to assume the defense of such action or counsel reasonably satisfactory to the indemnified
party, in each case, within a reasonable time after receiving notice of the commencement of the action; in each of which cases the reasonable
fees, disbursements and other charges of counsel will be at the expense of the Company. It is understood that the Company shall not, in
connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other
charges of more than one separate firm (plus local counsel) admitted to practice in such jurisdiction at any one time for all such similarly
situated Investor Parties. The Company will not be liable for any settlement of any action effected without its prior written consent,
which consent shall not be unreasonably withheld, delayed or conditioned. Notwithstanding anything in this Agreement, if at any time an
Investor Party shall have requested the Company to reimburse the Investor Party for fees and expenses of counsel as contemplated by the
third sentence of this paragraph, the Company agrees that it shall be liable for any settlement of any proceeding effected without its
written consent if (i) such settlement is entered into more than fifteen (15) days after receipt by the Company of the aforesaid request
and (ii) the Company shall not have reimbursed the Investor Party in accordance with such request prior to the date of such settlement.
The Company shall not, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any
judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this section (whether or not
any indemnified party is a party thereto), unless such settlement, compromise or consent (1) includes an express and unconditional release
of each indemnified party, in form and substance reasonably satisfactory to such indemnified party, from all liability arising out of
such litigation, investigation, proceeding or claim and (2) does not include a statement as to or an admission of fault, culpability or
a failure to act by or on behalf of any indemnified party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) To the fullest extent permissible
under applicable law, if the indemnification, hold harmless and/or exoneration rights, obligations and undertakings by the Company set
forth in <U>Section 9.1</U> are unavailable to Investor in whole or in part for any reason whatsoever (including in accordance with the
proviso in <U>Section 9.1(a))</U>, the Company, in lieu of indemnifying, holding harmless or exonerating Investor, shall pay, in the first
instance, the entire amount incurred by Investor for losses, liabilities, obligations, claims, contingencies, damages, costs and expenses
(including all judgments, amounts paid in settlement, court costs, all legal or other expenses reasonably incurred in investigating, preparing
or defending any litigation, commenced or threatened, or any claim whatsoever), in connection with any actual or threatened proceeding
without requiring Investor to contribute to such payment, and the Company hereby waives and relinquishes any right of contribution it
may have at any time against Investor. However, if any provision of this Agreement is held to be void, invalid, or unenforceable, any
liability Investor may have arising out of or relating to the Transaction Documents or the Commission Document (or any amendment thereto),
for loss or damage to which any other persons have also contributed, shall be several, and not joint, and, shall be limited to the fees
Investor actually receives pursuant to this Agreement, and in no event shall the Investor be obligated to contribute any amount to the
Company in excess of the aggregate discount to the VWAP for all purchase made by the Investor under this Agreement. No exclusion or limitation
on the liability of other responsible persons imposed or agreed at any time shall affect any assessment of Investor&rsquo;s liability
hereunder, nor shall settlement of or difficulty enforcing any claim, or the death, dissolution or insolvency of any such other responsible
persons or their ceasing to be liable for the loss or damage or any portion thereof, affect any such assessment. Investor does not accept
liability to any third party. For purposes of this <U>Section 9.2(b)</U>, any person who controls a party to this Agreement within the
meaning of the Securities Act, any affiliates of the Investor Party and any officers, directors, partners, employees or agents of the
Investor Party or any of its affiliates, will have the same rights to contribution as that party, and each director of the Company and
each officer of the Company who signed the Registration Statement will have the same rights to contribution as the Company, subject in
each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action
against such party in respect of which a claim for contribution may be made under this <U>Section 9.2(b)</U>, will notify any such party
or parties from whom contribution may be sought, but the omission to so notify will not relieve that party or parties from whom contribution
may be sought from any other obligation it or they may have under this <U>Section 9.2(b)</U> except to the extent that the failure to
so notify such other party materially prejudiced the substantive rights or defenses of the party from whom contribution is sought. No
party will be liable for contribution with respect to any action or claim settled without its written consent if such consent is required
pursuant to <U>Section 9.2(a)</U> hereof. The Company shall not enter into any settlement of any proceeding in which the Company is jointly
liable with Investor (or would be if joined in such proceeding) unless such settlement provides for a full and final release of all claims
against Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The remedies provided for in this
<U>Article IX</U> are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Investor Party
at law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
X&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>MISCELLANEOUS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.1. <U>Certain Fees
and Expenses</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;<B><U>Certain
Fees and Expenses</U></B>. Each party shall bear its own fees and expenses related to the transactions contemplated by the Transaction
Documents, except that (a) the Company will reimburse the fees and disbursements of legal counsel to the Investor in an amount up to $125,000
in connection with the entry into the Transaction Documents and the review of the Initial Registration Statement, with the initial reimbursement
to be made as of the Closing Date with respect to those expenses provided to the Company not less than two (2) Trading Days prior to the
Closing Date, and reimbursement of any further amounts to be made no later than the Commencement Date, and (b) the Company will reimburse
the fees and disbursements of legal counsel to the Investor in an amount not to exceed $25,000 per fiscal quarter &mdash; except for those
fiscal quarters in which additional diligence is reasonably required because of a material amendment or restatement to the Registration
Statement &ndash; in connection with the Investor&rsquo;s ongoing due diligence and review of any registration statements (including any
supplements or amendments thereto) and deliverables subject to <U>Section 6.16</U> within fourteen (14) calendar days following the applicable
Representation Date. Any amounts that remain due to the Investor under in this Section 10.1(i) within thirty (30) days of the original
due date for such expense shall be subject to an increase in the amount equal to three percent (3%) of the balance for such expense on
a monthly basis from the original due date for such expense. The Company shall pay all U.S. federal, state and local stamp and other similar
transfer and other taxes (other than income taxes) and duties levied in connection with issuance of the Shares pursuant hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<B><U>Legends</U></B>.
The certificate(s) or book-entry statement(s) representing the Shares issued pursuant to this Agreement, except as set forth below, shall
bear a restrictive legend in substantially the following form (and stop transfer instructions may be placed against transfer of such Shares
that is not in accordance with this Agreement and the Registration Rights Agreement):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">THE SECURITIES REPRESENTED HEREBY HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;ACT&rdquo;), OR UNDER THE SECURITIES LAWS OF ANY OTHER JURISDICTIONS.
THESE SECURITIES MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT OR APPLICABLE STATE SECURITIES LAWS (PURSUANT TO REGISTRATION
OR EXEMPTION THEREFROM).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(iii) &nbsp;<B><U>Notice
of Effectiveness</U></B>. On the Effective Date of the Initial Registration Statement and prior to Commencement, the Company shall deliver
or cause to be delivered to its Transfer Agent, the notice of effectiveness in the form attached as an exhibit to the Registration Rights
Agreement (the &ldquo;<B><I>Notice of Effectiveness</I></B>&rdquo;) relating to the Initial Registration Statement. With respect to any
post-effective amendment to the Initial Registration Statement, any New Registration Statement or any post-effective amendment to any
New Registration Statement, in each case declared effective by the Commission after the Commencement Date, the Company shall deliver or
cause to be delivered to its Transfer Agent, the Notice of Effectiveness, in each case modified as necessary to refer to such Registration
Statement or post-effective amendment and the Registrable Securities included therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(iv) <B><U>Removal of Legends
from Rule 144 Shares</U></B>. Upon the written request by the Investor to the Company if, at the time of such request, the Investor (i)
is not, and has not been during the preceding three months, an affiliate of the Company, (ii) has held the Shares subject to such request
for at least one year as determined in accordance with Rule 144, (iii) all of the other requirements of Rule 144 for the resale of the
Shares subject to such request are satisfied, and (iv) concurrently with such request, delivers to the Company, its counsel and the Transfer
Agent a written certification that the requirements set forth in the foregoing clauses (i) through (iii) are accurate, the Company shall,
no later than one (1) Trading Day following the delivery by the Investor to the Transfer Agent of one or more legended certificates or
book-entry statements representing the Shares (as applicable) subject to such request, together with such other documentation from the
Investor and its designated Broker-Dealer as the Transfer Agent deems necessary and appropriate, authorize the Transfer Agent to remove
the Securities Act restrictive legend (and any stop transfer instructions placed against transfer thereof) contemplated by <U>Section
10.1(ii)</U> affixed to the Shares subject to such request. At the times the Company authorizes the removal of the Securities Act restrictive
legends on the Shares subject to such request (and any stop transfer instructions placed against transfer thereof) pursuant to this <U>Section
10.1(iv)</U>, the Company shall, at its sole expense, use its commercially reasonable efforts to cause its legal counsel to issue to the
Transfer Agent a legal opinion or direction letter authorizing the Transfer Agent to remove the Securities Act restrictive legends contemplated
by <U>Section 10.1(ii)</U> on the Shares subject to such request (which legal opinion or direction letter may be delivered to the Transfer
Agent in advance setting forth the conditions to the removal of such legends). The Company shall be responsible for the fees of its Transfer
Agent and its legal counsel associated with any such legend removals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.2. <U>Specific Enforcement,
Consent to Jurisdiction, Waiver of Jury Trial</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(i) The Company and the Investor
acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed
in accordance with their specific terms or were otherwise breached. It is accordingly agreed that either party shall be entitled to an
injunction or injunctions to prevent or cure breaches of the provisions of this Agreement by the other party and to enforce specifically
the terms and provisions hereof (without the necessity of showing economic loss and without any bond or other security being required),
this being in addition to any other remedy to which either party may be entitled by law or equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(ii) Each of the Company and the
Investor (a) hereby irrevocably submits to the jurisdiction of the U.S. District Court and other courts of the United States sitting in
the State of New York for the purposes of any suit, action or proceeding arising out of or relating to this Agreement, and (b) hereby
waives, and agrees not to assert in any such suit, action or proceeding, any claim that it is not personally subject to the jurisdiction
of such court, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of the suit, action or proceeding
is improper. Each of the Company and the Investor consents to process being served in any such suit, action or proceeding by mailing a
copy thereof to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing in this <U>Section 10.2</U> shall affect or limit any right to serve
process in any other manner permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(iii) <B>EACH OF THE COMPANY AND
THE INVESTOR HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT TO ANY
LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR
DISPUTES RELATING HERETO. EACH OF THE COMPANY AND THE INVESTOR (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY
HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER
AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE ENTERED INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS
AND CERTIFICATIONS IN THIS <U>SECTION 10.2</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.3. <U>Entire Agreement</U></B>.
The Transaction Documents set forth the entire agreement and understanding of the parties with respect to the subject matter hereof and
supersedes all prior and contemporaneous agreements, negotiations and understandings between the parties, both oral and written, with
respect to such matters. There are no promises, undertakings, representations or warranties by either party relative to subject matter
hereof not expressly set forth in the Transaction Documents. All exhibits to this Agreement are hereby incorporated by reference in, and
made a part of, this Agreement as if set forth in full herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.4. <U>Notices</U></B>.
Any notice, demand, request, waiver or other communication required or permitted to be given hereunder shall be in writing and shall be
effective (a) upon hand delivery or electronic mail delivery at the address or number designated in <U>Exhibit F</U> (if delivered on
a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if
delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second business
day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such
mailing, whichever shall first occur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Either party hereto may from time
to time change its address for notices by giving at least five (5) days&rsquo; advance written notice of such changed address to the other
party hereto. In addition, each party hereto shall give at least five (5) days&rsquo; advance written notice to the other party hereto
of any change in the address or email address of such party&rsquo;s legal counsel set forth in <U>Exhibit F</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.5. <U>Waivers</U></B>.
No provision of this Agreement may be waived other than in a written instrument signed by the party against whom enforcement of such waiver
is sought. No failure or delay in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall
any single or partial exercise of any such power, right or privilege preclude other or further exercises thereof or of any other right,
power or privilege.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.6. <U>Amendments</U></B>.
No provision of this Agreement may be amended by the parties from and after the date that is one (1) Trading Day immediately preceding
the filing of the Initial Registration Statement with the Commission. Subject to the immediately preceding sentence, no provision of this
Agreement may be amended other than by a written instrument signed by both parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.7. <U>Headings</U></B>.
The article, section and subsection headings in this Agreement are for convenience only and shall not constitute a part of this Agreement
for any other purpose and shall not be deemed to limit or affect any of the provisions hereof. Unless the context clearly indicates otherwise,
each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof. The terms &ldquo;including,&rdquo;
&ldquo;includes,&rdquo; &ldquo;include&rdquo; and words of like import shall be construed broadly as if followed by the words &ldquo;without
limitation.&rdquo; The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo; &ldquo;hereof&rdquo; and words of like import refer to this
entire Agreement instead of just the provision in which they are found.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.8. <U>Construction</U></B>.
The parties agree that each of them and their respective counsel has reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents. In addition, each and every reference to share prices and number of
shares of Common Stock in any Transaction Document shall, in all cases, be subject to adjustment for any stock splits, stock combinations,
stock dividends, recapitalizations, reorganizations and other similar transactions that occur on or after the date of this Agreement.
Any reference in this Agreement to &ldquo;<B><I>Dollars</I></B>&rdquo; or &ldquo;$&rdquo; shall mean the lawful currency of the United
States of America. Any references to &ldquo;Section&rdquo; or &ldquo;Article&rdquo; in this Agreement shall, unless otherwise expressly
stated herein, refer to the applicable Section or Article of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.9. <U>Binding Effect</U></B>.
This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors. Neither the Company
nor the Investor may assign this Agreement or any of their respective rights or obligations hereunder to any Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.10. <U>No Third
Party Beneficiaries</U></B>. Except as expressly provided in <U>Article IX</U>, this Agreement is intended only for the benefit of the
parties hereto and their respective successors, and is not for the benefit of, nor may any provision hereof be enforced by, any other
Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.11. <U>Governing
Law</U></B>. This Agreement shall be governed by and construed in accordance with the internal procedural and substantive laws of the
State of New York, without giving effect to the choice of law provisions of such state that would cause the application of the laws of
any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.12. <U>Survival</U></B>.
The representations, warranties, covenants and agreements of the Company and the Investor contained in this Agreement shall survive the
execution and delivery hereof until the termination of this Agreement; <U>provided</U>, <U>however</U>, that (i) the provisions of <U>Article
VIII</U> (Termination), <U>Article IX</U> (Indemnification) and this <U>Article X</U> (Miscellaneous) shall remain in full force and effect
indefinitely notwithstanding such termination, and, (ii) so long as the Investor owns any Shares, the covenants and agreements of the
Company and the Investor contained in <U>Article VI</U> (Additional Covenants), shall remain in full force and effect notwithstanding
such termination for a period of six (6) months following such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.13. <U>Counterparts</U></B>.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party; <U>provided </U>that a facsimile
signature or signature delivered by e-mail in a &ldquo;.pdf&rdquo; format data file, including any electronic signature complying with
the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered due execution and shall
be binding upon the signatory thereto with the same force and effect as if the signature were an original signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.14. <U>Publicity</U></B>.
The Company shall afford the Investor and its counsel with a reasonable opportunity to review and comment upon, shall consult with the
Investor and its counsel on the form and substance of, and shall give due consideration to all such comments from the Investor or its
counsel on, any press release, Commission filing or any other public disclosure made by or on behalf of the Company relating to the Investor,
its purchases hereunder or any aspect of the Transaction Documents or the transactions contemplated hereby and thereby, prior to the issuance,
filing or public disclosure thereof. For the avoidance of doubt, the Company shall not be required to submit for review any such disclosure
(i) contained in periodic reports filed with the Commission under the Exchange Act if it shall have previously provided the same disclosure
to the Investor or its counsel for review in connection with a previous filing or (ii) any Prospectus Supplement if it contains disclosure
that does not reference the Investor, its purchases hereunder or any aspect of the Transaction Documents or the transactions contemplated
hereby and thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.15. <U>Severability</U></B>.
The provisions of this Agreement are severable and, in the event that any court of competent jurisdiction shall determine that any one
or more of the provisions or part of the provisions contained in this Agreement shall, for any reason, be held to be invalid, illegal
or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provision or part of a provision
of this Agreement, and this Agreement shall be reformed and construed as if such invalid or illegal or unenforceable provision, or part
of such provision, had never been contained herein, so that such provisions would be valid, legal and enforceable to the maximum extent
possible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Section 10.16. <U>Further Assurances</U></B>.
From and after the Closing Date, upon the request of the Investor or the Company, each of the Company and the Investor shall execute and
deliver such instrument, documents and other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate
fully the intent and purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[<I>Signature Pages Follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the
parties hereto have caused this Agreement to be duly executed by their respective authorized officer as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>CHARDAN CAPITAL MARKETS LLC</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/ Jonas Grossman</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Jonas Grossman</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">President</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SONIM TECHNOLOGIES, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/ Peter Liu</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Peter Liu</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><I>[Signature Page to ChEF Purchase Agreement]&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ANNEX I TO THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ChEF PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>DEFINITIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Affiliate</I></B>&rdquo;
shall mean any Person that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common
control with a Person, as such terms are used in and construed under Rule 144.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Average Price</I></B>&rdquo;
means a price per Share (rounded to the nearest tenth of a cent) equal to the quotient obtained by dividing (i) the aggregate gross purchase
price paid by the Investor for all Shares purchased pursuant to this Agreement with any offset necessary for compliance with the rules
of the Principal Market, by (ii) the aggregate number of Shares issued pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Bankruptcy Law</I></B>&rdquo;
shall mean Title 11, U.S. Code, or any similar U.S. federal or state law for the relief of debtors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Base Price</I></B>&rdquo;
means a price per Share equal to the sum of (i) Minimum Price and (ii) $0.6277 (subject to adjustment for any reorganization, recapitalization,
non-cash dividend, stock split, reverse stock split or other similar transaction that occurs on or after the date of this Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Block</I></B>&rdquo;
shall mean any trade on a single Trading Day to a single purchaser exceeding the lesser of (x) 20,000 shares of Common Stock and (y) five
percent (5%) of the total number (or volume) of shares of Common Stock traded on the Principal Market (or successor Principal Market)
during that Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Bloomberg</I></B>&rdquo;
shall mean Bloomberg, L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Closing Date</I></B>&rdquo;
shall mean the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Closing Sale Price</I></B>&rdquo;
shall mean, for the Common Stock as of any date, the last closing trade price for the Common Stock on the Principal Market, as reported
by Bloomberg, or, if the Principal Market begins to operate on an extended hours basis and does not designate the closing trade price
for the Common Stock, then the last trade price for the Common Stock prior to 4:00 p.m., New York City time, as reported by Bloomberg.
All such determinations shall be appropriately adjusted for any stock splits, stock dividends, stock combinations, recapitalizations or
other similar transactions during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Commission</I></B>&rdquo;
shall mean the U.S. Securities and Exchange Commission or any successor entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Commission Documents</I></B>&rdquo;
shall mean (1) all reports, schedules, registrations, forms, statements, information and other documents filed with or furnished to the
Commission by the Company pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act on or after January 1, 2025; (2) the Company&rsquo;s
definitive proxy statement, dated September 19, 2025, including the Annexes thereto, and all documents incorporated therein by reference;
(3) each Registration Statement, as the same may be amended from time to time, the Prospectus contained therein and each Prospectus Supplement
thereto and (4) all information contained in such filings and all documents and disclosures that have been and heretofore shall be incorporated
by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Common Stock Equivalents</I></B>&rdquo;
shall mean any securities of the Company or its Subsidiaries which entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Contract</I></B>&rdquo;
shall mean any written or oral legally binding contract, agreement, understanding, arrangement, subcontract, loan or credit agreement,
note, bond, indenture, mortgage, purchase order, deed of trust, lease, sublease, instrument, or other legally binding commitment, obligation
or undertaking.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Custodian</I></B>&rdquo;
shall mean any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Disclosure Documents</I></B>&rdquo;
shall mean (i) the Commission Documents, if any, incorporated by reference in each Registration Statement, (ii) each Registration Statement,
as the same may be amended from time to time, and the Prospectus contained therein and (ii) each Prospectus Supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>DTC</I></B>&rdquo;
shall mean The Depository Trust Company, a subsidiary of The Depository Trust &amp; Clearing Corporation, or any successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>DWAC Shares</I></B>&rdquo;
shall mean the Shares acquired or purchased by the Investor pursuant to this Agreement (a) that the Investor has resold in a manner described
under the caption &ldquo;Plan of Distribution&rdquo; in the Registration Statement and otherwise in compliance with <U>Section 4.11</U>
of this Agreement before the delivery of the Transfer Agent Confirmation regarding the resale of such Shares in accordance with this Agreement,
and (b) about which the Investor has (i) delivered to the Company, the Transfer Agent and legal counsel to the Company (A) the Transfer
Agent Confirmation relating to such Shares and (B) a customary broker&rsquo;s representation letter confirming, among other things, the
resale of such Shares in the manner described in clause (a) of this definition of DWAC Shares (including confirmation of compliance with
any relevant prospectus delivery requirements), and (ii) delivered to the Transfer Agent (M) a medallion-guaranteed stock power for such
resold Shares, and (N) instructions for the delivery of such Shares to the account with DTC of the Investor&rsquo;s designated Broker-Dealer
as specified in the Transfer Agent Deliverables, which Shares will be in the hands of the persons who purchase such Shares from the Investor
in the manner described in clause (a) of this definition of DWAC Shares, freely tradable and transferable without restriction on resale
and without stop transfer instructions maintained against the transfer thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>EDGAR</I></B>&rdquo;
shall mean the Commission&rsquo;s Electronic Data Gathering, Analysis and Retrieval System.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Effective Date</I></B>&rdquo;
shall mean, with respect to the Initial Registration Statement filed pursuant to Section 2(a) of the Registration Rights Agreement (or
any post-effective amendment thereto) or any New Registration Statement filed pursuant to Section 2(c) of the Registration Rights Agreement
(or any post-effective amendment thereto), as applicable, the date on which the Initial Registration Statement (or any post-effective
amendment thereto) or any New Registration Statement (or any post-effective amendment thereto) is declared effective by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Exchange Act</I></B>&rdquo;
shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Exempt Issuance</I></B>&rdquo;
shall mean the issuance of (a) Common Stock, options or other equity incentive awards to employees, officers, directors, consultants or
vendors of the Company pursuant to any equity incentive plan duly adopted for such purpose, by a majority of the members of the Company&rsquo;s
Board of Directors or of a committee of the Board of Directors established for such purpose, or (b) (1) any Shares issued to the Investor
or any of its affiliates or members pursuant to this Agreement, (2) any securities issued upon the exercise or exchange of or conversion
of any shares of Common Stock or Common Stock Equivalents held by the Investor or any of their respective affiliates or members at any
time, or (3) any securities issued upon the exercise or exchange of or conversion of any Common Stock Equivalents issued and outstanding,
or for which agreements to issue are in effect, as of the date hereof, provided that such securities referred to in this clause (3) have
not been amended since such date to increase the number of such securities or to decrease the conversion price, exercise price, exchange
rate or other price or rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>FINRA</I></B>&rdquo;
shall mean the Financial Industry Regulatory Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Fundamental Transaction</I></B>&rdquo;
shall mean that (i) the Company shall, directly or indirectly, in one or more related transactions, (1) consolidate or merge with or into
(whether or not the Company is the surviving corporation) another Person, with the result that the holders of the Company&rsquo;s capital
stock immediately prior to such consolidation or merger together beneficially own less than 50% of the outstanding voting power of the
surviving or resulting corporation, or (2) sell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially
all of the properties or assets of the Company to another Person, or (3) take action to facilitate a purchase, tender or exchange offer
by another Person that is accepted by the holders of more than 50% of the outstanding shares of Common Stock (excluding any shares of
Common Stock held by the Person or Persons making or party to, or associated or affiliated with the Persons making or party to, such purchase,
tender or exchange offer), or (4) consummate a stock or share purchase agreement or other business combination (including, without limitation,
a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than
50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making
or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business
combination), or (5) reorganize, recapitalize or reclassify its Common Stock, or (ii) any &ldquo;person&rdquo; or &ldquo;group&rdquo;
(as these terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act) is or shall become the &ldquo;beneficial owner&rdquo;
(as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of 50% of the aggregate ordinary voting power represented by
issued and outstanding Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Governmental Authority</I></B>&rdquo;
shall mean (i) any federal, provincial, state, local, municipal, national or international government or governmental authority, regulatory
or administrative agency, governmental commission, department, board, bureau, agency or instrumentality, court, tribunal, arbitrator or
arbitral body (public or private); (ii) any self-regulatory organization; or (iii) any political subdivision of any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Initial Registration
Statement</I></B>&rdquo; shall have the meaning assigned to such term in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Intraday VWAP Purchase
Commencement Time</I></B>&rdquo; shall mean, with respect to an Intraday VWAP Purchase made pursuant to <U>Section 3.1, </U>thirty (30)
minutes after the later of (i) the Investor&rsquo;s receipt of an Intraday VWAP Purchase Notice and (ii) the VWAP Purchase Termination
Time of a VWAP Purchase effected on the same VWAP Purchase Date (as applicable) <U>provided</U>, <U>however</U>, that if a VWAP Purchase
Notice is not delivered before 9:00 a.m., New York City time, on the same VWAP Purchase Date, then the Intraday VWAP Purchase Commencement
Time shall start only if the Investor accepts such Intraday VWAP Purchase Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Intraday VWAP Purchase
Share Amount</I></B>&rdquo; shall mean, with respect to an Intraday VWAP Purchase made pursuant to <U>Section 3.1</U>, the amount of Shares
being irrevocably offered by the Company to the Investor for purchase by the Investor in such Intraday VWAP Purchase as specified by the
Company in the applicable Intraday VWAP Purchase Notice during the Intraday VWAP Purchase Period on any VWAP Purchase Date, which amount
shall be specified as a percentage, not to exceed the VWAP Purchase Share Percentage, of the volume of trades of the Company&rsquo;s Common
Stock on the Principal Market for the applicable Intraday VWAP Purchase Period, as reported by Bloomberg through its &ldquo;VWAP&rdquo;
function, but with Block transactions excluded; <U>provided</U> that the Company may limit the amount of shares of Common Stock included
in the Intraday VWAP Purchase Share Amount to a fixed number of shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Intraday VWAP Purchase
Notice</I></B>&rdquo; shall mean, with respect to an Intraday VWAP Purchase made pursuant to <U>Section 3.1</U>, an irrevocable written
notice delivered by the Company to the Investor offering the Investor the Intraday VWAP Purchase Share Amount and directing the Investor
to purchase such portion of that amount as is necessary to give effect to the VWAP Purchase Commitment Amount (as set forth further in
<U>Section 3.1</U>), at the applicable VWAP Purchase Price therefor, on the applicable VWAP Purchase Date for such Intraday VWAP Purchase
in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Intraday VWAP Purchase
Period</I></B>&rdquo; shall mean, with respect to an Intraday VWAP Purchase made pursuant to <U>Section 3.1,</U> the period on the applicable
VWAP Purchase Date beginning at the applicable Intraday VWAP Purchase Commencement Time and ending at the close of trading on such VWAP
Purchase Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Investment Period</I></B>&rdquo;
shall mean the period commencing on the Effective Date of the Initial Registration Statement and expiring on the date this Agreement terminates
pursuant to <U>Article VIII</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Material Contracts</I></B>&rdquo;
means any other Contract that is expressly referred to in or filed or incorporated by reference as an exhibit to a Commission Document
or that, individually or in the aggregate, if terminated, suspended or subject to default by a party thereto, would have a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Minimum Price</I></B>&rdquo;
means the lower of: (i) the Nasdaq official closing price of the Common Stock on the Trading Market (as reflected on Nasdaq.com) on the
date of this Agreement and (ii) the average Nasdaq official closing price of the Common Stock on the Trading Market (as reflected on Nasdaq.com)
for the five (5) consecutive Trading Days ending on the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>New Registration
Statement</I></B>&rdquo; shall have the meaning assigned to such term in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Person</I></B>&rdquo;
shall mean any person or entity, whether a natural person, trustee, corporation, partnership, limited partnership, limited liability company,
trust, unincorporated organization, business association, firm, joint venture, governmental agency or authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Post-Effective Amendment
Period</I></B>&rdquo; shall mean the period commencing at 9:30 a.m., New York City time, on the fifth (5th) Trading Day immediately prior
to the filing of any post-effective amendment to the Initial Registration Statement or any New Registration Statement, and ending at 9:30
a.m., New York City time, on the Trading Day immediately following, the Effective Date of such post-effective amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Principal Market</I></B>&rdquo;
shall mean the Nasdaq Capital Market; <U>provided, however</U>, that in the event the Company&rsquo;s Common Stock is ever listed or traded
on the New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, or the Nasdaq Capital Market, then the &ldquo;Principal
Market&rdquo; shall mean such other market or exchange on which the Company&rsquo;s Common Stock is then listed or traded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Process</I></B>&rdquo;
(or &ldquo;<B><I>Processing</I></B>&rdquo; or &ldquo;<B><I>Processes</I></B>&rdquo;) means the collection, use, storage, processing, recording,
distribution, transfer, import, export, protection (including security measures), disposal or disclosure or other activity regarding Personal
Data (whether electronically or in any other form or medium).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Prospectus</I></B>&rdquo;
shall mean the prospectus in the form included in a Registration Statement, as supplemented from time to time by any Prospectus Supplement,
including the documents incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Prospectus Supplement</I></B>&rdquo;
shall mean any prospectus supplement to the Prospectus filed with the Commission from time to time pursuant to Rule 424(b) under the Securities
Act, including the documents incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Registrable Securities</I></B>&rdquo;
shall have the meaning assigned to such term in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Registration Period</I></B>&rdquo;
shall have the meaning assigned to such term in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Registration Statement</I></B>&rdquo;
shall have the meaning assigned to such term in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Restricted Period</I></B>&rdquo;
shall mean the period commencing on the Closing Date and expiring on the Trading Day next following the expiration or termination of this
Agreement as provided in <U>Article VIII</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Rule 144</I></B>&rdquo;
shall mean Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any
similar rule or regulation hereafter adopted by the Commission having substantially the same effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Securities Act</I></B>&rdquo;
shall mean the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Shares</I></B>&rdquo;
shall mean the shares of Common Stock that are and/or may be purchased by the Investor under this Agreement pursuant to one or more VWAP
Purchase Notices or Intraday VWAP Purchase Notices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Short Sales</I></B>&rdquo;
shall mean &ldquo;short sales&rdquo; as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Specified Transaction</I></B>&rdquo;
shall mean a transaction in which the Company or any of its subsidiaries (i) issues or sells any securities with a conversion price, exercise
price, exchange rate or other price or rate that is based upon and/or varies with the trading price of shares of Common Stock after the
date of issuance; (ii) issues or sells any securities at a price, or with a conversion price, exercise price, exchange rate or other price
or rate, that is subject to being reset after the date of issuance of such security or upon the occurrence of specified or contingent
events; (iii) issues or sells any securities that are subject to or contain any put, call, redemption, buy-back, price reset or other
similar provision or mechanism (including a &ldquo;Black-Scholes&rdquo; put or call right) that provides for the issuance of additional
equity securities of the Company or the payment of cash by the Company; or (iv) effects or enters into any agreement to effect any issuance
by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) in connection
with any &ldquo;equity line of credit&rdquo; or &ldquo;at-the-market&rdquo; or other continuous offering or similar offering of shares
of Common Stock or Common Stock Equivalents, other than with the Investor or its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Subsidiary</I></B>&rdquo;
shall mean any corporation or other entity of which at least a majority of the securities or other ownership interest having ordinary
voting power for the election of directors or other persons performing similar functions are at the time owned directly or indirectly
by the Company and/or any of its other Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Trading Day</I></B>&rdquo;
shall mean any day on which the Principal Market or, if the Common Stock is then listed on a successor Principal Market, such Principal
Market is open for trading (regular way), including any day on which the Principal Market (or successor Principal Market, as applicable)
is open for trading (regular way) for a period of time less than the customary time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Transaction Documents</I></B>&rdquo;
shall mean, collectively, this Agreement and the exhibits hereto, the Registration Rights Agreement and the exhibits thereto, and each
of the other agreements, documents, certificates and instruments (including the VWAP Purchase Notices and Intraday VWAP Purchase Notices)
entered into or furnished by the parties hereto in connection with the transactions contemplated hereby and thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Transfer Agent</I></B>&rdquo;
shall mean Equiniti Trust Company, LLC, the sole transfer agent and branch registrar of the Company or any successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>VWAP</I></B>&rdquo;
shall mean, for the Common Stock for a specified period, the dollar volume-weighted average price for the Common Stock on the Principal
Market, for such period, as reported by Bloomberg through its &ldquo;VWAP&rdquo; function. All such determinations shall be appropriately
adjusted to exclude any sales of shares of Common Stock through Block transactions and adjusted for any reorganization, non-cash dividend,
stock split, reverse stock split, stock combination, recapitalization or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>VWAP Purchase Commencement
Time</I></B>&rdquo; shall mean, with respect to a VWAP Purchase made pursuant to <U>Section 3.1</U>, 9:30:01 a.m., New York City time,
on the applicable VWAP Purchase Date, or such later time on such VWAP Purchase Date publicly announced by the Principal Market (or successor
Principal Market) as the official open (or commencement) of trading (regular way) on the Principal Market (or successor Principal Market,
as applicable) on such VWAP Purchase Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>VWAP Purchase Commitment
Amount</I></B>&rdquo; means, with respect to a VWAP Purchase made pursuant to <U>Section 3.1</U>, a number of shares of Common Stock equal
to the least of (i) a number of shares of Common Stock which, when aggregated with all other shares of Common Stock then beneficially
owned by the Investor and its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder),
would result in the beneficial ownership by the Investor of more than the Beneficial Ownership Limitation, (ii) a number of shares of
Common Stock which would result in the total aggregate VWAP Purchase Price to be paid by the Investor for the total VWAP Purchase Share
Amount purchased by the Investor in such VWAP Purchase made on one VWAP Purchase Date, when added to (if applicable) the total Intraday
VWAP Purchase Share Amount purchased by the Investor in an Intraday VWAP Purchase on the same VWAP Purchase Date, to exceed one million
U.S. dollars ($1,000,000), (iii) a number of Shares equal to (A) the VWAP Purchase Share Percentage multiplied by (B) the total number
(or volume) of shares of Common Stock traded on the Principal Market (or successor Principal Market) during the applicable VWAP Purchase
Period (or Intraday VWAP Purchase Period) on the applicable VWAP Purchase Date and (iv) the VWAP Purchase Share Amount (for a VWAP Purchase)
or the Intraday VWAP Purchase Share Amount (for an Intraday VWAP Purchase).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>VWAP Purchase Date</I></B>&rdquo;
shall mean, with respect to a VWAP Purchase or Intraday VWAP Purchase made pursuant to <U>Section 3.1</U>, the Trading Day on which the
Investor receives, after 6.00 a.m., New York City time, but prior to 9:00 a.m., New York City time, on such Trading Day, a valid VWAP
Purchase Notice for a VWAP Purchase, or the Trading Day on which the Investor receives, after 6:00 a.m., New York City time, an Intraday
VWAP Purchase Notice that is binding on the Investor or that the Investor accepts, in each case in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>VWAP Purchase Notice</I></B>&rdquo;
shall mean, with respect to a VWAP Purchase made pursuant to <U>Section 3.1</U>, an irrevocable written notice delivered by the Company
to the Investor offering the Investor the VWAP Purchase Share Amount and directing the Investor to purchase such portion of that amount
as is necessary to give effect to the VWAP Purchase Commitment Amount (as set forth further in <U>Section 3.1</U>), at the applicable
VWAP Purchase Price therefor on the applicable VWAP Purchase Date for such VWAP Purchase in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>VWAP Purchase Period</I></B>&rdquo;
shall mean, with respect to a VWAP Purchase made pursuant to <U>Section 3.1</U>, the period on the applicable VWAP Purchase Date for such
VWAP Purchase beginning at the applicable VWAP Purchase Commencement Time and ending at the applicable VWAP Purchase Termination Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>VWAP Purchase Price</I></B>&rdquo;
shall mean the purchase price per Share to be purchased by the Investor in such VWAP Purchase or Intraday VWAP Purchase on such VWAP Purchase
Date equal to ninety-six and one-half percent (96.5%) of the VWAP over the applicable VWAP Purchase Period or Intraday VWAP Purchase Period,
as applicable, on such VWAP Purchase Date for such VWAP Purchase or Intraday VWAP Purchase, to be appropriately adjusted for any sales
of shares of Common Stock through Block transactions, any reorganization, non-cash dividend, stock split, reverse stock split, stock combination,
recapitalization or other similar transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>VWAP Purchase Share
Amount</I></B>&rdquo; shall mean, with respect to a VWAP Purchase made pursuant to <U>Section 3.1</U>, the amount of Shares being irrevocably
offered by the Company to the Investor for purchase by the Investor in such VWAP Purchase as specified by the Company in the applicable
VWAP Purchase Notice during the VWAP Purchase Period on any VWAP Purchase Date, which amount shall be specified as a percentage (the &ldquo;<B><I>Target
Percentage</I></B>&rdquo;), not to exceed the VWAP Purchase Share Percentage, of the volume of trades of the Company&rsquo;s Common Stock
on the Principal Market for the applicable VWAP Purchase Period, as reported by Bloomberg through its &ldquo;VWAP&rdquo; function, but
with Block transactions excluded; <U>provided</U> that the Company may limit the amount of shares of Common Stock included in the VWAP
Purchase Share Amount to a fixed number of shares of Common Stock (such fixed number of shares of Common Stock, if specified by the Company,
the &ldquo;<B><I>Target Number</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>VWAP Purchase Share
Percentage</I></B>&rdquo; shall mean, with respect to a VWAP Purchase or Intraday VWAP Purchase made pursuant to <U>Section 3.1</U>, twenty
percent (20%).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>VWAP Purchase Termination
Time</I></B>&rdquo; shall mean, with respect to a VWAP Purchase made pursuant to <U>Section 3.1</U>, the earlier of (a) 4:00 p.m., New
York City time, on the applicable VWAP Purchase Date, or such earlier time publicly announced by the Principal Market (or successor Principal
Market) as the official close of trading (regular way) on the Principal Market on such applicable VWAP Purchase Date and (b) such time
as the aggregate volume of trades of Common Stock that count towards VWAP on the applicable VWAP Purchase Date is such that the Target
Percentage of such volume equals the Target Number.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM OF REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OFFICER&rsquo;S CERTIFICATE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECRETARY&rsquo;S CERTIFICATE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT D</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM OF VWAP PURCHASE NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 50%">From:</TD>
    <TD STYLE="text-align: left; width: 50%">[&#9679;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">To:</TD>
    <TD STYLE="text-align: left">Scott Blakeman</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Attention:</TD>
    <TD STYLE="text-align: left">[***]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Copy to:</TD>
    <TD STYLE="text-align: left">[&#9679;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">[***]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Subject:</TD>
    <TD STYLE="text-align: left">VWAP Purchase Notice</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Date:</TD>
    <TD STYLE="text-align: left">[&#9679;], 202[&#9679;]</TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top">VWAP Purchase Commencement Time:</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">[&#9679;]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the terms and subject to the conditions
contained in the ChEF Purchase Agreement (the &ldquo;<B><I>Agreement</I></B>&rdquo;) between Sonim Technologies, Inc., a Delaware corporation
(the &ldquo;<B><I>Company</I></B>&rdquo;), and Chardan Capital Markets LLC (the &ldquo;<B><I>Investor</I></B>&rdquo;), dated September
29, 2025, the Company hereby requests the Investor to purchase a VWAP Purchase Share Amount equal to [&#9679;] percent of the volume of
trades of the Company&rsquo;s Common Stock on the Principal Market for the applicable VWAP Purchase Period, as reported by Bloomberg through
its &ldquo;VWAP&rdquo; function, but with Block transactions excluded. [The preceding offer is limited in that it does not exceed [&#9679;]
shares of the Company&rsquo;s common stock, par value $0.001 per share.] Capitalized terms used but not defined herein shall have the
meanings ascribed to them in the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 50%"><FONT STYLE="text-transform: uppercase"><B>SONIM TECHNOLOGIES, Inc.</B></FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">By: _______________________________</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Title:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>CHARDAN CAPITAL MARKETS LLC</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">By: _______________________________</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT E</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM OF INTRADAY VWAP PURCHASE NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 50%">From:</TD>
    <TD STYLE="text-align: left; width: 50%">[&#9679;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">To:</TD>
    <TD STYLE="text-align: left">Scott Blakeman</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Attention:</TD>
    <TD STYLE="text-align: left">[***]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Copy to:</TD>
    <TD STYLE="text-align: left">[&#9679;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">[***]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Subject:</TD>
    <TD STYLE="text-align: left">Intraday VWAP Purchase Notice</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Date:</TD>
    <TD STYLE="text-align: left">[&#9679;], 202[&#9679;]</TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top">Intraday VWAP Purchase Commencement Time:</TD>
    <TD STYLE="text-align: left">[&#9679;]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the terms and subject to the conditions
contained in the ChEF Purchase Agreement (the &ldquo;<B><I>Agreement</I></B>&rdquo;) between Sonim Technologies, Inc., a Delaware corporation
(the &ldquo;<B><I>Company</I></B>&rdquo;), and Chardan Capital Markets LLC (the &ldquo;<B><I>Investor</I></B>&rdquo;), dated September
29, 2025, [and the VWAP Purchase Notice delivered by the Company to the Investor on [&#9679;],] the Company hereby requests the Investor
to purchase an Intraday VWAP Purchase Share Amount equal to [&#9679;] percent of the volume of trades of the Company&rsquo;s Common Stock
on the Principal Market for the applicable Intraday VWAP Purchase Period, as reported by Bloomberg through its &ldquo;VWAP&rdquo; function,
but with Block transactions excluded. [The preceding offer is limited in that it does not exceed [&#9679;] shares of the Company&rsquo;s
common stock, par value $0.001 per share.] Capitalized terms used but not defined herein shall have the meanings ascribed to them in the
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 50%; vertical-align: bottom"><FONT STYLE="text-transform: uppercase"><B>SONIM TECHNOLOGIES, Inc.</B></FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: bottom">By: _______________________________</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: bottom">Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: bottom">Title:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: bottom"><B>CHARDAN CAPITAL MARKETS LLC</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: bottom">By: _______________________________</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: bottom">Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: bottom">Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT F</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTICES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD>1.</TD>
    <TD STYLE="text-align: left">If to the Company:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Sonim Technologies, Inc.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">4445 Eastgate Mall, Suite 200</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">San Diego, CA 92121</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">E-mail: [***]</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Attention: Clay Crolius</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">With a copy (which shall not constitute notice) to:</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Venable, LLP</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">151 W. 42nd Street, 49th Floor</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">New York, NY 10036</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Attention: William N. Haddad, Kirill Y. Nikonov</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">E-mail: WNHaddad@Venable.com, KYNikonov@Venable.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD>2.</TD>
    <TD>If to the Investor:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Chardan Capital Markets LLC</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">One Pennsylvania Plaza, Suite 4800</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">New York, NY 10119</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Email: [***]</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Attention: Scott Blakeman; Erik Luchs</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">With a copy (which shall not constitute notice) to:</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Goodwin Procter, LLP</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">620 Eighth Avenue</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">New York, NY 10018</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">Email: jplatt@goodwinlaw.com</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Attention: Justin Platt</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 50; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex10-2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">REGISTRATION RIGHTS AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">THIS REGISTRATION RIGHTS AGREEMENT
(this &ldquo;<B><I>Agreement</I></B>&rdquo;), dated as of September 29, 2025 is by and between Chardan Capital Markets LLC, a New York
limited liability company (the &ldquo;<B><I>Investor</I></B>&rdquo;), and Sonim Technologies, Inc., a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">RECITALS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company and the Investor have
entered into that certain ChEF Purchase Agreement, dated as of the date hereof (the &ldquo;<B><I>Purchase Agreement</I></B>&rdquo;), pursuant
to which the Company may issue, from time to time, to the Investor up to the lesser of (i) $500.0 million in aggregate gross purchase
price of newly issued shares (the &ldquo;<B><I>Shares</I></B>&rdquo;) of the Company&rsquo;s common stock, par value $0.001 per share
(&ldquo;<B><I>Common Stock</I></B>&rdquo;), and (ii) the Exchange Cap (to the extent applicable under Section 3.3 of the Purchase Agreement),
as provided for therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the terms of, and
in consideration for the Investor entering into, the Purchase Agreement, and to induce the Investor to execute and deliver the Purchase
Agreement, the Company has agreed to provide the Investor with certain registration rights with respect to the Registrable Securities
(as defined herein) as set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the representations, warranties, covenants and agreements contained herein and in the Purchase Agreement, and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, intending to be legally bound hereby, the Company and the
Investor hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;I</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>DEFINITIONS</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.&#9;<U>Definitions</U>.
<FONT STYLE="font-style: normal; font-weight: normal">Capitalized terms used herein and not otherwise defined herein shall have the respective
meanings set forth in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Adverse Disclosure</I></B>&rdquo;
shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment of the Chief Executive
Officer of the Company or the Board of Directors of the Company, after consultation with counsel to the Company, (i) would be required
to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain
any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein (in the case
of any Prospectus, in the light of the circumstances under which they were made) not misleading, (ii) would not be required to be made
at such time if the Registration Statement were not being filed, declared effective or used, as the case may be, and (iii) the Company
has a bona fide business purpose for not making such information public.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Agreement</I></B>&rdquo;
shall have the meaning assigned to such term in the preamble of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Business Day</I></B>&rdquo;
means any day other than Saturday, Sunday or any other day on which commercial banks in New York, New York are authorized or required
by law to remain closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Closing Date</I></B>&rdquo;
shall mean the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Commission</I></B>&rdquo;
means the U.S. Securities and Exchange Commission or any successor entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Common Stock</I></B>&rdquo;
shall have the meaning assigned to such term in the preamble of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Company</I></B>&rdquo;
shall have the meaning assigned to such term in the preamble of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Effective Date</I></B>&rdquo;
means the date that the applicable Registration Statement has been declared effective by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Effectiveness Deadline</I></B>&rdquo;
means (i) with respect to the Initial Registration Statement required to be filed pursuant to <U>Section 2(a)</U>, the earlier of (A)
the 90<SUP>th</SUP> calendar day following the filing date thereof if the Commission notifies the Company that it will &ldquo;review&rdquo;
such Registration Statement, and (B) the 10<SUP>th</SUP> calendar day after the date the Company is notified (orally or in writing, whichever
is earlier) by the Commission that such Registration Statement will not be &ldquo;reviewed&rdquo; or will not be subject to further review
and (ii) with respect to any New Registration Statements that may be required to be filed by the Company pursuant to this Agreement, the
earlier of (A) the 90<SUP>th</SUP> calendar day following the filing date of the additional Registration Statement if the Commission notifies
the Company that it will &ldquo;review&rdquo; the Registration Statement, and (B) the 10<SUP>th</SUP> calendar day after the date the
Company is notified (orally or in writing, whichever is earlier) by the Commission that the New Registration Statement will not be &ldquo;reviewed&rdquo;
or will not be subject to further review.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Eligible Market</I></B>&rdquo;
means The New York Stock Exchange, Inc., NYSE American, LLC, The Nasdaq Global Select Market, The Nasdaq Global Market or The Nasdaq Capital
Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Filing Deadline</I></B>&rdquo;
means the tenth (10<SUP>th</SUP>) Business Day following (i) with respect to the Initial Registration Statement required to be filed pursuant
to Section 2(a), the date of this Agreement or, (ii) with respect to any New Registration Statements that may be required to be filed
by the Company pursuant to this Agreement, following the sale of substantially all of the Registrable Securities, included in the Initial
Registration Statement or the most recent prior New Registration Statement, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Investor</I></B>&rdquo;
shall have the meaning assigned to such term in the preamble of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Person</I></B>&rdquo;
means any person or entity, whether a natural person, trustee, corporation, partnership, limited partnership, limited liability company,
trust, unincorporated organization, business association, firm, joint venture, governmental agency or authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Prospectus</I></B>&rdquo;
means the prospectus in the form included in the Registration Statement at the applicable Effective Date of the Registration Statement,
as supplemented from time to time by any Prospectus Supplement, including the documents incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Prospectus Supplement</I></B>&rdquo;
means any prospectus supplement to the Prospectus filed with the Commission from time to time pursuant to Rule 424(b) under the Securities
Act, including the documents incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>&ldquo;<B>register</B>,&rdquo;</I>
&ldquo;<B><I>registered</I></B>,&rdquo; and &ldquo;<B><I>registration</I></B>&rdquo; refer to a registration effected by preparing and
filing one or more Registration Statements in compliance with the Securities Act and pursuant to Rule 415 and the declaration of effectiveness
of such Registration Statement(s) by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Registrable Securities</I></B>&rdquo;
means all of (i) the Shares and (ii) any capital stock of the Company issued or issuable with respect to such Shares, including, without
limitation, (1) as a result of any stock split, stock dividend, recapitalization, merger, exchange, consolidation, spin-off, reorganization
or similar event or otherwise and (2) shares of capital stock of the Company into which the shares of Common Stock are converted or exchanged
and shares of capital stock of a successor entity into which the shares of Common Stock are converted or exchanged, in each case until
such time as such securities cease to be Registrable Securities pursuant to Section 2(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Registration Statement</I></B>&rdquo;
means a registration statement or registration statements of the Company filed under the Securities Act covering the resale by the Investor
of Registrable Securities, as such registration statement or registration statements may be amended and supplemented from time to time,
including all documents filed as part thereof or incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Rule 144</I></B>&rdquo;
means Rule 144 promulgated by the Commission under the Securities Act, as such rule may be amended from time to time, or any other similar
or successor rule or regulation of the Commission that may at any time permit the Investor to sell securities of the Company to the public
without registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Rule 415</I></B>&rdquo;
means Rule 415 promulgated by the Commission under the Securities Act, as such rule may be amended from time to time, or any other similar
or successor rule or regulation of the Commission providing for offering securities on a delayed or continuous basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Trading Market</I></B>&rdquo;
means The Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;II</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>REGISTRATIONS</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.&#9;<U>Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a)&nbsp;<U>Mandatory
Registration</U>. The Company shall promptly prepare and, as soon as practicable, but in no event later than the Filing Deadline, file
with the Commission the Initial Registration Statement on Form S-1 (or any successor form) covering the resale by the Investor of (i)
all of the Shares and (ii) the maximum number of additional Registrable Securities as shall be permitted to be included thereon pursuant
to the Purchase Agreement and in accordance with applicable Commission rules, regulations and interpretations so as to permit the resale
of such Registrable Securities by the Investor under <U>Rule 415</U> under the Securities Act at then prevailing market prices (and not
fixed prices) (the &ldquo;<B><I>Initial Registration Statement</I></B>&rdquo;). The Initial Registration Statement shall contain the &ldquo;Selling
Stockholder&rdquo; and &ldquo;Plan of Distribution (Conflicts of Interest)&rdquo; sections in the form agreed to by the Investor. The
Company shall use its commercially reasonable efforts to have the Initial Registration Statement declared effective by the Commission
as promptly as practicable, but in no event later than the applicable Effectiveness Deadline following the filing thereof with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b)&nbsp;<U>Legal
Counsel</U>. Subject to Section 5 hereof, the Investor shall have the right to select one legal counsel to review and oversee, solely
on its behalf, any registration pursuant to this Section 2 (&ldquo;<B><I>Legal Counsel</I></B>&rdquo;), which shall be Goodwin Procter
LLP, or such other counsel as thereafter designated by the Investor. Other than as set forth in the Purchase Agreement, the Company has
no obligation to reimburse the Investor for any and all legal fees and expenses of the Legal Counsel incurred in connection with each
registration contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c)&nbsp;<U>Sufficient
Number of Shares Registered</U>. If at any time all Registrable Securities are not covered by the Initial Registration Statement filed
pursuant to Section 2(a) as a result of Section 2(e) or otherwise, the Company shall use its commercially reasonable efforts to file with
the Commission one or more additional Registration Statements so as to cover all of the Registrable Securities not covered by such Initial
Registration Statement, in each case, as soon as practicable (taking into account any position of the staff of the Commission (&ldquo;<B><I>Staff</I></B>&rdquo;)
with respect to the date on which the Staff will permit such additional Registration Statement(s) to be filed with the Commission and
the rules and regulations of the Commission) (each such additional Registration Statement, a &ldquo;<B><I>New Registration Statement</I></B>&rdquo;)
but in no event later than the applicable Filing Deadline for such New Registration Statement. The Company shall use its commercially
reasonable efforts to cause each such New Registration Statement to become effective as promptly as practicable following the filing thereof
with the Commission, but in no event later than the applicable Effectiveness Deadline for such New Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d)&nbsp;<U>No
Inclusion of Other Securities</U>. The Company may not include any securities other than Registrable Securities on any Registration Statement
pursuant to Section 2(a) or Section 2(c) without consulting the Investor and Legal Counsel and obtaining the Investor&rsquo;s written
approval (email being sufficient) prior to filing such Registration Statement with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e)&nbsp;<U>Offering</U>.
If the Staff or the Commission seeks to characterize any offering pursuant to a Registration Statement filed pursuant to this Agreement
as constituting an offering of securities that does not permit such Registration Statement to become effective and be used for resales
by the Investor on a delayed or continuous basis under Rule 415 at then-prevailing market prices (and not fixed prices), or if after the
filing of any Registration Statement pursuant to Section 2(a) or Section 2(c), the Company is otherwise required by the Staff or the Commission
to reduce the number of Registrable Securities included in such Registration Statement, then the Company shall reduce the number of Registrable
Securities to be included in such Registration Statement (after consultation with the Investor and Legal Counsel as to the specific Registrable
Securities to be removed therefrom) until such time as the Staff and the Commission shall so permit such Registration Statement to become
effective and be used as aforesaid. Notwithstanding anything in this Agreement to the contrary, if after giving effect to the actions
referred to in the immediately preceding sentence, the Staff or the Commission does not permit such Registration Statement to become effective
and be used for resales by the Investor on a delayed or continuous basis under Rule 415 at then-prevailing market prices (and not fixed
prices), the Company shall not request acceleration of the Effective Date of such Registration Statement, the Company shall promptly (but
in no event later than 48 hours after the conclusion of any discussions with the Staff or Commission with respect thereto) request the
withdrawal of such Registration Statement pursuant to Rule 477 under the Securities Act, and the Effectiveness Deadline shall automatically
be deemed to have elapsed with respect to such Registration Statement at such time as the Staff or the Commission has made a final and
non-appealable determination that the Commission will not permit such Registration Statement to be so utilized (unless prior to such time
the Company has received assurances from the Staff or the Commission that a New Registration Statement filed by the Company with the Commission
promptly thereafter may be so utilized). In the event of any reduction in Registrable Securities or if the Commission does not permit
such Registration Statement to become effective and used for resales by the Investor on a delayed or continuous basis under Rule 415 at
then-prevailing market prices pursuant to this paragraph, the Company shall use its commercially reasonable efforts to file one or more
New Registration Statements with the Commission in accordance with Section 2(c) until such time as all Registrable Securities have been
included in Registration Statements that have been declared effective and the Prospectuses contained therein are available for use by
the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f)&nbsp;Any
Registrable Security shall cease to be a &ldquo;<B><I>Registrable Security</I></B>&rdquo; at the earliest of the following: (i) when a
Registration Statement covering such Registrable Security becomes or has been declared effective by the Commission and such Registrable
Security has been sold or disposed of pursuant to such effective Registration Statement; (ii) when such Registrable Security is acquired
by the Company or one of its Subsidiaries; and (iii) such securities may be sold without registration pursuant to Rule 144 or any successor
rule promulgated under the Securities Act without volume or manner of sale restrictions and without current public information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;III</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>RELATED
OBLIGATIONS</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.&#9;<U>Related
Obligations</U>. <FONT STYLE="font-style: normal; font-weight: normal">The Company shall use its commercially reasonable efforts to effect
the registration of the Registrable Securities in accordance with the terms of this Agreement and the intended method of disposition
thereof, and, pursuant thereto, during the term of this Agreement, the Company shall have the following obligations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a)&nbsp;The
Company shall promptly prepare and file with the Commission the Initial Registration Statement pursuant to Section 2(a) hereof and, as
applicable, one or more New Registration Statements pursuant to Section 2(c) hereof with respect to the Registrable Securities, but in
no event later than the applicable Filing Deadline therefor, and the Company shall use its commercially reasonable efforts to cause each
such Registration Statement to become effective as soon as practicable after such filing, but in no event later than the applicable Effectiveness
Deadline therefor. Subject to Allowable Grace Periods (as defined below), the Company shall use its commercially reasonable efforts to
keep each Registration Statement effective (and the Prospectus contained therein available for use) pursuant to Rule 415 for resales by
the Investor on a continuous basis at then-prevailing market prices (and not fixed prices) at all times until the earlier of (i) the date
on which the Investor shall have sold all of the Registrable Securities covered by such Registration Statement and (ii) the one year anniversary
of the date of termination of the Purchase Agreement if as of such date the Investor holds no Registrable Securities (or, if applicable,
the date on which such securities cease to be Registrable Securities after the date of termination of the Purchase Agreement) (the &ldquo;<B><I>Registration
Period</I></B>&rdquo;). Notwithstanding anything to the contrary contained in this Agreement (but subject to the provisions of Section
3(p) hereof), the Company shall ensure that, when filed and at all times while effective, each Registration Statement (including, without
limitation, all amendments and supplements thereto) and the Prospectus (including, without limitation, all amendments and supplements
thereto) used in connection with such Registration Statement shall not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein, or necessary to make the statements therein (in the case of Prospectuses, in the light
of the circumstances in which they were made) not misleading. The Company shall submit to the Commission, as soon as reasonably practicable
after the date that the Commission informs the Company that no review of a particular Registration Statement will be made by the Staff
or that the Staff has no further comments on a particular Registration Statement (as the case may be), a request for acceleration of effectiveness
of such Registration Statement to a time and date as soon as reasonably practicable in accordance with Rule 461 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b)&nbsp;Subject
to Section 3(p) of this Agreement, the Company shall, as soon as reasonably practicable, use its commercially reasonable efforts to prepare
and file with the Commission such amendments (including, without limitation, post-effective amendments) and supplements to each Registration
Statement and the Prospectus used in connection with each such Registration Statement, which Prospectus is to be filed pursuant to Rule
424 promulgated under the Securities Act, as may be necessary to keep each such Registration Statement effective (and the Prospectus contained
therein current and available for use) at all times during the Registration Period for such Registration Statement, and, during such period,
comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities of the Company required
to be covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance
with the intended methods of disposition by the Investor. Without limiting the generality of the foregoing, the Company covenants and
agrees that (i) at or before 8:30 a.m. (New York City time) on the second (2nd) Trading Day immediately following the Effective Date of
the Initial Registration Statement and any New Registration Statement (or any post-effective amendment thereto), the Company shall file
with the Commission in accordance with Rule 424(b) under the Securities Act the final Prospectus to be used in connection with sales pursuant
to such Registration Statement (or post-effective amendment thereto), and (ii) if the transactions contemplated by any VWAP Purchase or
Intraday VWAP Purchase are material to the Company (individually or collectively with all other prior VWAP Purchases or Intraday VWAP
Purchases, the consummation of which have not previously been reported in any Prospectus Supplement filed with the Commission under Rule
424(b) under the Securities Act or in any report, statement or other document filed by the Company with the Commission under the Exchange
Act and incorporated by reference in the Registration Statement and the Prospectus), or if otherwise required under the Securities Act
(or the interpretations of the Commission thereof), in each case as reasonably determined by the Company and the Investor, then, at or
before 8:30 a.m., New York City time, on the first (1st) Trading Day immediately following the VWAP Purchase Date, if a VWAP Purchase
Notice or Intraday VWAP Purchase Notice was properly delivered to the Investor hereunder in connection with such VWAP Purchase or Intraday
VWAP Purchase, the Company shall file with the Commission a Prospectus Supplement pursuant to Rule 424(b) under the Securities Act with
respect to the VWAP Purchase(s) or Intraday VWAP Purchase(s), the total VWAP Purchase Price for the Shares subject to such VWAP Purchase(s)
or Intraday VWAP Purchase(s) (as applicable), the applicable VWAP Purchase Price(s) for such Shares and the net proceeds that are to be
(and, if applicable, have been) received by the Company from the sale of such Shares. To the extent not previously disclosed in the Prospectus
or a Prospectus Supplement, the Company shall disclose in its Quarterly Reports on Form 10-Q and in its Annual Reports on Form 10-K the
information described in the immediately preceding sentence relating to all VWAP Purchase(s) or Intraday VWAP Purchase(s) consummated
during the relevant fiscal quarter and shall file such Quarterly Reports and Annual Reports with the Commission within the applicable
time period prescribed for such report under the Exchange Act. In the case of amendments and supplements to any Registration Statement
on Form S-1 or Prospectus related thereto which are required to be filed pursuant to this Agreement (including, without limitation, pursuant
to this Section 3(b)) by reason of the Company filing a report on Form 8-K, Form 10-Q or Form 10-K or any analogous report under the Exchange
Act, the Company shall have such report incorporated by reference into such Registration Statement and Prospectus, if applicable, or shall
file such amendments (including post-effective amendments) or supplements to the Registration Statement or Prospectus with the Commission
on the same day on which the Exchange Act report is filed which created the requirement for the Company to amend or supplement such Registration
Statement or Prospectus, for the purpose of including or incorporating such report into such Registration Statement and Prospectus. The
Company consents to the use of the Prospectus (including, without limitation, any supplement thereto) included in each Registration Statement
in accordance with the provisions of the Securities Act and with the securities or &ldquo;Blue Sky&rdquo; laws of the jurisdictions in
which the Registrable Securities may be sold by the Investor, in connection with the resale of the Registrable Securities and for such
period of time thereafter as such Prospectus (including, without limitation, any supplement thereto) (or in lieu thereof, the notice referred
to in Rule 173(a) under the Securities Act) is required by the Securities Act to be delivered in connection with resales of Registrable
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c)&nbsp;The
Company shall (A) permit Investor and Legal Counsel an opportunity to review and comment upon (i) each Registration Statement at least
four (4) Trading Days prior to its filing with the Commission and (ii) all amendments and supplements to each Registration Statement (including,
without limitation, the Prospectus contained therein) (except for Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current
Reports on Form 8-K, and any similar or successor reports or Prospectus Supplements the content of which is limited to that set forth
in such reports) at least four (4) Trading Days prior to their filing with the Commission, and (B) shall reasonably consider any comments
of the Investor and Legal Counsel on any such Registration Statement or amendment or supplement thereto or to any Prospectus contained
therein. The Company shall promptly furnish to Legal Counsel, without charge, (i) electronic copies of any correspondence from the Commission
or the Staff to the Company or its representatives relating to each Registration Statement (which correspondence shall be redacted to
exclude any material, non-public information regarding the Company or any of its Subsidiaries), (ii) after the same is prepared and filed
with the Commission, one (1) electronic copy of each Registration Statement and any amendment(s) and supplement(s) thereto, including,
without limitation, financial statements and schedules, all documents incorporated therein by reference, if requested by the Investor,
and all exhibits and (iii) upon the effectiveness of each Registration Statement, one (1) electronic copy of the Prospectus included in
such Registration Statement and all amendments and supplements thereto; <U>provided</U>, <U>however</U>, the Company shall not be required
to furnish any document (other than the Prospectus, which may be provided in .PDF format) to Legal Counsel to the extent such document
is available on EDGAR at the time of Legal Counsel&rsquo;s request).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d)&nbsp;Without
limiting any obligation of the Company under the Purchase Agreement, the Company shall promptly furnish to the Investor, without charge,
(i) after the same is prepared and filed with the Commission, at least one (1) electronic copy of each Registration Statement and any
amendment(s) and supplement(s) thereto, including, without limitation, financial statements and schedules, all documents incorporated
therein by reference, if requested by the Investor, all exhibits thereto, (ii) upon the effectiveness of each Registration Statement,
one (1) electronic copy of the Prospectus included in such Registration Statement and all amendments and supplements thereto (or such
other number of copies as the Investor may reasonably request from time to time) and (iii) such other documents, including, without limitation,
copies of any final Prospectus and any Prospectus Supplement thereto, as the Investor may reasonably request from time to time in order
to facilitate the disposition of the Registrable Securities owned by the Investor; <U>provided</U>, <U>however</U>, the Company shall
not be required to furnish any document (other than the Prospectus, which may be provided in .PDF format) to the Investor to the extent
such document is available on EDGAR).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e)&nbsp;The
Company shall take such action as is reasonably necessary to (i) register and qualify, unless an exemption from registration and qualification
applies, the resale by the Investor of the Registrable Securities covered by a Registration Statement under such other securities or &ldquo;Blue
Sky&rdquo; laws of all applicable jurisdictions in the United States, (ii) prepare and file in those jurisdictions, such amendments (including,
without limitation, post-effective amendments) and supplements to such registrations and qualifications as may be necessary to maintain
the effectiveness thereof during the Registration Period, (iii) take such other actions as may be reasonably necessary to maintain such
registrations and qualifications in effect at all times during the Registration Period, and (iv) take all other actions reasonably necessary
or advisable to qualify the Registrable Securities for sale in such jurisdictions; <U>provided</U>, <U>however</U>, the Company shall
not be required in connection therewith or as a condition thereto to (x) qualify to do business in any jurisdiction where it would not
otherwise be required to qualify but for this Section 3(e), (y) subject itself to general taxation in any such jurisdiction, or (z) file
a general consent to service of process in any such jurisdiction. The Company shall promptly notify Legal Counsel and the Investor of
the receipt by the Company of any notification with respect to the suspension of the registration or qualification of any of the Registrable
Securities for sale under the securities or &ldquo;Blue Sky&rdquo; laws of any jurisdiction in the United States or its receipt of actual
notice of the initiation or threatening of any proceeding for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f)&nbsp;The
Company shall notify Legal Counsel and the Investor in writing of the happening of any event, as promptly as reasonably practicable after
becoming aware of such event, as a result of which the Prospectus included in a Registration Statement, as then in effect, includes an
untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements
therein (in the case of Prospectuses, in the light of the circumstances under which they were made), not misleading (provided that in
no event shall such notice contain any material, non-public information regarding the Company or any of its Subsidiaries), and, subject
to Section 3(p), promptly prepare a supplement or amendment to such Registration Statement and such Prospectus contained therein to correct
such untrue statement or omission and deliver one (1) electronic copy of such supplement or amendment to Legal Counsel and the Investor
(or such other number of copies as Legal Counsel or the Investor may reasonably request). The Company shall also promptly notify Legal
Counsel and the Investor in writing (i) when a Prospectus or any Prospectus Supplement or post-effective amendment has been filed, when
a Registration Statement or any post-effective amendment has become effective (notification of such effectiveness shall be delivered to
Legal Counsel and the Investor by e-mail promptly following such effectiveness), and when the Company receives written notice from the
Commission that a Registration Statement or any post-effective amendment will be reviewed by the Commission, (ii) of any request by the
Commission for amendments or supplements to a Registration Statement or related Prospectus or related information, (iii) of the Company&rsquo;s
reasonable determination that a post-effective amendment to a Registration Statement would be appropriate and (iv) of the receipt of any
request by the Commission or any other federal or state governmental authority for any additional information relating to the Registration
Statement or any amendment or supplement thereto or any related Prospectus. The Company shall, as promptly as reasonably practicable (x)
respond to any comments received from the Commission with respect to a Registration Statement or any amendment thereto and (y) prepare
and file any such supplement or amendment to such Registration Statement and such Prospectus with the Commission as required pursuant
to the determination or requests set forth under subsections (ii) to (iv) above. Nothing in this Section 3(f) shall limit any obligation
of the Company under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(g)&nbsp;The
Company shall (i) use its commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness
of a Registration Statement or the use of any Prospectus contained therein, or the suspension of the qualification, or the loss of an
exemption from qualification, of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is
issued, to obtain the withdrawal of such order or suspension at the earliest possible time and (ii) notify Legal Counsel and the Investor
of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(h)&nbsp;The
Company shall hold in confidence and not make any disclosure of information concerning the Investor provided to the Company unless (i)
disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information is
necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required to be disclosed in such
Registration Statement pursuant to the Securities Act, (iii) the release of such information is ordered pursuant to a subpoena or other
final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such information has been made generally
available to the public other than by disclosure in violation of this Agreement or any other Transaction Document. The Company agrees
that it shall, upon learning that disclosure of such information concerning the Investor is sought in or by a court or governmental body
of competent jurisdiction or through other means, give prompt written notice to the Investor and allow the Investor, at the Investor&rsquo;s
expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(i)&nbsp;Without
limiting any obligation of the Company under the Purchase Agreement, the Company shall use its commercially reasonable efforts either
to (i) cause all of the Registrable Securities covered by each Registration Statement to be listed on the Trading Market, or (ii) secure
designation and quotation of all of the Registrable Securities covered by each Registration Statement on another Eligible Market. The
Company shall pay all fees and expenses in connection with satisfying its obligation under the preceding sentence. In addition, the Company
shall reasonably cooperate with the Investor and any Broker-Dealer through which the Investor proposes to sell its Registrable Securities
in effecting a filing with FINRA pursuant to FINRA Rule 5110 as reasonably requested by the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(j)&nbsp;Investor
hereby represents, warrants and covenants to the Company that it will resell the Shares only pursuant to the Registration Statement in
which such Shares are included, in a manner described under the caption &ldquo;Plan of Distribution&rdquo; in such Registration Statement,
and in a manner in compliance with all applicable U.S. federal and state securities laws, rules and regulations, including, without limitation,
any applicable prospectus delivery requirements of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(k)&nbsp;Upon
the written request of the Investor, the Company shall use its commercially reasonable efforts, as soon as reasonably practicable after
receipt of notice from the Investor and subject to Section 3(p) hereof, (i) incorporate in a Prospectus Supplement or post-effective amendment
such information as the Investor reasonably requests to be included therein relating to the sale and distribution of Registrable Securities,
including, without limitation, information with respect to the number of Registrable Securities being offered or sold, the purchase price
being paid therefor and any other terms of the offering of the Registrable Securities to be sold in such offering; (ii) make all required
filings of such Prospectus Supplement or post-effective amendment after being notified of the matters to be incorporated in such Prospectus
Supplement or post-effective amendment; and (iii) supplement or make amendments to any Registration Statement or Prospectus contained
therein if reasonably requested by the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(l)&nbsp;The
Company shall use its commercially reasonable efforts to cause the Registrable Securities covered by a Registration Statement to be registered
with or approved by such other governmental agencies or authorities in the United States as may be necessary to consummate the disposition
of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(m)&nbsp;The
Company shall make generally available to its security holders (which may be satisfied by making such information available on EDGAR)
as soon as practical, but not later than ninety (90) days after the close of the period covered thereby, an earnings statement (in form
complying with, and in the manner provided by, the provisions of Rule 158 under the Securities Act) covering a twelve-month period beginning
not later than the first day of the Company&rsquo;s fiscal quarter next following the applicable Effective Date of each Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(n)&nbsp;The
Company shall use its commercially reasonable efforts to comply with all applicable securities laws, and all other applicable rules and
regulations of the Commission in connection with any registration hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(o)&nbsp;Within
one (1) Business Day after each Registration Statement which covers Registrable Securities is declared effective by the Commission, the
Company shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities (with copies to the
Investor) confirmation that such Registration Statement has been declared effective by the Commission in the form attached hereto as <U>Exhibit
A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(p)&nbsp;Notwithstanding
anything to the contrary contained herein (but subject to the last sentence of this Section 3(p)), at any time after the Effective Date
of a particular Registration Statement, the Company may, upon written notice to the Investor, suspend the Investor&rsquo;s use of any
prospectus that is a part of any Registration Statement (in which event the Investor shall discontinue sales of the Registrable Securities
pursuant to such Registration Statement contemplated by this Agreement, but may, in its sole discretion, settle any previously made sales
of Registrable Securities) if the Company (x) is pursuing an acquisition, merger, tender offer, reorganization, disposition or other similar
transaction and the majority of the Board determines in good faith that (A) the Company&rsquo;s ability to pursue or consummate such a
transaction would be materially adversely affected by any required disclosure of such transaction in such Registration Statement or other
registration statement or (B) such transaction renders the Company unable to comply with Commission requirements, in each case under circumstances
that would make it impractical or inadvisable to cause any Registration Statement (or such filings) to be used by Investor or to promptly
amend or supplement any Registration Statement contemplated by this Agreement on a post effective basis, as applicable, or (y) is required
to make an Adverse Disclosure (each, an &ldquo;<B><I>Allowable Grace Period</I></B>&rdquo;); <U>provided</U><I>, </I><U>however</U>, that
in no event shall the Investor be suspended from selling Registrable Securities pursuant to any Registration Statement for a period that
exceeds twenty (20) consecutive Trading Days or an aggregate of sixty (60) days in any three hundred and sixty-five (365)-day period;
and <I>provided, further</I>, the Company shall not effect any such suspension (A) during the first ten (10) consecutive Trading Days
after the Effective Date of the particular Registration Statement or (B) if a VWAP Purchase Notice or Intraday VWAP Purchase Notice has
been delivered to the Investor, before the fifth (5<SUP>th</SUP>) Trading Day following the later of (i) the date on which the Company
has issued all Shares issuable pursuant to the VWAP Purchase or Intraday VWAP Purchase to which such VWAP Purchase Notice or Intraday
VWAP Purchase Notice relates and (ii) the date on which the Investor has paid to the Company the VWAP Purchase Amount for all Shares issuable
pursuant to the VWAP Purchase or Intraday VWAP Purchase to which such VWAP Purchase Notice or Intraday VWAP Purchase Notice relates. The
Company agrees that it shall not send any VWAP Purchase Notice or Intraday VWAP Purchase Notice to the Investor during an Allowable Grace
Period. Upon disclosure of such information or the termination of the condition described above, the Company shall provide prompt notice,
but in any event within one (1) Business Day of such disclosure or termination, to the Investor and shall promptly terminate any suspension
of sales it has put into effect and shall take such other reasonable actions to permit registered sales of Registrable Securities as contemplated
in this Agreement (including as set forth in the first sentence of Section 3(f) with respect to the information giving rise thereto unless
such material, non-public information is no longer applicable). Notwithstanding anything to the contrary contained in this Section 3(p),
if the Company is obligated in accordance with the terms of the Purchase Agreement to deliver DWAC Shares to a person purchasing such
Shares from the Investor in a resale of such Registrable Securities with respect to which the Investor has entered into a contract for
sale, and delivered a copy of the Prospectus included as part of the particular Registration Statement to the extent applicable, in each
case prior to the Investor&rsquo;s receipt of the notice of an Allowable Grace Period and for which the Investor has not yet settled,
the Company shall deliver DWAC Shares to such person in accordance with the terms of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;IV</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>OBLIGATIONS
OF THE INVESTOR</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.&#9;<U>Obligations
of the Investor</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a)&nbsp;At
least five (5) Business Days prior to the first anticipated filing date of each Registration Statement (or such shorter period to which
the parties agree), the Company shall notify the Investor in writing of the information the Company requires from the Investor with respect
to such Registration Statement and, as a condition precedent to the obligations of the Company to complete the registration pursuant to
this Agreement with respect to the Registrable Securities of the Investor, the Investor shall promptly furnish to the Company such information
regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it,
as shall be reasonably required to effect and maintain the effectiveness of the registration of such Registrable Securities and shall
promptly execute such documents in connection with such registration as the Company may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b)&nbsp;The
Investor, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of each Registration Statement hereunder, unless the Investor has notified the Company in
writing of the Investor&rsquo;s election to exclude all of the Investor&rsquo;s Registrable Securities from such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c)&nbsp;The
Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 3(p)
or the first sentence of 3(f), the Investor shall (i) as soon as is reasonably practicable discontinue disposition of Registrable Securities
pursuant to any Registration Statement(s) covering such Registrable Securities until the Investor&rsquo;s receipt of the copies of the
supplemented or amended Prospectus contemplated by Section 3(p) or the first sentence of Section 3(f) or receipt of notice that no supplement
or amendment is required and (ii) maintain the confidentiality of any information included in such notice delivered by the Company unless
(x) otherwise required by law or subpoena or final, non-appealable order from a court or governmental body of competent jurisdiction,
(y) as required by a regulator in connection with regulatory action that is not targeted at the matters that are subject to this Agreement,
or (z) such information has been made generally available to the public other than by disclosure by the Investor in violation of this
Agreement or any other Transaction Document. Notwithstanding anything to the contrary in this Section 4(c), the Company shall cause its
Transfer Agent to deliver DWAC Shares, free from all restrictive legends, to a transferee of the Investor in accordance with the terms
of the Purchase Agreement in connection with any sale of Registrable Securities with respect to which the Investor has entered into a
contract for sale prior to the Investor&rsquo;s receipt of a notice from the Company of the happening of any event of the kind described
in Section 3(p) or the first sentence of Section 3(f) and for which the Investor has not yet settled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d)&nbsp;The
Investor covenants and agrees that it shall use commercially reasonable efforts to comply with the prospectus delivery and other requirements
of the Securities Act as applicable to it in connection with the sale of Registrable Securities pursuant to a Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;V</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>EXPENSES
OF REGISTRATION</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Section&nbsp;5.&#9;<U>Expenses
of Registration.</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Except as otherwise provided in
Section 10.1(i) of the Purchase Agreement, all reasonable expenses of the Company and of the Investor (other than sales or brokerage commissions
and legal counsel fees and expenses) incurred in connection with registrations, filings or qualifications pursuant to Sections 2 and 3,
including, without limitation, all registration, listing and qualifications fees, printers and accounting fees, and fees and disbursements
of counsel for the Company, shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;VI</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>INDEMNIFICATION</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Section&nbsp;6.&#9;<U>Indemnification.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a)&nbsp;To the fullest extent
permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, its affiliates, each of their
respective directors, officers, shareholders, members, partners, employees, agents, representatives (and any other Persons with a functionally
equivalent role of a Person holding such titles notwithstanding the lack of such title or any other title) and each Person, if any, who
controls the Investor within the meaning of the Securities Act or the Exchange Act and each of the directors, officers, shareholders,
members, partners, employees, agents, representatives (and any other Persons with a functionally equivalent role of a Person holding
such titles notwithstanding the lack of such title or any other title) of such controlling Persons (each, an &ldquo;<B><I>Investor Party</I></B>&rdquo;
and collectively, the &ldquo;<B><I>Investor Parties</I></B>&rdquo;), from and against all losses, liabilities, obligations, claims, contingencies,
damages, costs and expenses (including all judgments, amounts paid in settlement, court costs, all reasonable out-of-pocket legal or
other expenses reasonably incurred in investigating, preparing or defending any litigation, commenced or threatened, or any claim whatsoever),
amounts paid in settlement or expenses, joint or several, (collectively, &ldquo;<B><I>Claims</I></B>&rdquo;) reasonably incurred in investigating,
preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any
court or governmental, administrative or other regulatory agency, body or the Commission, whether commenced, pending or threatened, whether
or not an Investor Party is or may be a party thereto (&ldquo;<B><I>Indemnified Damages</I></B>&rdquo;), to which any Investor Party
may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect thereof) are as a result
of, related to or arise out of or are based upon (a) (i) any untrue statement or alleged untrue statement of a material fact in a Registration
Statement or any post-effective amendment thereto or in any filing made in connection with the qualification of the offering under the
securities or other &ldquo;Blue Sky&rdquo; laws of any jurisdiction in which Registrable Securities are offered (&ldquo;<B><I>Blue Sky
Filing</I></B>&rdquo;), or the omission or alleged omission to state a material fact required to be stated therein or necessary to make
the statements therein not misleading or (ii) any untrue statement or alleged untrue statement of a material fact contained in any Prospectus
(as amended or supplemented) or in any Prospectus Supplement or the omission or alleged omission to state therein any material fact necessary
to make the statements made therein, in light of the circumstances under which the statements therein were made, not misleading (the
matters in the foregoing clauses (i) and (ii) being, collectively, &ldquo;<B><I>Violations</I></B>&rdquo;) or (b) any breach by the Company
of its representations, warranties, covenants or agreements under this Agreement. The Company agrees to promptly notify the Investor
of the commencement of any litigation or proceedings against the Company or any of its officers, directors or controlling person in connection
with the issue and sale of the Registrable Shares or in connection with the Registration Statement or the Prospectus. Subject to Section
6(c), the Company shall reimburse the Investor Parties, promptly as such expenses are incurred and are due and payable, for any reasonable
and documented legal fees or other reasonable and documented expenses incurred by them in connection with investigating or defending
any such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this Section 6(a):
(i) shall not apply to a Claim by an Investor Party arising out of or based upon a Violation which occurs in reliance upon and in conformity
with information furnished in writing to the Company by the Investor for the Investor expressly for use in connection with the preparation
of the Registration Statement, Prospectus or Prospectus Supplement or any such amendment thereof or supplement thereto (it being hereby
acknowledged and agreed that the written information set forth on <U>Exhibit B</U> is the only written information furnished to the Company
by or on behalf of the Investor expressly for use in any Registration Statement, Prospectus or Prospectus Supplement); and (ii) shall
not be available to the Investor to the extent such Claim is based on a failure of the Investor to deliver or to cause to be delivered
the Prospectus (as amended or supplemented) made available by the Company (to the extent applicable), including, without limitation,
a corrected Prospectus, if such Prospectus (as amended or supplemented) or corrected Prospectus was timely made available by the Company
pursuant to Section 3(d) and then only if, and to the extent that, following the receipt of the corrected Prospectus no grounds for such
Claim would have existed; and (iii) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without
the prior written consent of the Company, which consent shall not be unreasonably withheld or delayed. Such indemnity shall remain in
full force and effect regardless of any investigation made by or on behalf of the Investor Party and shall survive the transfer of any
of the Registrable Securities by the Investor pursuant to Section 9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b)&nbsp;In
connection with any Registration Statement in which the Investor is participating, the Investor agrees to severally and not jointly indemnify,
hold harmless and defend, to the same extent (in terms of the nature of Claims and Indemnified Damages) and in the same manner as set
forth in Section 6(a), the Company, each of its directors, each of its officers who signs the Registration Statement and each Person,
if any, who controls the Company within the meaning of the Securities Act or the Exchange Act (each, an &ldquo;<B><I>Company Party</I></B>&rdquo;),
against any Claim or Indemnified Damages to which any of them may become subject, under the Securities Act, the Exchange Act or otherwise,
insofar as such Claim or Indemnified Damages arise out of or are based upon any Violation, in each case, to the extent, and only to the
extent, that such Violation occurs in reliance upon and in conformity with information furnished in writing to the Company by the Investor
for the Investor expressly for use in connection with the preparation of the Registration Statement, Prospectus or Prospectus Supplement
or any such amendment thereof or supplement thereto (it being hereby acknowledged and agreed that the written information set forth on
<U>Exhibit B</U> is the only written information furnished to the Company by or on behalf of the Investor expressly for use in any Registration
Statement, Prospectus or Prospectus Supplement); and, subject to Section 6(c) and the below provisos in this Section 6(b), the Investor
shall reimburse a Company Party any legal or other expenses reasonably incurred by such Company Party in connection with investigating
or defending any such Claim; <U>provided</U>, <U>however</U>, the indemnity agreement contained in this Section 6(b) and the agreement
with respect to contribution contained in Section 7 shall not apply to amounts paid in settlement of any Claim if such settlement is effected
without the prior written consent of the Investor, which consent shall not be unreasonably withheld or delayed; and <U>provided, further</U>
that the Investor shall be liable under this Section 6(b) for only that amount of a Claim or Indemnified Damages as does not exceed the
net proceeds to the Investor as a result of the applicable sale of Registrable Securities pursuant to such Registration Statement, Prospectus
or Prospectus Supplement. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of
such Company Party and shall survive the transfer of any of the Registrable Securities by the Investor pursuant to Section 9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c)&nbsp;Promptly
after receipt by an Investor Party or Company Party (as the case may be) under this Section 6 of notice of the commencement of any action
or proceeding (including, without limitation, any governmental action or proceeding) involving a Claim, such Investor Party or Company
Party (as the case may be) shall, if a Claim in respect thereof is to be made against any indemnifying party under this Section 6, deliver
to the indemnifying party a written notice of the commencement thereof. The indemnifying party shall have the right to participate in,
and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control of
the defense thereof with counsel mutually satisfactory to the indemnifying party and the Investor Party or the Company Party (as the case
may be); <U>provided</U>, <U>however</U>, an Investor Party or Company Party (as the case may be) shall have the right to retain its own
counsel with the reasonable fees and expenses of such counsel to be paid by the indemnifying party if (i) the indemnifying party has agreed
in writing to pay such fees and expenses; (ii) the indemnifying party shall have failed promptly to assume the defense of such Claim and
to employ counsel reasonably satisfactory to such Investor Party or Company Party (as the case may be) in any such Claim; (iii) the named
parties to any such Claim (including, without limitation, any impleaded parties) include both such Investor Party or Company Party (as
the case may be) and the indemnifying party, and such Investor Party or such Company Party (as the case may be) shall have been advised
by counsel that a conflict of interest is likely to exist if the same counsel were to represent such Investor Party or such Company Party
and the indemnifying party (in which case, if such Investor Party or such Company Party (as the case may be) notifies the indemnifying
party in writing that it elects to employ separate counsel at the expense of the indemnifying party, then the indemnifying party shall
not have the right to assume the defense thereof on behalf of the indemnified party and such counsel shall be at the expense of the indemnifying
party); or (iv) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available
to it or another indemnified party that are different from or in addition to those available to the indemnifying party, <U>provided further</U>
that in the case of clause (iii) above the indemnifying party shall not be responsible for the reasonable fees and expenses of more than
one (1) separate legal counsel for all Investor Parties or Company Parties (as the case may be). The Company Party or Investor Party (as
the case may be) shall reasonably cooperate with the indemnifying party in connection with any negotiation or defense of any such action
or Claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the Company Party
or Investor Party (as the case may be) which relates to such action or Claim. The indemnifying party shall keep the Company Party or Investor
Party (as the case may be) reasonably apprised at all times as to the status of the defense or any settlement negotiations with respect
thereto. No indemnifying party shall be liable for any settlement of any action, claim or proceeding effected without its prior written
consent; <U>provided</U>, <U>however</U>, the indemnifying party shall not unreasonably withhold, delay or condition its consent. Notwithstanding
anything in this Agreement, if at any time an Investor Party shall have requested the Company to reimburse the Investor Party for fees
and expenses of counsel as contemplated by Section 6(a), the Company agrees that it shall be liable for any settlement of any proceeding
effected without its written consent if (i) such settlement is entered into more than 15 days after receipt by the Company of the aforesaid
request and (ii) the Company shall not have reimbursed the Investor Party in accordance with such request prior to the date of such settlement.
No indemnifying party shall, without the prior written consent of the Company Party or Investor Party (as the case may be), consent to
entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional term thereof the giving
by the claimant or plaintiff to such Company Party or Investor Party (as the case may be) of a release from all liability in respect to
such Claim or litigation, and such settlement shall not include any admission as to fault on the part of the Company Party. For the avoidance
of doubt, the immediately preceding sentence shall apply to Sections 6(a) and 6(b) hereof. Following indemnification as provided for hereunder,
the indemnifying party shall be subrogated to all rights of the Company Party or Investor Party (as the case may be) with respect to all
third parties, firms or corporations relating to the matter for which indemnification has been made. The failure to deliver written notice
to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party of
any liability to the Investor Party or Company Party (as the case may be) under this Section 6, unless and solely to the extent that the
indemnifying party is materially and adversely prejudiced by the failure to receive such notice in its ability to defend such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d)&nbsp;No
Person involved in the sale of Registrable Securities who is guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of the Securities Act) in connection with such sale shall be entitled to indemnification from any Person involved in such sale of Registrable
Securities who is not guilty of fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e)&nbsp;The
indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, promptly upon the receipt of bills or as the Indemnified Damages are incurred; <U>provided</U> that any Person receiving any
payment pursuant to this Section 6 shall promptly reimburse the Person making such payment for the amount of such payment to the extent
a court of competent jurisdiction makes a final determination that such Person receiving such payment was not entitled to such payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f)&nbsp;The
indemnity and contribution agreements contained herein in Section 6 and Section 7 shall be in addition to (i) any cause of action or similar
right of the Company Party or Investor Party against the indemnifying party or others, including any rights under the Purchase Agreement,
and (ii) any liabilities the indemnifying party may be subject to pursuant to applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;VII</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>CONTRIBUTION</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Section&nbsp;7.&#9;<U>Contribution</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In order to provide for just and
equitable contribution in circumstances in which the indemnification provided for in Section 6 for any reason is held to be unavailable
or insufficient to hold an indemnified party harmless, the indemnifying party will make maximum contribution with respect to any amounts
for which it would otherwise be liable under Section 6 to the fullest extent permitted by law; <U>provided</U>, <U>however</U>: no contribution
shall be made under circumstances where the maker would not have been liable for indemnification under the fault standards set forth in
Section 6 of this Agreement. If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the
allocation of contribution shall be made in such proportion as is appropriate to reflect the relative fault of the Company, on the one
hand, and the Investor Party, on the other hand, with respect to the statements or omission that resulted in such loss, claim, liability,
expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering.
Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material
fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Investor Party, the
intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission.
The Company and the Investor Party agree that it would not be just and equitable if contributions pursuant to this Section 7 were to be
determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred
to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense, or damage, or action
in respect thereof, referred to above in this Section 7 shall be deemed to include, for the purpose of this Section 7, any legal or other
expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim to the extent
consistent with Section 6 hereof. Notwithstanding the foregoing provisions of this Section 7, the contribution by any seller of Registrable
Securities shall be limited in amount to the amount of net proceeds received by such seller from the applicable sale of such Registrable
Securities pursuant to such Registration Statement and no person found guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.
Notwithstanding the provisions of this Section 7, the Investor shall not be required to contribute, in the aggregate, any amount in excess
of the amount by which the net proceeds actually received by the Investor from the applicable sale of the Registrable Securities subject
to the Claim exceeds the amount of any damages that the Investor has otherwise been required to pay, or would otherwise be required to
pay under Section 6(b), by reason of such untrue or alleged untrue statement or omission or alleged omission. For purposes of this Section
7, any person who controls a party to this Agreement within the meaning of the Securities Act, any affiliates of the Investor Party and
any officers, directors, partners, employees or agents of the Investor Party or any of its affiliates, will have the same rights to contribution
as that party, and each director of the Company and each officer of the Company who signed the Registration Statement will have the same
rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after
receipt of notice of commencement of any action against such party in respect of which a claim for contribution may be made under this
Section 7, will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve
that party or parties from whom contribution may be sought from any other obligation it or they may have under this Section 7 except to
the extent that the failure to so notify such other party materially prejudiced the substantive rights or defenses of the party from whom
contribution is sought. No party will be liable for contribution with respect to any action or claim settled without its written consent
if such consent is required pursuant to Section 6(c) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;VIII</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>REPORTS
UNDER THE EXCHANGE ACT</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Section&nbsp;8.&#9;<U>Reports
Under the Exchange Act</U>. <FONT STYLE="font-style: normal; font-weight: normal">With a view to making available to the Investor the
benefits of Rule 144, the Company agrees to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a)&nbsp;use
its commercially reasonable efforts to make and keep public information available, as those terms are understood and defined in Rule 144;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b)&nbsp;use
its commercially reasonable efforts to file with the Commission in a timely manner all reports and other documents required of the Company
under the Securities Act and the Exchange Act so long as the Company remains subject to such requirements (it being understood that nothing
herein shall limit any of the Company&rsquo;s obligations under the Purchase Agreement) and the filing of such reports and other documents
is required for the applicable provisions of Rule 144;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c)&nbsp;furnish
to the Investor so long as the Investor owns Registrable Securities (or securities that have ceased to be Registrable Securities pursuant
to Section 2(f))(iii), promptly upon request, (i) a written statement by the Company, if true, that it has complied with the reporting,
submission and posting requirements of Rule 144 and the Exchange Act, (ii) a copy of the most recent annual or quarterly report of the
Company and such other reports and documents so filed by the Company with the Commission if such reports are not publicly available via
EDGAR, and (iii) such other information as may be reasonably requested to permit the Investor to sell such securities pursuant to Rule
144 without registration;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d)&nbsp;take
such additional action as is reasonably requested by the Investor to enable the Investor to sell the Registrable Securities pursuant to
Rule 144, including, without limitation, delivering all such legal opinions, consents, certificates, resolutions and instructions to the
Company&rsquo;s Transfer Agent without unreasonable delay as may be reasonably requested from time to time by the Investor and otherwise
use commercially reasonable efforts to fully cooperate with Investor and Investor&rsquo;s broker in their efforts to effect such sale
of securities pursuant to Rule 144; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e)&nbsp;promptly
inform the Investor once the securities may be sold without registration pursuant to Rule 144 or any successor rule promulgated under
the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;IX</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>ASSIGNMENT
OF REGISTRATION RIGHTS</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Section&nbsp;9.&#9;<U>Assignment
of Registration Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a)&nbsp;The
Company shall not assign this Agreement or any of its rights or obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b)&nbsp;The
Investor may assign or delegate its rights, duties or obligations under this Agreement, in whole or in part, to any of its affiliates
(&ldquo;<B><I>Permitted Transferee</I></B>&rdquo;) to whom it transfers Registrable Securities; <U>provided</U> that such Registrable
Securities remain Registrable Securities following such transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;X</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>AMENDMENT
OR WAIVER</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Section&nbsp;10.&#9;<U>Amendment
or Waiver</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">No provision of this Agreement
may be (i) amended other than by a written instrument signed by both parties hereto or (ii) waived other than in a written instrument
signed by the party against whom enforcement of such waiver is sought. Failure of any party to exercise any right or remedy under this
Agreement or otherwise, or delay by a party in exercising such right or remedy, shall not operate as a waiver thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;XI</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>MISCELLANEOUS</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Section&nbsp;11.&#9;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a)&nbsp;Solely
for purposes of this Agreement, a Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed to
own of record such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more Persons
with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received from
such record owner of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b)&nbsp;Any
notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement shall be given
in accordance with Section 10.4 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c)&nbsp;The
Company and the Investor acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that either party shall
be entitled to an injunction or injunctions to prevent or cure breaches of the provisions of this Agreement by the other party and to
enforce specifically the terms and provisions hereof (without the necessity of showing economic loss and without any bond or other security
being required), this being in addition to any other remedy to which either party may be entitled by law or equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d)&nbsp;All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal laws
of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New
York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. Each
party hereby irrevocably submits to the exclusive jurisdiction of the federal courts sitting in The City of New York, Borough of Manhattan,
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein,
and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject
to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such
suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being
served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any manner permitted by law. If any provision of this Agreement shall
be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability of
the remainder of this Agreement in that jurisdiction or the validity or enforceability of any provision of this Agreement in any other
jurisdiction. <B>EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e)&nbsp;The
Transaction Documents set forth the entire agreement and understanding of the parties solely with respect to the subject matter thereof
and supersedes all prior and contemporaneous agreements, negotiations and understandings between the parties, both oral and written, solely
with respect to such matters. There are no promises, undertakings, representations or warranties by either party relative to subject matter
hereof not expressly set forth in the Transaction Documents. Notwithstanding anything in this Agreement to the contrary and without implication
that the contrary would otherwise be true, nothing contained in this Agreement shall limit, modify or affect in any manner whatsoever
(i) the conditions precedent to a VWAP Purchase or Intraday VWAP Purchase contained in Article VII of the Purchase Agreement or (ii) any
of the Company&rsquo;s obligations under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f)&nbsp;The
parties agree that each of them and their respective counsel has reviewed and had an opportunity to revise this Agreement and, therefore,
the normal rule of construction to the effect that any ambiguities are to resolved against the drafting party shall not be employed in
the interpretation of this Agreement. In addition, each and every reference to share prices and number of shares of Common Stock in this
Agreement shall, in all cases, be subject to adjustment for any stock splits, stock combinations, stock dividends, recapitalization, reorganizations
and other similar transactions that occur on or after the date of this Agreement. Any reference in this Agreement to &ldquo;<B><I>Dollars</I></B>&rdquo;
or &ldquo;$&rdquo; shall mean the lawful currency of the United States of America. Any references to &ldquo;Section&rdquo; or &ldquo;Article&rdquo;
in this Agreement shall, unless otherwise expressly stated herein, refer to the applicable Section or Article of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(g)&nbsp;This
Agreement shall inure to the benefit of and be binding upon the parties hereto, the Permitted Transferees and their respective successors.
This Agreement is not for the benefit of, nor may any provision hereof be enforced by, any Person, other than the parties hereto, any
Permitted Transferee, their respective successors and the Persons referred to in Sections 6 and 7 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(h)&nbsp;The
headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Unless the
context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural
forms thereof. The terms &ldquo;including,&rdquo; &ldquo;includes,&rdquo; &ldquo;include&rdquo; and words of like import shall be construed
broadly as if followed by the words &ldquo;without limitation.&rdquo; The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo; &ldquo;hereof&rdquo;
and words of like import refer to this entire Agreement instead of just the provision in which they are found.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(i)&nbsp;This
Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall
become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile signature
or signature delivered by e-mail in a &ldquo;.pdf&rdquo; format data file, including any electronic signature complying with the U.S.
federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered due execution and shall be binding
upon the signatory thereto with the same force and effect as if the signature were an original signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(j)&nbsp;Each
party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such
other agreements, certificates, instruments and documents as any other party may reasonably request in order to carry out the intent and
accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(k)&nbsp;The
language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules of
strict construction will be applied against any party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(l)&nbsp;The
provisions of Article V (Expenses of Registration), Article VI (Indemnification), Article VII (Contributions) and this Article XI (Miscellaneous)
shall remain in full force and effect indefinitely notwithstanding termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[<I>Signature Pages Follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, Investor
and the Company have caused their respective signature page to this Registration Rights Agreement to be duly executed as of the date first
written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: bottom"><B>COMPANY:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: bottom"><B>SONIM TECHNOLOGIES, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 5%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 45%; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">By:</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; vertical-align: bottom"><I>/s/ Peter Liu</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">Name: </TD>
    <TD STYLE="text-align: left; vertical-align: bottom">Peter Liu</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">Title: </TD>
    <TD STYLE="text-align: left; vertical-align: bottom">Chief Executive Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: bottom"><B>INVESTOR:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: bottom"><B>CHARDAN CAPITAL MARKETS LLC</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: left; text-indent: 0in">By:</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; text-align: left; text-indent: 0in"><I>/s/ Jonas Grossman</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: left; text-indent: 0in">Name:</TD>
    <TD STYLE="vertical-align: bottom; text-align: left; text-indent: 0in">Jonas Grossman</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: left; text-indent: 0in">Title:</TD>
    <TD STYLE="vertical-align: bottom; text-align: left; text-indent: 0in">President</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><U>EXHIBIT A</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">FORM OF NOTICE OF EFFECTIVENESS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">OF REGISTRATION STATEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="background-color: white">Equiniti Trust
Company, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">6201 15<SUP>th</SUP> Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Brooklyn, NY 11219</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Attention: [___]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Re: Sonim Technologies, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Reference is made to the offering
and resale of shares (the &ldquo;Shares&rdquo;) of common stock, par value $0.001 per share (the &ldquo;Common Stock&rdquo;), of Sonim
Technologies, Inc. (the &ldquo;Company&rdquo;) by Chardan Capital Markets LLC (the &ldquo;Purchaser&rdquo;) after they are issued to the
Purchaser in accordance with the ChEF Purchase Agreement, dated as of September 29, 2025, by and between the Company and the Purchaser,
pursuant to the Company&rsquo;s registration statement on Form S-1 (No. 333-[___]) filed with the Securities and Exchange Commission (the
&ldquo;Commission&rdquo;) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). The registration statement,
together with all amendments thereto filed with the Commission on or before the date of this letter, is referred to herein as the &ldquo;Registration
Statement.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Registration Statement became
effective under the Securities Act on [___], 2025 and, based solely on our review of the Commission&rsquo;s &ldquo;Stop Orders&rdquo;
web page (http://sec.gov/litigation/stoporders.shtml), no stop order suspending the effectiveness of the Registration Statement has been
issued under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This letter is being furnished
by us solely for your benefit in your capacity as transfer agent and registrar of the Common Stock in connection with the sale of the
Shares by the Company to the Purchaser, and neither it nor the opinions it contains may be relied on for any other purpose or by anyone
else.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">[<I>Signature Pages Follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><U>EXHIBIT B</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">WRITTEN INFORMATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The business address of Chardan
Capital Markets LLC is One Pennsylvania Plaza, Suite 4800, New York, NY 10119.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Options: NewSection Last; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>sonm-20250929.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWamGKbP9z5Z8aekhvWB1bRlKfyYnzn0DPSBkIxMG0dwN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:SONM="http://sonimtech.com/20250929" elementFormDefault="qualified" targetNamespace="http://sonimtech.com/20250929">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://sonimtech.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="sonm-20250929_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="sonm-20250929_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>sonm-20250929_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xml:lang="en-US">Entity Information, Former Legal or Registered Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>sonm-20250929_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="sonm-20250929.xsd#Cover" roleURI="http://sonimtech.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sonimtech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_deiEntityInformationFormerLegalOrRegisteredName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInformationFormerLegalOrRegisteredName" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 29, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 29,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Sonim
Technologies, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001178697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3336783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4445
Eastgate Mall<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San
Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">378-8100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SONM<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Not
applicable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sonimtech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>sonm-20250929.xsd</File>
    <File>sonm-20250929_lab.xml</File>
    <File>sonm-20250929_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "SONM",
   "nsuri": "http://sonimtech.com/20250929",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "sonm-20250929.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "sonm-20250929_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sonm-20250929_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 60,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 24
   },
   "report": {
    "R1": {
     "role": "http://sonimtech.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001493152-25-015997-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-015997-xbrl.zip
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M)<D :PI"JD1M@W;2VJX06^,^:8CM!LAP=.73<#]@RZW3'F46QHK\E< :ZXO
MI3@Z""3"$ZPG0,S_7L,G>5;59'"C)D-KCRRZ5+[=F7V!N1<_%WURM/:61F5A
MI9\/T$_IX"(:;^8HE'N]]1QSQ5B3I;XURG1,*,G22_557LD17;9UDXY-I"N3
MA[B2E92#&?6&G:&7B/$Z:QLQX)-/&X8M@GL>.3:OOP]88],;WG>7-G'KD;5:
M8QWN$!9.4*T8QO#$_L ;]@KT!'Z6!\+L8=D#=3-"I<BWIB_;'S'03&GIM2VT
M\5,X1FEG]': H6,H&*B[8CL6[)&U5#&['I>.F5=.VZYK+_M,SFU*LE=G7;L^
M%<8VE^K9FRRD9RW.4E*Y5&X@I9)A8_''])ZJ'-/+R'):%4348L#J'+X2^>LS
MJ]FC&E,7&-M)T@?R^X&"OF%INHK;%Q!AGOY#GLJ+3ZT\7=8S7*=4]P \ ]K>
M#BRFSEQ?DJYU.XC4\[2%PUG$_.W#P/JX7#-G>RJ&:?S\YV&']KT)XZM@4NN%
MZPGN&$]I]!OG8AO*1=VZJ4TR.PC;G[ W62\SHE6X=##3IL+%1B7<:AN].]FQ
M]Z&5_)[ZI5Y#P[C H/XP\)4)M;K!67;I'K4^BSZ8/7H[0XXP9XK2^\*0\$:X
MFC0(D%C)14WWWT?IK?81BS(>?"W*^)1%&0^^%F7\88LR4NF4^Y1..7%);M,T
MA%0!&&P-.CF+[%=RV+Y0.GO;1-64K&RZJ]'(J(AC9]30&K](AN7*YOE+<V$7
M,[*(T1N]T6L2) /LJIVR.\LW/W['=Q7S%9,^DFZZ #EL%IN_9 1,76.T#9>G
M3GE;2Z@LV1$J)!^XE]_]]MO\NP??D:686I7]@&[\Z(<[/_SP7VII7[3TX1(,
M,TJ!;.MZJY,C],AZA8!%AH!90$-0#+2A?].!XN<&;W76!;A ZQGR+!(=$/WU
M$!3C(=L_Q ODVNK&3R$C)#5XJAR%O4%S),AL(>5@&*;IJTX:Z@5[11N.1LJT
M2G)/V"]37=...\M 'Q,;[%0]X6]B%255/>?%^_I\?3Z8?Z(,1D_WWH2.=YQ?
MD7:Y*2>]QP4$&[)$O!>%5V"48$M)SL!:NSL>R0PC*.)#RP2M\AF+[.^\..K[
M\#CA\UHYA,2U'C,1K_,&%\;;V,4XMFTYINZ$G'<]:&B, 8M< T8,/;(;@,+*
MRW_3U1]0O.294K2Q:^I?!RHW6L)VRKCG?+AK;E)F%34:(=#<33UQ-VE$E]=(
M'!QI9,V=ILMM#?.R?92[)7/TC3**W5=^-'95?3S47U AW2<)1+HGM;_ ;GI-
M#N\O[8)ZS0MLY-U)[%@:F1'P8Q(1$!+-KAWECZ^JE#AL4R&7%;9FN&Q ?,_J
M)>'. K*3K0/<\1:C"/$M7&,^\1,Q!>^H) 5TX+1DN&B#\7QD93?2T.6FRNZ6
MP%:_+SG[\4KG9G2*L7E?M"M<)B<<D7(H!D7("44H3$"Q,FRNKJL,KV%%Y 13
M75RE3%XBIJ2:#,HI.M9'QG$<7W"6@(/7/ ..!"*RA>Q-5L*//;ACOUX)91TJ
MGFD B>(#1HBHTB>6;NF^X)'<T(26^T* 3[O=&L'13]^/736O.@G;#Z\3D9BZ
M=Q=H)O Y/:9\T[A.<Z9XP"VD7\=?ZX;L/MZ'=2]5G&7%B1+6QF:G<'_8U'"J
ME.>R8.M_3@DI_.!%T9?%OS/JA8MJ6QLZ<];"EX=X_14F@_<F:J 2YG6^X)@J
M?(F??&?6GKOVI>D&W@983C85"^:U!^8X #5%M\O 7"<8+'78?QA0JMM<7Y]I
M,'S33+Z$<@C'A/4WN.N[8I%L F\-IUN('#A3U5N_'1=I2;DS4I=Q7%[Z3)&[
M5KU?5EPRNFI-R'[_^  <S(NZ#6E\H@(@S#L^QB]BD$X;K&^Y.>5,#^/.(>[@
MOH&RRZU!7<PZM5-J4&PT<7%=-)GFBSC(EL),'A5!$=L#UA:N# 4&=Y1/PJ'N
M,U&SZ+BF0L>LX#HV&/RRZA;,2^P,3;Y=#!\<Z=]"BZI&WB!,NK[N;IQ4E$RY
M:W&%IW(H 0^JL.%K3BI,'D0HI#FE$5P51+$@E(K<2'"%;G?YDK"F,,FU@]BG
M,;,[+(XX.>&S1DA-(J+B,<J6-"$<&R>P\WJ!VN*1<0=+"5/^W!HR%8Q^0,'H
MQ\XQVIN\=)[1+^Y >2T:FZ*P%8A .=7MP>7O\+ .3^#&+O$#59PSB'TD'CM*
M]>K=6RG9VA3"S3<)OI:ZU3V6C/L&<]2O,LGUZNVXT2P__,H[H:#&T U-(#JE
MNUL!UL4"G4"J-:8>*L3N%L5T7<O%^TC_%$>PM"4DEY;>+P_O4PI_O9#%<\88
M!D$3Z>.4TSP$;:>&W'(>WZ\214D/0H_[@76?K0<<!X1W!Z=Y:<[2PAS74;@.
M6*J2"(5/5C2'O2)(8D* B8&4<1'["9@J)\#?@^!BG3]>:V6,AHU4--KF"-I#
MW:\_<A25-+H%@59-$]J5=,$,.AMN#4"04)J%#V-,(V6#9'/,6KR,!49WVK8E
M F59N](XU/Z7.]F%._W)"K7P W9CFZ M2Q"P'WX]'*V+?[B[Q?5 E5!F,!?9
M5G7X0'!7[L,M0N2S17Q:XK@7/,5[.>CC-8K.%7%AJXJ*[2^J).]+."Q]JJM#
ME5-:3-%]0A.LGJ.H@M?7=CM8>KJ UA;^Y)8>[S@;>HC1OGU+[\&GO=8_G\;H
M#[EHK^U7AZ[=-Y*'@J-(%QG3F<KJ//[YHU[LMN0LR76^J31LK!3-1$G"66;Q
M)(TA0*7E7C:QSMCK!WM@\,KJ>"'T:6X((W7LOC8^^,)K#,C_8; ]#[]B>SXE
MMN?A5VS/'P#;XW;XV<L7;X/),,P0;KP?L_42[JL9:"Q2Q,<H?PC,>/X/KM_&
MGWZ,,NX;C,V6E7]&PX+KZO735Z^?OGGZXNWQV^<O7[R!^^K%D^R?QZ]?'[]X
M^_SIF^SEL^SMWY]FSU_\X^F;MR]?JUOZ64WC4ZSN1C,@,-\E%7)>O"-T$)6J
M:_9T=RK[T&[^\8LSIQ[<.2)SZF5W"G;V?\2;P#5ZH_92Y")ZPRK8CAH;>)+Y
M6F$#"S7N9]I>:LWYL'-$-%S (,L%=E !8X)-LM)Y6LY.(ZN#,U"+XM+%?LDL
MP7]H@>"79P,_$.**X_7JK.V"77N%0861+3H3!#BYJSULU(;]XN $9<3X)2OR
M74AIP%:-X^VLA;@WB4U$_EH:M$&;ZRF:$HET]K?8761'T"/?3"^X ?FTL$UO
M'>_ HG7?0N=Q?2[1UD1U'_Y[,*?>E=>\$;!<D#P5!6;JZ/",R'+_AX-GY&<X
MYU$Q<\)_7'2)^ UW\7&]"2FMQLT7BE!:HE\J.0/1+YU7%%JI>Y,U?>J2,3=8
M1\=@0W/D76-/'(,I8X%Q5M7@MM>K-<;="M8<]+FTP;1@H'A&%7KLLXKRW<5I
M@45"2!>2$"Z8."@:E*X\,[ E#$:XA_#Y$$"B'AS<(I]4GQ;-NVZ]7,VH?1.L
M)-PR^-\@KT:]YA@C+&" ]?H\AR?! I?R!]JM[@+_B%&9W)$!\#]ML12I1*H(
M8E<VYPI:\A3A@U-.$@K+I4R"MJ*=YU*F;,LF><-P8;L*\3GLN,+T*""R-T$Q
M6#&:DW-ODHV3]P0Q+5,5B:K$QS3P!_Y!^J*#+U&!,U0>7"5D@(>56_41$MQI
MMMRK-:HM8S93DMVD(KH]+1>5].^JYK*4EBM;;D(;)"Z$FT]"\E%J6-K3Q76X
M/NY)1H#+@>4;+K/"S5015O;4VK.)J"X*$PK*A] 1,]DBTA6YT4APY6(=98$3
M8%Y:X0C37 KJEL;1[Y"K3\M(/'%8/HG/4U [C!;TE#Y0*#+I6%.@L*N9-(B8
M&G@'\5$^#HUY)8WHY-13<E')CF.>'B5FX9:7$T1*2^=7B)33ZA2<7)2[JF18
M]AHKJEF<UYA<@CG!_YVVV# (5J9J$+2WJ(BSQCT)\7"ZE$/89H(L@TQ(ILKD
M?TVQ-$\KD3?)"I4R5B5JHAP-2!S=HIT1J(HHK"HXGO2'-?X)L00YEU>>2D\A
M5I_$ED&K_J]U>:H#+ZL9@H+D/;-VW=''IUA/VN"7: %1U0_Z_ 4V".E3GK=I
M*<OAX)5HW*+OJQ73HM#LO59'PYGOIEP36#.!.7)Y;\_2*J">^B#WG!8JP7V.
MURW)%T+730XC-]' 4'CR0'3XCG"+3X6U+, @$R0C]45=KDT.9V4QLD2#0\WM
M:3TL.2:,9H[5S7S(I$FS$U#)( CD-DQHV$3Z]0Q4484V#7K+!JH5[@ 9+_F3
MQLH,B&H@Q*0T2(SAMF>Q#:66") )YR:B2<9>'IIZG/,K*566<Y_V=U+]6R]<
MG;%9%-H!+@+:*.QU(\\E% ?E,,2R<W<6->7C&^MF5U/+O (?OAVY96 #H15#
MSM),/GO^XO5Q K0/'YR!.W3!CE4NC=;G7+QKT)-5%'?@NEW-)2A14CY4>CW<
MNNH&@TEW1=ZO9FX+9"0J9E?I=P@CGHEO>(1>@"8QU+-1\V"W7+X+96XB) X5
MR9F"Z/&VJ48A0"L' ?T2#3N&G1S//,6IVVJ,7*S[#?$3QSE<N)_# JL%Y"BV
M&9TZ0K']\.Z1L#R\]FKBR9>X$YPG?%V)U*-D/GT/=BE)>(B>-"R06%> $2C#
MTF.HRAB%W<[GCLJ6J#@0BKQBRAWW-N7_GZ%2E+=2P3V;U8'&%2WD3MAO=][<
M48.&WT+7@2>)8/>/SW9(1\M..^L0&! %"9PN 6N,R!I*IU4P#K"YG:TEK,Y3
M&BA+*R"/;7+@--3$=>/O#8NDUN:_Q&'@KG=VP?WZZ4"9<WW4"AA>$9]W;O+;
MK[G)3YF;_/9K;O+V<I.?"YOS@SO?DL)_[G&QMC_T8N&<B2!NQDA @:&!RP0.
M4<-U#VH-Y8@-*DX-I?]27*.DL37^%KHVV%[31B?F>F'',&P;!@HM$1;UWYFO
MNZ;NS[C(Q3M39'=Z.I@87\*17AA(>5'W;=>;/B,<LVC7*Q.U<]@7837S)3[;
M+D]T;]E^D6+DT&:_P  ICB,[@^,$5\&IN-E=W;\;ND\ZEVE5,!BE@BUJS^&"
MQ>^S>S[^.ESU,PWJAC4_6*[0U155*,./O A0G%EAC;"O*ZH+%M;I&GL2+SF"
M-,^J"]#?LMMG&$#O:HVGPN!Z9A1"5[_MG5$W'&5<!>NPI[)39NN+^1PU-E^'
M[7()%^RZD2Q- <M!PJ,RRHX%19+AO_M+G =Q_]BK_&+H/"".#]P^QZB9.!WA
M(B7. [M=NGKV3&S8KCN@)IC C\M/&KS/B1RKT3@-_;5<8Z<%4!2DP/EIKL40
MCG$]2YT@R768 T"QG5S_$"\+ARS/VQ(4D41**'Y1.%QD@HE0VP&@-:8YFR%%
M[493:@,B+5,Z,33A:"U257A*_KI]=&9-S6]-!,\F;;ZAJ)BF;0(^,%?D'P]V
M$& 66;%L$*G(\?X.RJE=UDU"'YNH<;MN^FHQ0E5YD\A$5+'.N@69[E8!ZQ8-
M>U&=LC:!4U2\)[&;4;^,FC-CN"QU2<,*D*(2J)%2CU!OE.!<](Y_S0!L2;##
MN/RX@DFH;*Y?Q5B56<D#2Q?2+W&\6D5*-'E(A@8ST]![71G^CH(BU\C[J0%<
MS5/XZ=!IND%V@0[V[U,)^/DXNM]I+NEO)DB'38DNZNIR5T>W:;/?&HHX$,"B
M=^XG>G#D?4K4+]"_/BPX$B3$$GULI-/W7 -*X<>R$KYII$H%7>K"E/#?H(XU
M3VFO;RT7+>J.+QJ\&3"1&/B H[=_@\).ER<?3L$TH)S*V,A']D,H[36N-1QH
MOQE$S*=NQ?7Y2-SW3N(X_;LW>0,^YVQ04Y6*@!N"3A?,5;-);;505U"HNN5R
M<<TW]^9])'HZ$%"NZ(72\_>91%BVLFAD[VQ@["#%9NDVVY6[?O$[_H/N^"NB
M['@#QP>4]IMB8?NO'9,:H>QFV*P^77ZN>"0/7JD:S#R6'"%R1*$F&T0U&I>@
MK_H6X_$Y&'^@1:C?*%DK^L\\N)J6KEQ8;F7.?F+Z60*N/<Z'MEKCK/O;>AG>
MNWLW$J8W?W_I8#6V2,W0%MMR?N%7!N_ME.3?VT'*V06K OX%.GAX(*CG)(U3
M&T$FBVLB[E;4[=S!D=(D4FY2.*7V>Q?4?SXB?G279)RB]""-(%*_X26)!5>5
M#=XG5)MM4>3L*"3MH18_W FNHM;T/L:_]@]WL7T,S#J1K!:4G:/B-F;!L%V'
MJ4YM0]]!.3*ONI:D8VV=B94$8D/R$IL*,WGL17&I25'SY14";LW#ZP$],8BE
M:$Y#YV>*_;]($3N2G 2W"?"M9T?DRI.(. CS ,!LI0V_+%P/:C<A#TWHZXR5
M^9!8>5B&W[]AOQ;\>64+'F,6A_RVFVS3&-+CSM45-BTKXD:;1%+@97JW_$HN
MI!,</5$U_^D%]V-'6#^D".0?GVG)Q6<ZK-TK04Y>_OKJ^,7_?BT$&2L$<3T_
MHSH0VP7HVG4@JGF_O$*0AXE"D'QO\C<LR7CC2V>3%08VW*N</6A[OUE/^[JL
M"^)WI4[P:X*%T1MV+P39USY*8GLHI(UPVI@8T$R';2MN2D;"OMK_ A7?E_7,
M!<<M_O/.SO,!3U,G) A(2L(@DUL]K\78RQ1Z.&N[92L7EVL3[IL-N/CY>"%,
M,"D>%".S[7PR>X.'TS:TD)U ->%! CZ\,@%:;7,X>((.LG)5 >(AR?S)!9/Y
MSPI/)< <C52BS(M0):M+@L@G>FT85"5P13P0@Y@4PU2'35_%8Y\:=-&'35'&
MLEJN!. 258N&G1;8R9G[./2MV6:V/<(-DQR=--!U/!]^KM="3/+Z&:PN1CA<
M'PW\S>4&#BYJ0K;M$4U8/$ #("!J;E*C/NT)*U105JC/S6;D)BFT[S-%-C.)
MW8J6XC0@AZ+A\I18/=<'7#$F$0- ?$0W9ES)_+2J9@5W0<,'D'IRD(6(O5LE
M3JGK@&&#$'BZ+4-Q'?[#_2(D;_E55_]85I_K^@>D+9\U4N6[KTB53XE4^>XK
M4N4/4$6_NXW%=9M661F,"E78N;]=145SD@*D[+4SH,#Z&=A0WEP(HSB]FC&!
MQ8"?-<8\85R^,8D<<H*BXF&MS$B5*-S>KAS$X64JSDQ*?0-6,HU>XX1.\391
M+W"+IKT4 *;+[-NRQ&%V/;@4,(2[P5I+&IZM5+[!&I/A23' +&QA.&[H[;MJ
M(_@Q+ W##,PO-8PW:L+I<A&9&NT,K2I=/+7/JI\5V+A*VB=3^A=L'XYCB*4F
M\'RJ7$Q-/V7%X/!3DR<N7M_ <;NQE'SE;I9/+Q3PO$'.;#*V#O%-&6-'S:61
MV_8.1N93M/3XZB<<J<7!&VO0FANP$;U/.F1AS@$6QO<#%#N&S MP*7WYNI7)
M.0*>R!%=(*A)<EV+NL*J&]A5K,*2H)1_%*9)8'#3KJ!J J'%GTL_YJZ:KWM,
MA#GAP]]T]<P;Y,3BO^L0T<M1%6,8W?%C[!-^)<T4&]@-M+)[KK:%;\P9S(4&
M7T7XW0O^7 M8N8;MRXL"/Y3:SZ!X'V3GJ:_135+[)LKW-SM48364J1V-.AMJ
M2Q1412Y_-4+IC>5XOEP%W#]BB4;UX-GX; 7[&LFC1&Q&6/I0DDSKNK:S3?^T
M.:R)/O/3J%D#TVH&F,*M=4#J,20X!,8K;1TKI.'7L^3$HZLU1#V)YM[F62C1
MNPY6B )0VSFF "S$DY.YB37 2TEAE, .' '1M9J3W#QNBZXD,7E">@]1B4H=
M8-NG&.X =T<HZ;?C<A^YMX,'68GH#0X(+T_J;#/,N9X4R] P2._/."G!D*S7
M^ILCE 2P-Z.<!/KS%"6!_7N:FR"[ 34!B>S'Y";(+#7!*#,!-]GYB-0$V368
M"?8F7ZD)ME]/7,$&9P@68R%R$9$3&'4SX^_QF1V+SO3:PXU5\$AG&&INO*M=
M!L96@&&PO08DO\U-6!,$O&/M>4:96*RJ#8V@O8FW@D2O-H?>$KJ1N7E],"K5
MI-+JP?\#S6[K-8.^RGK7>P_#E(T%O-.:Y.7]DTQPV*DXF?W=FQS?R,J&46\P
M$,B!6@@CMK<GC6X(YF\V&PO>IRL[:KG]F/:3XI#4L7TE _'(2 YPQ@OH:OCC
MU>M$ Q./ Q?O.QNE*#DPBH:YGZ;DP<?/#]KPRS!UA6'364?ZER=/W9.F'-<F
M'I@9Z-:>6S.X:3GR G45T;92%-6 1L8L5JN&.JX71<U0/Y)%V5*_&KIQU72+
M:<<W3X[S%\(BW?:NJR/"^7"J/DS?(F$IVS+KCC,7+CP0@QMB8\)Y.1A1$B?D
M&UZ=);BE>)_!\5T46$H=[;438[1!9J! 0=]V5ZX#L_6L(JR^.8!D@].GZ!"'
MU@3N7<6X#7H06LGF)!$?Q$W<5(%:*IL&;BN7DHA+;0I@E K$<Z2X67$F8&\B
M?.6:MII7SE/=791OYG?[$QTMBR%IT87G.WU5'Y;U8JVP4+5)#/\M-Q(5;!9,
M]/34VWEQS8*ATA[46)@Z]QW+&VS^21!8_$.^K&)?;UXO;+]+DZI"&FNQ1#NT
MP;&^83FL_7='X,1RA>.7GMN('P78&I,+HD=(UY\GZ#<,B>A/8.-7F :.VEOZ
MU@;Q&!Y?<<GR]=_%O_P(:9(_G&7&%>W/?2?*-'Q,.^:VIE.N8::W %PQ>/(/
M\RA=!RA+2><.OA^2U%F5W&3"&%):1&\A&,X_6A97YP(Y[*IYVZ6]_#HTA[1<
M)4_9;<8\R+.-]IN/9%&Y'#X3HW.]AN=0317O\7\&8;H^B-,A\XYG;0I"=;FU
M:(S.,L:-1I']XY+07Q</8<*3N*K?$/1;>PHGI>^B996/,_; 8WN,8-Z43Q6$
M]PD5<<Q&>=))RA(6->7IP:/$?VUOYL ]\F2B07L[&R#(7'$M*!I_#NPJ?-[Y
MU>^_YE<_97[U^Z_YU3]5?O7;6Z15O)58;_0@LJ>O%?6]/G$BT?>JO>MN8S;8
M4'&S/95C,"PF-V2O4:.;V2=A-]R;[$AOF'TB=D-JG;&=WC#;C=W0N/*&]"_.
M3*=X#VF#<(= 53 77'V.] '$L^TSA%RTZ"P#K>6VR#[-(@^""V,C,N1T.E_V
M1HD30*,*'SC19"!E\Z]I8;A6N V9%#>!!/T*( W;>OHO(A+<KR]NR"BIR7ZP
M,D-&R9!.<HQ'<L@1N7WR>;!@T?YB*!1]ZMWW-TDO:7E[=^.>,D414MU^5J5K
M)G1LJ9;79CWB/Q_<A/)28)>>\S+[0,K+?&#S!Y;X""$FJ9%=4 ZCN,U .G?!
M,PCA&+W*WBN2ODPQ,FPG!BX2_<V&Y3XAD65:9C@XL&LW]&1$*T&?.4:9N8DM
M4\DM;X\N,]O*EIG@L=B;Q$06@P-P79)-<^*'&?Y1\R57G>HSZD'17M*1NFZV
M'8R(E6/@U",JQ6W!#O!P, J?RYKW\:+3,?/Y&MOKF^@%@O)C&U\ZV,[O21%"
MT20W)_@T@OM!_)ZL6#?0ZPV98=*4G_7*YY-'V3TW$<XX#?^QFX#]X>)R3,#A
MH]@F-)R#2Z9(>%>QV#_"EG"@(>##$TQ#M8L^>XDGV7_Y=8643B ICT#!4M$Z
M[I?S9O[DJ\PMSXN#(0 *GKFXXM@X&,C@.MC^E"WJ08J2H]JB<B$.^B=4%7>-
MO3<]O/?0J,>P;A_]+=5 [NKAN*J/SI/N]$QLI@Q?PO61&SAVB>J5;(=@J-DD
M1W;S8?![34M=I(DU'SP<Z;%[)SO>PA9 V5L/7': G("2U \;QYSYP0H7#(H[
MYC9A\&I,.RU#VOA<KGCUOGS[:P=U=-15O"#A N@\4 '*55Z2 4;>?:(2R&9@
MMJSMZ'TC2AB%%670L!"JL]+[FS.F@=U51@) <FXBQI%M1!K<$8J/U3='#DI-
MUAWA_A*KAY$!#NNC+<TW<+]>HH5:2NI OV[7:&]B%RG73)"*%Y/T))_(#_N$
MZ9_?HY\YJ[_I 8/81LK>7=:E9' ]'K/1G&&XQ/QE\$<7!9[)RC48]:I*)9N$
M27#J8?M2$F])*4CWT5L1\6V$;Z2X'QP]'(>?'$3A,K%J,M:^E#UUFH29&=V(
MYP4?LO:<;6TY.-$7(B5,7_*T&O!SERNC8^_8CLF5($"-,P7<KW"@L.B+JN"I
M"]A/^)WKF"LP,U2!MB,M'MXK-W)^12U5';*GPOVX@5+!&;:.SYK,52F2B%LA
M6U4<<YXZ,]5IST&O:M/G>\J0%VPE#Q.:#VQ=<(YA"7JNALG6?15FSPT?B2O=
M-9^]62^EZ3.WN4<V/BP47+6G%3Z'S@CJMU*4Y5;!SVY)[DEJ=Q3\>P]0,8P9
M$1\H^BHGMR+[V8ZB[X(["RUEH!MB5G=P#V.B=E8-<&M7C!9$.<T__=%9A<(F
MD;:DJ-W:43*-!%*6R"T?)5P"K">;H?505N?M:5<L8?'9ACBGX,2A,O[ >2G$
M4/68K0W<1/:<8B2R\.2 L,DU9H190[5PY)11B9EGD&%2TO+L.*^JSSNA^\/7
MA.ZG3.C^\$4E=&]@?OY.MNQ,;-F4F[4?(D%128$.HQA(4H6(NJ7AC3-"13K:
MJ2=S4XTJ;8%3K]J#@9N]S1-4+@6%3@?.(&M]!Y\B_ZBKD'V Z:M'9X]T?I]N
M^IG,/AELH*#H&'7R3EF%71B=3]9=A]_E,-@!&VQLLJJ3#Z9U?XV-(1\V*,!-
M/50RU;WWB?),ZNXH]<00[SPP__[ KOV7X$:7PRBB+^_"(/^6=@D7=9$]??*W
MX]<!E8D%X8(05!3J41"NR 8)%/R)F._)+E]/T9XE5YNPNTBE7=+AEVJJ<E!J
MZ Q.(\NQEY6BL;G.T?#8 !N504^-/2-/HH?FY8JZ4Q +^+!E@*H.46:4E*(3
MYG]!ECN/SJTM69W) HZ,><KAYUBS5NJZDM5-3@$X<12@K5U6*5QX7=DX#IM8
M6 ?"UI71"G0&CW+:$(1BJ1E"#3SR/_LU'/NF5 H=IT*T-0('.HUJ]*X8+\>.
MD6+'EAZ$:;^ HUSQ4<:\(1K"=(5ZIB'OM@TCT'K]4<)LRP6<)H4*SP+K='9_
M$"XDYUNBU\2+1 [GW@0IRQ=7^6B,('>XL<24'--OHK"N9@^Z"7_;!SB/WGG3
M7".': 1LG5MZ='#PZR3G$L(A^K-LOF@%]\%"QR=N X53<LAD6FT:LQ8)8T^6
MMG2H!H%N^YPO+/"R<.TG0KI/^OV:J9/+G6(ONAI;;]^$T^X+6A%$LJ0:8M?]
MP5:EBGR%//O[0;'#WXZ/7\6E#D*XP3YRP=TB>F+" \^YEIX.A#KLKL8$*731
M;WH*B,R!:L59JNF+-F;1GU$K"+$QPPW#32(M1[.@H=NYR,85#L>4.MAN"E(%
M=*.37+B>.-(Z+SH;=[)C!EAQ=VEBFV$"$YC"E++C;FR, :M"$*C]:?R#+/J^
M[Z7@?Y7\,@9'<!-CX#^7E2._#$56IY5VOQM<)_L8RT0I#NMKCO7K3^DIL?3=
M5&IL?92$24>M84NB?O@_:?MX:Y<JX:3-CHX4<9)[S )A,*2)X+KW42K6(@[V
MQX1]FS>"^ %P)S@B)> M@7WXWQ8EWF12=-M7I?B4>"PZH4  U8"V.^P:06!]
M%IOT<A#^I(7NG/7FCM?X.ZVF1%V^$("6B<"#[X:E_N@T%.>HKYR*XK-J"MDP
M]9Q8@SM90!L[+6;O3CL$%F*TJ>U^Q(#MJOK+SV_YA;;L4-* RBT1C2=]!-B$
MB@1V^]4L-FF^,49I76Q=61NH=!X]90=4P*B04)2AZL90>=DKG,0K&KXJ(8]=
M'5S6;CRCE(C)!^M-:E&Q<JD:.T!)J,B]#7 2TLH)KR2CJ+T<P<,[['B$!Y$/
M#C_]SJ=F!?[]#-(Y&Z3BD@>-XTP$G39TJ+ECZXATGC6%/!KKYI>==C8CK@(-
MF4NM7RBW(F?.KMIX38]<S_B :=N^T\@#BE+L(G(EAO?UD@_:-[J@-7?C@4T&
M!,&I:UU32:R6?S2Y?#L]SZ!CA]S!@PV58@ZF*+,5"J9Q%N>;/'93Z<:D-@-M
MRC"()IC/^>&T6) )#$8O(JL-_%."?7+M7\!@"BGCIU)%MA_@W5&3:;@HI/F)
M7IG'WJXE4N@"M_<$^^)I=?$KN$TI5Y1]?W3W$/[_>P\/[]T]X"1=P+^;#%H(
MP#W<7BI9W(F[ERD_2K>[USU#Z4IT.4-8L'A:=+3FLI18+4KZT0OQ.5@$^.:M
MC63$.MN(E_=S//"Y9N:9&PDV&E/J;RDT%[WI.1PS4(D#T^N_-R"\P_X?WBV2
MPBJ2I8)O&7$VLNI_"("'HO98Z1H<KC'[!8:TQK1&?"NGHUF!KNH'G@>BWM&T
MT0+AY HIE>7 @4SAF/TP/!>1VZO3=8U!Q*8*8ZIL:,"2O"!]=0G2<K@ ?4BL
M,\Z\&.E+I4B\>]\=CX2(\<WN6T=/4_M[$&!X8PQ<BOV*PI^$KR[F\YI(1M6\
M+HQ]*U=!VQG>+-?9QB"[E4<2-FQU]GGG9H_N?DW.?LKD[-'=+RH[^^<JMV6#
M]_0@>UR\0R:4&@->O[W),Q#S*(A%WTAQ@V#]'S=#A1L144(ME?S_VL+%<%P6
MYST^C&LQ,9".NI+">#,-J%'-@OHUSG>\%&0TWBR*<[Q^C-B'A?0%5U71(8$/
MWDU/JEE%% 7WC_+LWMU[#^B;\!_WL[I/76$!^\EQTZP=J!^'^ SS(F =_3??
M6/JVL9?E'#3 %&:Y=NT2U9O#<@X?[Z$Z2$93,Z-:LV%!J=@/E#[[>L,[:>02
M(N>8'Z3+9TQ#+&7H"<M%;)'9?A#QQ,ZY::HF%QX 66$ID[(O&%=0G4D1G37Q
M!)JYS4;2K$4W+>"B/GSY?E%=<:IUCNW[[B7(9L(O4VQX$!#;X,=]"4F8LP/)
MU=61086^'',_;R*$B7B58ADH+:MHB_2R%7>H%]'&GNLS(7)CPSIGZO 4$-.U
M A'C.*I2-*Q0X[+B8B]).QT><;Y>G'H,)!G0(?NH:S^Y-Q'Z@8M*IV:">%KY
M9UIGR'>B!21B;GP^4<)WYJ?#QR>2,,SS._CMUM=&M.>X[9PYQV2W99@RU1Z@
MD<1>[;/[<.#P_3_<_3:]W)R)&<2WB1\-]5F?VP0;3J#/X^!#6 <R4K7CV--]
M4IP_<L4))B/\#,,/41G@$G/*3"7IBOY$C6S8#-OF<?#MP?*[[G>&1<<HYYYB
MQ@W3_XEWZ<*W0S'>(3B!/4(%*UQF[ZIJZ1"6'-+A\EV-Z0C;IEQ%M2NQQ^^X
M)]5:Y69NFYD6O$4= D'O5,+O2,69UO7 Z#VS&S@/7(K-*XV<7#&ODBYBY]Q,
M?\""2'\RZC0G8*R,V6UZPC]T*3^*J6W*^0GD*ZCA6E+SXLJU00!96G>*<T5N
M#ZSL+WR#3EI/+-@DTB^W!=SZL3$+A627\,-%E@[TR9[1,P,2$@KGU[V&JIV<
M)XDC<BZZW[1-A.5;1>^@F([P2R&LPO9[HK*]56J?4G?$5MLN&<?>-4V;,Y=
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MJ:'6WP3DA7NO(XO#]  ?M &<+8H:T<R.@+XERECFH735'<("HF&.A?0,QTR
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MQ8&R#"Z'S?A9NR@*+@A>X!+7VT9?>"9;7?$ %$9WW\9Z1!D2NVM:.GP]"&_
MZK1I\8?H76H&=(-T\28B\-BGL&Q,"#7BHPXR.\/%7BP*14PA,*FG_R9LDA;F
MTOW4'!+1-[4Q]F %7G.6ZEW6K.:MTH(2>A3RQL^+BY:S6-K3.,=.U(*I\L#1
M'5IX;6KMZI&/\A"6OD5=76B#;P\_9GT;J%O5BI0=M<J0<WE.%F"AO)*)2'F_
M8$[T>]Q:(<#T<["$S[V/^UZSP<X.'(AD1(Y4*/!O&"MFLO#A)88MK=!3DM;H
M=)D)1!W#" %2/3>MN>GZI#MU<# -5SN<A+,UK#F"0Q><3R\%Q\23LV!O$N/_
M@/7<KN72>U_/"!ZV8L9#3"X7/9D'2[C,UJM"(&I478_L(MLNNFB/4D41C[2;
MW$5EU5&YJ1!DJ=>!6C/>I'6FCC><6+$K)Z#?F;U)HBS$W/P#&\&; :XB24<^
M"F3O3(OX4<RM!5RF0!>^+SL)&17?YPYVAGC4=B7ET"'F![=\ %[M*LK66L0R
MN+Q@2>! Z.],&8W"].'R<8V"?>D A<AV">0G2O?-A<]\>KG]2+L.N<T?B$H^
M$)36M,T.Z_6W<Y!]  O29YV$?O@U"?U)D] /OR:A_P!)Z'OWM+'?\W-V&)$8
M"G-P,X/<)"-A#/T3PWYR9Z-K_"K7:#09FAJBV=HA \N2=N(8HBODE-#3Q1QC
M$.):"YM/#/,3B-^VUZ-%C"J>R\:6<"V O0WZCQC'<N621&0;6#O@27$$2;JI
M.UZP&;8,*;5[$,6>6ZS1F)'#,%?THS2S18>,@FE*4I8)H-(]F/RVL (E*-0[
M8(>Y'/[2K B#7W6(-(R:QI,SN-T,64J=(HN/KO]Z"9_0_:IFGTPH7OK9&8BI
MYH:U+X1@%^&[_UX7?7TH_R[7JZM4D4VB'E$C[O!TV-R*> F#%@\[,;T]<DT:
M.X-ZRT5X+5I,:)=[UY6+2AO:$&G)56RA("FHWLNFLQ561. M,$?$H)T1JEY#
MQ"X"[(Z0%GNVLW=(B8@?;.TT WLD+Z!=X5=H!R];0S*,I%^_W%VRTF&U.QD_
M>)YO;9&':,/4*J>7EYV(D?6E(W"]]<VNL;SD$^$C!<!W6^M[<:!AFU0\;U-^
MO4#6_,9GMH-.1]BMF)>VO' FLONF-(T1K$#0S#S-!6X.!=)^=LZDGU9--<?N
MWL'1")T5=P+@-SXU$N)/&4GI]FP.-OO"T""*2"C#6,@OIB5OU)BR*EFU2:4/
M*6XMTI&FHS@#_&H>-MX4K2JZSX4$N?T<E[;,%VP,Z=4!.A^+58IL!A=W>\[
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M_FL!<[UH^SN@4@Z_O_L0-/_]!X</'MZ_=_0H>_;Z\-NC@SR+D\$[I=@XC.0
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MFYS9O UH.ZFLYGP#E:?S:L985$C7FYY'ICD8 BS"F!JQ^3C"&\:CA^#@J,+
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M/UU)=>S4%N%K4".?/6L\T0U2P.L"U?V>"MC>3%(=QO2\.%42W9=4/F#.O0D
M.!V>5ABD_/M!ZC"Q%*$4F#NR;/IB42W!&C[-+&65-1"JV%M=H16#0NAXA?^B
M $PC2*NL+6V#FP_%26]IP;=-/F"9,D_TJ,:VG_D#+7-<SZEGY*!M5)$FF=L
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M'(5=A*VM%<,L7Z]I/*$(< D/OT#X2VYY]>CW4"KAQ<BZ5$H;MCIVTL^NFT<
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MX:#!;WR&]80)UJEMB=5?:7WSX/'>>0[=BBECI0;]+KMLH290,^0GFN'/2C&
MPXVI^.CF4)^6([-<O= O2)8:,\]:>Q),HIQY"6(BY/^V>#,6G9HZ:"K\<N&
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M9\W;]MJ,WT-[MO.LW(P5.XO86CJ*P4G5KM?$'J%?X5D?$=<X8E.([4.IO<T
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M(]T/>UW,7?R)%6! _II(FJ"4QB9Y4Z(RR[G R*P;E*A9+854%7YVBJ%>A"%
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M(0%5$P''[8JB1EB;+P>[^WY93?)BN:*:EJ:=9OEB4"7(XL;0U#:'OF^RX B
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M'!E$@JM9LK68KNID6HX<.M?LM_$,0JIT4U<P&R.\IG'IZ"8F'#B"YRY%ZX#
MQ #GI=)PX$2NC3&!'??6=A$U%>)G?#/PR6N8"D54Q1?1UFD2'F8)0K>K(&1
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MVR<:2Z10*@52UX9MBT"01YAYT7B9LL$V9?='D=15R66Y,K8?*,%-\-MDC[.
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M<!P?!OVB6CJ?W= G<YZLEF;?G '["I730[4"#K!\V[1-NLSU5$K)&GDZVL0
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M($LXJRM.\/;%>[D<?9(L9NS- G.$KT R-L. 7E!_/8:E,^-LM^ QS7/KQ;2
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MAN9NK.".T_[/VR8\RZ>4MS:O,*F$"F6EE^I)=>Z]/5A":Y#=+'*!A*21%Y[
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M]*E$=CT5=E1490?'$FO!$N^/#6'V)@&D,Q$CJNQ/HNQV=W1QO%RK'ODFA?T
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M^1^ZO-LKUV)9X, 5O;(V8E!N-5A)[CS+VKK*0E9SBPG%RWK>K[_IF4D">8&
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M@83RCR;^[@A_%S[_&RF,$U\Y_@0#R4\2%#[07YX.V" P^U&\7&;I-)YD2=3
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M&../^';JM'5@Y)3=,-W_VTBD#B^($D1:9HNDAF6IX!6\$7CQ0<*K[0?*=;S
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M;4@B*+J-/V%\D3[>#/+W].V5%NL.[?05^XM73E+8(NN-1V#D05^' _)ZG8+
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M0>TLQ%RN,:+M@$'QK,\3N8N23\L$>J_=2L[TX(72E$PYA5(KESFEPX&N]^'
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MI=LP!M_XQ2 !"B0QTMBVM/SV1B?HD&9%'\%'CY@O2NOOZ:;",RCR$;65M,:
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M%KASF>APH\DS8O-22I7NOIL!C)TE&M4SDBI54S+S&6-5>D9)78[[#)A@MG1
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MW^Z]N7*,WE7F!'P[B-XC ]&C.#7,C@ZCB]?^\^CGUPL8=:CD+$ EU&8+J/X
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M$@W0I$CBZ@[E<MZ&_?U1]O>'I?"?:S5%.;^]C*DON,76H&1386?+OO0B)ZX
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M88<?D%%[* F[TDEJUPZL$HG9?-[;?"R3'"H4H:Y@5&4HMR(,.*X";HG9$RB
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M,(ND+$T5&+X_:J(KDQ "<ZIM4H#)*OR%AO%(EQF1PB.$X4=KG2G#\2>3&+,
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MZ>1D4J< L;*_LU&LU6KUK>W:G(0$_W-?AAZ"#5H44V*5I'TB@7;W/X[+''\
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MH$)"4?Q6*949\*1% 4K >U[$B>/ /P'3A%7+OX?VA,1<O;WJN)H,A*S-F@G
MC^E=W?!-5SA&P1'Y-)+SF(+D*+=!SWOP]XOH*S'A>_'A:E.UWMJT.$M\;-)4
MR=418;'8M=RXZ:J:K8+VS<9@Z)XFOC>'KJ<)4!?FCUV68+YDA#Y2*_T,@;F!
MI3(JTIQ2]0<]Q05DU-K J]<HC+'J(.D94 9JWBH9-L3X+C"MS:J%<KU>V-K8
MTO(9,LP+38@ M&B1X7'-RDYI9^?WR<CK1%@3JXKP+AY]G "<' /E- CST"[3
MY!U ^J93[);<D3=+5F3&(?3 IOAC;D(%81DX%FR0"BO35Q6NE8X@90W.@I:5
M37,$A.&(4)9Z$?JI<E$4ZCF1\+MH0(MH@"HY4.A(@&'WX1C0V(]B]0]<@J66
M(%5\@Q5C71'I,381M4:%DY@X*A1Q G=J\=;=>Z@I/0)P2+7D8<UNO;JU%1?M
M%J+V0VBLP$M>,M&G$#DU;7,8#%$/1-X !JG5R819PYDDEZG"U=+'*?<^L068
M %;4([<XOW@FN0F9L,"L?$UHUVHATZ,0D&[E/+2IGM 56U^2T5U55Z;-)DU+
M.IH01BTGIY3( C#*N$N*B<0%E@IE^22QB>H4A^KX1LGC6TUW1U G?4*EEWV-
M6AQLUFN;J\;:6IX *H!99NF!O .AG 2*6]R!95[F+(4E;%CHWVOWR/]+&PXO
M3^.$!FH?! SH2N#F8#54=.W93'.T9..8;?%T^950=6#R[K,6>?[XG2/6$XK
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MX*W<D?6N8XSQSX$_M/;_'U!+ P04    " "Q@#U;9/CA"R<#  #E"P  $0
M '-O;FTM,C R-3 Y,CDN>'-DM5;;<MHP$'WO3/]!];MOI$D#@63:9))A DD&
MFDO[TA'V AIDR95D(/GZ2KYP,Q"@+4_R[CEG=[V[,O6+:431&(0DG#4LW_$L
M!"S@(6&#AO78M;]V+YM-"UV<?_R ]*_^R;;1-0$:UM 5#^PFZ_,S=(<CJ*$;
M8""PXN(,/6&:& N_)A0$NN113$&!=F21:NC$J?20;>\@^P0LY.*QTYS)#I6*
M9<UU)Y.)P_@83[@822?@T6Z"7855(F=JWM3+?[O1VT0&,W+UI!W++],.>1D
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M&O: *2@'7S<"=3=3T\<_4$L#!!0    ( +& /5N/A<!E-PL  ":)   5
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M%"VE:RX JR8:ABPH.NS>0$ JN5]&'CBF62('L%Y(VE+GIQN V=:IAZ$+BA/
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M+3$N:'1M4$L! A0#%     @ L8 ]6\DR>K:\60  :?4!  H
M ( !LO\  &5X,3 M,BYH=&U02P$"% ,4    " "Q@#U;FQD-8L,C  #5 P$
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7;%!+!08     !@ & &X!  #MDP$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sonm-20250929.xsd" xlink:type="simple"/>
    <context id="AsOf2025-09-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
        </entity>
        <period>
            <startDate>2025-09-29</startDate>
            <endDate>2025-09-29</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-09-29" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-09-29" id="Fact000004">0001178697</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-09-29" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-09-29" id="Fact000010">2025-09-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-09-29" id="Fact000011">Sonim Technologies, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-09-29" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-09-29" id="Fact000013">001-38907</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-09-29" id="Fact000014">94-3336783</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-09-29" id="Fact000015">4445 Eastgate Mall</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-09-29" id="Fact000016">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-09-29" id="Fact000017">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-09-29" id="Fact000018">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-09-29" id="Fact000019">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-09-29" id="Fact000020">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-09-29" id="Fact000021">378-8100</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName contextRef="AsOf2025-09-29" id="Fact000022">Not applicable.</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications contextRef="AsOf2025-09-29" id="Fact000023">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-09-29" id="Fact000024">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-09-29" id="Fact000025">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-09-29" id="Fact000026">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-09-29" id="Fact000027">Common     Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-09-29" id="Fact000028">SONM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-09-29" id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-09-29" id="Fact000030">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
